JMP (JMP) 10-Q 4 May 17 2017 Q1 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	3 Months Ended
	Mar. 31, 2017	Apr. 28, 2017
Document Information [Line Items]
Entity Registrant Name	JMP GROUP LLC
Entity Central Index Key	1,302,350
Trading Symbol	jmp
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Entity Common Stock, Shares Outstanding (in shares)		21,673,824
Document Type	10-Q
Document Period End Date	Mar. 31, 2017
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	Q1
Amendment Flag	false

Condensed Consolidated Statemen

Condensed Consolidated Statements of Financial Condition (Current Period Unaudited) - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016
Cash and cash equivalents	$ 81,235	$ 85,492
Restricted cash	67,133	227,656
Receivable from clearing broker	6,051	6,586
Investment banking fees receivable, net of allowance for doubtful accounts of $80 and zero at March 31, 2017 and December 31, 2016, respectively	8,122	5,681
Marketable securities owned, at fair value	20,558	18,722
Incentive fee receivable	242	499
Other investments (includes $19,989 and $21,459 measured at fair value at March 31, 2017 and December 31, 2016, respectively)	30,279	32,869
Loans held for sale	1,437	32,488
Loans held for investment, net of allowance for loan losses of $1,155 and $443 at March 31, 2017 and December 31, 2016, respectively	1,157	1,930
Total loans, net	610,955	654,127
Interest receivable	2,549	3,429
Cash collateral posted for total return swap	25,940	25,000
Fixed assets, net	2,863	3,143
Deferred tax assets	7,942	7,942
Other assets	14,725	20,266
Total assets	881,188	1,125,830
Marketable securities sold, but not yet purchased, at fair value	5,206	4,747
Accrued compensation	8,520	36,158
Asset-backed securities issued	613,354	825,854
Interest payable	5,769	6,317
Bond payable (net of debt issuance costs of $1,937 and $2,042 at March 31, 2017 and December 31, 2016, respectively)	91,890	91,785
Deferred tax liability	2,653	3,872
Other liabilities	25,056	21,803
Total liabilities	752,448	990,536
Commitments and Contingencies
Common shares, $0.001 par value, 100,000,000 shares authorized; 22,780,052 shares issued at both March 31, 2017 and December 31, 2016; 21,659,239 and 21,457,054 shares outstanding at March 31, 2017 and December 31, 2016, respectively	23	23
Additional paid-in capital	136,246	135,945
Treasury shares at cost, 1,120,813 and 1,322,998 shares at March 31, 2017 and December 31, 2016, respectively	(6,608)	(7,792)
Accumulated deficit	(15,487)	(8,799)
Total JMP Group LLC shareholders' equity	114,174	119,377
Nonredeemable Non-controlling Interest	14,566	15,917
Total equity	128,740	135,294
Total liabilities and equity	881,188	1,125,830
Total assets	881,188	1,125,830
Total liabilities	752,448	990,536
Variable Interest Entity (VIE) or Potential VIE, Information Unavailability [Member]
Restricted cash	63,391	225,777
Loans held for sale	1,437	32,488
Total loans, net	610,955	654,127
Interest receivable	1,447	2,180
Other assets	117	178
Total assets	677,347	914,750
Asset-backed securities issued	613,354	825,854
Interest payable	4,368	4,580
Other liabilities	1,316	1,192
Total liabilities	619,038	831,626
Total assets	677,347	914,750
Total liabilities	$ 619,038	$ 831,626

Condensed Consolidated Stateme3

Condensed Consolidated Statements of Financial Condition (Current Period Unaudited) (Parentheticals) - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016
Cash on deposit with clearing broker	$ 250	$ 250
Allowance for doubtful accounts	80	0
Investments at Fair Value	19,989	21,459
Loans held for investment, allowance	1,155	433
Loans collateralizing asset-backed securities issued, allowance	7,095	6,540
Asset-backed securities issued, net of debt issuance costs	2,988	3,271
Bond payable, net of debt issuance costs	$ 1,937	$ 2,042
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, authorized (in shares)	100,000,000	100,000,000
Common stock, issued (in shares)	22,780,052	22,780,052
Common stock, outstanding (in shares)	21,659,239	21,457,054
Treasury shares (in shares)	1,120,813	1,322,998

Condensed Consolidated Stateme4

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Thousands		3 Months Ended
		Mar. 31, 2017	Mar. 31, 2016
Revenues
Investment banking		$ 13,600	$ 18,296
Brokerage		5,286	6,095
Asset management fees		5,911	9,326
Principal transactions		(1,893)	930
Gain (loss) on sale and payoff of loans		847	(376)
Gain on repurchase of asset-backed securities issued		210
Net dividend income		266	263
Other income		445	226
Non-interest revenues		24,672	34,760
Interest income		9,067	12,401
Interest expense		(8,095)	(7,975)
Net interest income	[1]	972	4,426
Provision for loan losses		(1,266)	(631)
Total net revenues after provision for loan losses		24,378	38,555
Non-interest expenses
Compensation and benefits		21,798	27,425
Administration		1,819	1,818
Brokerage, clearing and exchange fees		759	761
Travel and business development		915	1,291
Communications and technology		1,053	1,016
Occupancy		1,111	936
Professional fees		1,162	1,073
Depreciation		311	332
Other		677	621
Total non-interest expenses		29,605	35,273
Net income (loss) before income tax expense		(5,227)	3,282
Income tax expense (benefit)		(1,084)	50
Net income (loss)		(4,143)	3,232
Less: Net income attributable to nonredeemable non-controlling interest		597	1,429
Net income (loss) attributable to JMP Group LLC		$ (4,740)	$ 1,803
Net income (loss) attributable to JMP Group LLC per common share:
Basic (in dollars per share)		$ (0.22)	$ 0.08
Diluted (in dollars per share)		(0.22)	0.08
Distributions declared per common share (in dollars per share)		$ 0.09	$ 0.12
Weighted average common shares outstanding:
Basic (in shares)		21,573	21,349
Diluted (in shares)		21,573	21,865
[1]	The Net Interest Income adjustment is comprised of the non-cash net amortization of liquidity discounts at JMP Credit, due to scheduled contractual repayments, and amortization expense related to an intangible asset.

Condensed Consolidated Stateme5

Condensed Consolidated Statements of Changes in Equity (Unaudited) - USD ($) shares in Thousands, $ in Thousands	Common Stock [Member]	Treasury Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Nonredeemable Noncontrolling Interest [Member]	Total
Balance (in shares) at Dec. 31, 2015	22,780
Balance at Dec. 31, 2015	$ 23	$ (6,763)	$ 135,003	$ (3,151)	$ 27,782	$ 152,894
Net income (loss)				1,803	1,429	3,232
Additonal paid-in capital - share-based compensation			1,020			1,020
Distributions and distribution equivalents declared on common shares and restricted share units				(2,615)		(2,615)
Purchases of shares of common shares for treasury		(2,629)				(2,629)
Reissuance of shares of common shares from treasury		45				45
Distributions to non-controlling interest holders					(1,704)	(1,704)
Balance (in shares) at Mar. 31, 2016	22,780
Balance at Mar. 31, 2016	$ 23	(9,347)	136,023	(3,963)	27,507	150,243
Balance (in shares) at Dec. 31, 2016	22,780
Balance at Dec. 31, 2016	$ 23	(7,792)	135,945	(8,799)	15,917	135,294
Net income (loss)				(4,740)	597	(4,143)
Additonal paid-in capital - share-based compensation			301			301
Distributions and distribution equivalents declared on common shares and restricted share units				(1,948)		(1,948)
Purchases of shares of common shares for treasury		(184)				(184)
Reissuance of shares of common shares from treasury		1,368				1,368
Distributions to non-controlling interest holders					(2,040)	(2,040)
Capital contributions from non-controlling interest holders					92	92
Balance (in shares) at Mar. 31, 2017	22,780
Balance at Mar. 31, 2017	$ 23	$ (6,608)	$ 136,246	$ (15,487)	$ 14,566	$ 128,740

Condensed Consolidated Stateme6

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Cash flows from operating activities:
Net income (loss)	$ (4,143)	$ 3,232
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Provision for doubtful accounts	90
Provision for loan losses	1,266	631
Accretion of deferred loan fees	(840)	(360)
Amortization of liquidity discount, net		(36)
Amortization of debt issuance costs	105	117
Amortization of original issue discount, related to CLO II and CLO III	702	598
Interest paid in kind		(53)
(Gain) loss on sale and payoff of loans	(1,027)	376
Gain on repurchase of bonds payable and asset-backed securities issued	(210)	(87)
Change in other investments:
Income from investments in equity method investees	690	(283)
Fair value on other equity investments	1,462	(97)
Realized loss on other investments	(371)	(19)
Depreciation and amortization of fixed assets	311	332
Share-based compensation expense	780	1,242
Deferred income taxes	(1,219)	(1,480)
Net change in operating assets and liabilities:
Decrease in interest receivable	880	39
Increase in receivables	(1,739)	(1,915)
Decrease (increase) in marketable securities	(1,836)	1,055
Decrease (increase) in restricted cash (excluding restricted cash reserved for lending activities)	944	337
Decrease in deposits and other assets	(8,675)	4,586
Increase in marketable securities sold, but not yet purchased	459	89
Increase in interest payable	(548)	434
Increase in accrued compensation and other liabilities	(24,518)	(24,201)
Net cash used in operating activities	(37,437)	(15,463)
Cash flows from investing activities:
Purchases of fixed assets	(31)	(72)
Purchases of other investments	(990)	(2,779)
Sales of other investments	9,364	11,694
Funding of loans collateralizing asset-backed securities issued	(50,122)	(52,181)
Funding of loans held for sale	(2,752)
Sale and payoff of loans collateralizing asset-backed securities issued	111,743	53,698
Principal receipts on loans collateralizing asset-backed securities issued	16,728	15,861
Net change in restricted cash reserved for lending activities	159,579	(6,090)
Net changes in cash collateral posted for derivative transactions	(940)	(240)
Net cash provided by investing activities	242,579	19,891
Cash flows from financing activities:
Repurchase of bonds payable		(385)
Repayment of asset-backed securities issued	(206,202)	(11,824)
Distributions and distribution equivalents paid on common shares and RSUs	(1,954)	(2,616)
Net cash settlement of RSU vesting	889	(2,629)
Capital contributions of nonredeemable non-controlling interest holders	92
Distributions to non-controlling interest shareholders	(2,040)	(1,704)
Employee taxes paid on shares withheld for tax-withholding purposes	(184)
Net cash used in financing activities	(209,399)	(19,158)
Net decrease in cash and cash equivalents	(4,257)	(14,730)
Cash and cash equivalents, beginning of period	85,492	68,551
Cash and cash equivalents, end of period	81,235	53,821
Supplemental disclosures of cash flow information:
Cash paid during the period for interest	8,991	7,317
Cash paid during the period for taxes	2
Non-cash investing and financing activities:
Reissuance of shares of common share from treasury related to vesting of restricted share units and exercises of share options	1,368	45
Distributions declared but not yet paid	$ 650	$ 849

Note 1 - Organization and Descr

Note 1 - Organization and Description of Business	3 Months Ended
	Mar. 31, 2017
Notes to Financial Statements
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	1. JMP Group LLC, together with its subsidiaries (collectively, the “Company”), is a diversified capital markets firm headquartered in San Francisco, California. The Company conducts its brokerage business through JMP Securities LLC (“JMP Securities”), its asset management business through Harvest Capital Strategies LLC (“HCS”), HCAP Advisors LLC (“HCAP Advisors”), JMP Asset Management LLC (“JMPAM”), JMP Realty I LLC (“JMP Realty”), and JMP Credit Advisors LLC (“JMPCA”), and certain principal investments through JMP Investment Holdings LLC (“JMP Investment Holdings”), JMP Realty Trust Inc., and JMPCA. The above entities, other than HCAP Advisors, are wholly-owned subsidiaries. JMP Securities is a U.S. registered broker-dealer under the Securities Exchange Act of 1934, 1940, third 2016 January 2015

Note 2 - Summary of Significant

Note 2 - Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2017
Notes to Financial Statements
Significant Accounting Policies [Text Block]	2. Basis of Presentation These condensed consolidated financial statements and related notes are unaudited and have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10 10 10 December 31, 2016 The consolidated accounts of the Company include the wholly-owned subsidiaries, JMP Securities, HCS, JMPCA, JMP Investment Holdings, JMPCA TRS, JMP Asset Management Inc., JMP Realty Trust Inc., and the partially-owned subsidiaries CLO I, CLO II, CLO III and HCAP Advisors. All material intercompany accounts and transactions have been eliminated in consolidation. Non-controlling interest on the Consolidated Statements of Financial Condition at March 31, 2017 December 31, 2016 third See Note 2

Note 3 - Recent Accounting Pron

Note 3 - Recent Accounting Pronouncements	3 Months Ended
	Mar. 31, 2017
Notes to Financial Statements
New Accounting Pronouncements and Changes in Accounting Principles [Text Block]	3. ts Accounting Standards Updates (“ASU”) 2014 09, 2015 14, 2016 10 2016 12 , Revenue from Contracts with Customers (Topic 606), 2016 08, Principal versus Agent Considerations (Topic 606) were issued in May 2014, August 2015, April 2016, May 2016 March 2016, December 15, 2017, 2014 09, December 15, 2016. ASU 2016 01, Recognition and Measurement of Financial Assets and Financial Liabilities (Subtopic 825 10) January 2016. may December 15, 2017, 2016 01 ASU 2016 02, Leases (Topic 842) February 2016 2016 02 December 15, 2018. ASU 2016 07, Simplifying the Transition to the Equity Method of Accounting (Topic 323) March 2016. December 15, 2016, 2016 07 ASU 2016 09, Improvements to Employee Share-Based Payment Accounting (Topic 718) March 2016 December 31, 2016. 2016 09 ASU 2016 13, Measurement of Credit Losses on Financial Instruments (Topic 326), June 2016 December 31, 2019. 2016 13 may ASU 2016 15, Classification of Certain Cash Receipts and Cash Payments (Topic 230), August 2016 eight zero The amendments in this standard are effective for fiscal years beginning after December 15, 2017, 2016 15 ASU 2016 16, Income Taxes (Topic 740) October 2016 December 15, 2017 ASU 2016 18, Statement of Cash Flows (Topic 230) December 15, 2017 ASU 2017 01, Business Combinations (Topic 805) December 15, 2017 December 15, 2018 December 15, 2019.

Note 4 - Fair Value Measurement

Note 4 - Fair Value Measurements	3 Months Ended
	Mar. 31, 2017
Notes to Financial Statements
Fair Value Disclosures [Text Block]	4. The following tables provide fair value information related to the Company’s financial instruments at March 31, 2017 December 31, 2016: At March 31, 2017 (In thousands) Carrying Value Fair Value Level 1 Level 2 Level 3 Total Assets: Cash and cash equivalents $ 81,235 $ 81,235 $ - $ - $ 81,235 Restricted cash and deposits 67,133 67,133 - - 67,133 Marketable securities owned 20,558 20,558 - - 20,558 Other investments 12,420 - 12,420 - 12,420 Other investments measured at net asset value (1) 17,859 - - - - Loans held for investment, net of allowance for loan losses 1,157 - - 1,270 1,270 Loans collateralizing asset-backed securities issued, net of allowance for loan losses 610,955 - 610,948 - 610,948 Cash collateral posted for total return swap 25,940 25,940 - - 25,940 Total assets: $ 837,257 $ 194,866 $ 623,368 $ 1,270 $ 819,504 Liabilities: Marketable securities sold, but not yet purchased $ 5,206 $ 5,206 $ - $ - $ 5,206 Asset-backed securities issued 613,354 - 621,785 - 621,785 Total return swap 140 - 140 - 140 Bond payable 91,890 - 94,803 - 94,803 Total liabilities: $ 710,590 $ 5,206 $ 716,728 $ - $ 721,934 At December 31, 2016 (In thousands) Carrying Value Fair Value Level 1 Level 2 Level 3 Total Assets: Cash and cash equivalents $ 85,492 $ 85,492 $ - $ - $ 85,492 Restricted cash and deposits 227,656 227,656 - - 227,656 Marketable securities owned 18,722 18,722 - - 18,722 Other investments 13,697 - 13,697 - 13,697 Other investments measured at net asset value (1) 19,172 - - - - Loans held for sale 32,488 - 33,651 33,651 Loans held for investment, net of allowance for loan losses 1,930 - - 1,824 1,824 Loans collateralizing asset-backed securities issued, net of allowance for loan losses 654,127 - 685,392 - 685,392 Cash collateral posted for total return swap 25,000 25,000 - - 25,000 Total assets: $ 1,078,284 $ 356,870 $ 732,740 $ 1,824 $ 1,091,434 Liabilities: Marketable securities sold, but not yet purchased $ 4,747 $ 4,747 $ - $ - $ 4,747 Asset-backed securities issued 825,854 - 831,854 - 831,854 Bond payable 91,785 - 94,517 - 94,517 Total liabilities: $ 922,386 $ 4,747 $ 926,371 $ - $ 931,118 (1) In accordance with ASC 820 10, Recurring Fair Value Measurement The following tables provide information related to the Company’s assets and liabilities carried at fair value on a recurring basis at March 31, 2017 December 31, 2016: (In thousands) March 31, 2017 Carrying Value Level 1 Level 2 Level 3 Total Marketable securities owned 20,558 $ 20,558 $ - $ - $ 20,558 Other investments: Investments in hedge funds managed by HCS 12,420 - 12,420 - 12,420 Investments in private equity funds managed by HCS (1) 4,045 . . - - Investments in funds of funds managed by HCS (1) 5 - - - - Total investment in funds managed by HCS (1) 16,470 - 12,420 - 12,420 Limited partnership in investments in private equity/ real estate funds (1) 3,519 - - - - Total other investments 19,989 - 12,420 - 12,420 Total assets: 40,547 $ 20,558 $ 12,420 $ - $ 32,978 Marketable securities sold, but not yet purchased 5,206 5,206 - - 5,206 Total return swap 140 - 140 - 140 Total liabilities: 5,346 $ 5,206 $ 140 $ - $ 5,346 (In thousands) December 31, 2016 Carrying Value Level 1 Level 2 Level 3 Total Marketable securities owned 18,722 $ 18,722 $ - $ - $ 18,722 Other investments: Investments in hedge funds managed by HCS 12,444 - 12,444 - 12,444 Investments in private equity funds managed by HCS (1) 4,227 . . - - Investments in funds of funds managed by HCS (1) 5 - - - - Total investment in funds managed by HCS (1) 16,676 - 12,444 - 12,444 Limited partnership in investments in private equity/ real estate funds (1) 3,530 - - - - Total return swap 1,253 1,253 1,253 Total other investments 21,459 - 13,697 - 13,697 Total assets: $ 40,181 $ 18,722 $ 13,697 $ - $ 32,419 Marketable securities sold, but not yet purchased 4,747 4,747 - - 4,747 Total liabilities: $ 4,747 $ 4,747 $ - $ - $ 4,747 (1) In accordance with ASC 820 10, Transfers between levels of the fair value hierarchy result from changes in the observability of fair value inputs used in determining fair values for different types of financial assets and are recognized at the beginning of the reporting period in which the event or change in circumstances that caused the transfer occurs. The Company’s Level 2 2 The investments in private equity funds managed by HCS and JMPAM are recognized using the fair value option. The Company uses the reported net asset value per share as a practical expedient to estimate the fair value of the funds. The risks associated with these investments are limited to the amounts of invested capital, remaining capital commitment and any management and incentive fees receivable. The Company uses the reported net asset value per share as a practical expedient to estimate the fair value of HGC, HGC II and JMPRP. The Company holds a limited partner investment in a private equity fund, managed by a third third As of March 31, 2017 December 31, 2016, Redemption Redemption Fair Value at Unfunded Commitments Dollars in thousands Frequency Notice Period March 31, 2017 December 31, 2016 March 31, 2017 December 31, 2016 Investments in Funds of Funds managed by HCS (1) N/A N/A $ 5 $ 5 $ - $ - Limited partner investments in private equity/ real estate funds Nonredeemable N/A $ 3,519 $ 3,530 $ - $ - Investment in private equity funds managed by HCS Nonredeemable N/A $ 4,045 $ 4,227 $ 1,085 $ 1,085 (1) Investments in Funds of Funds managed by HCS began the process of liquidation on December 31, 2015. Non-recurring Fair Value Measurements The Company's assets that are measured at fair value on a non-recurring basis result from the application of lower of cost or market accounting or write-downs of individual assets. As of March 31, 2017 December 31, 2016, $2.9 $1.9 March 31, 2017 2016, $1.0 zero, Loans Held for Investment At March 31, 2017 December 31, 2016, four Effective July 1, 2013, $2.0 10% July 1, 2018. 2016, $0.4 March 31, 2017 December 31, 2016, $1.0 $1.2 $1.7 $0.4 $1.1 $1.6 March 31, 2017 December 31, 2016, Investments at Cost On April 5, 2011, $0.3 December 31, 2015, $1.7 $1.7 first 2016, $0.1 $0.5 second 2016, $6.0 On November 16, 2015, $2.0 three March 31, 2016, $0.1 $0.2 September 26, 2016, $0.1 On December 2, 2015, $12.8 March 31, 2016, $0.1 $0.1 September 26, 2016, 21.6% $0.4 March 31, 2017 December 31, 2016, $9.3 $10.8 Derivative Financial Instruments In the second 2015, tenor 36 18 18 December 31, 2016, March 31, 2017, three March 31, 2017 2016, $1.3 $0.1 $0.1 $1.3 March 31, 2017 December 31, 2016, $25.0 first 2017, $0.9 $25.9 may May 2018.

Note 5 - Loans Collateralizing

Note 5 - Loans Collateralizing Asset-backed Securities Issued and Loans Held for Sale	3 Months Ended
	Mar. 31, 2017
Notes to Financial Statements
Loans Collateralizing Asset Backed Securities Issued and Loans Held for Sale [Text Block]	5 . Loans Collateralizing Asset-backed Securities Issued Loans collateralizing asset-backed securities issued and loans held for sale are commercial loans securitized and owned by the Company’s CLOs. The loans consist of those loans within the CLO securitization structure at the acquisition date of CLO I and loans purchased by the CLOs subsequent to the CLO I acquisition date. In the fourth 2016, March 31, 2017 December 31, 2016: (In thousands) Loans Collateralizing Asset-backed Securities Loans Held for Sale March 31, 2017 December 31, 2016 March 31, 2017 December 31, 2016 Outstanding principal $ 624,130 $ 667,237 $ 1,454 $ 33,748 Allowance for loan losses (7,095 ) (6,540 ) - - Liquidity discount - - - (772 ) Deferred loan fees, net (6,080 ) (6,570 ) (17 ) (308 ) Valuation allowance N/A N/A - (180 ) Total loans, net $ 610,955 $ 654,127 $ 1,437 $ 32,488 Loans recorded upon the acquisition of CLO I at fair value reflect a liquidity discount. The table below summarizes the activity in the loan principal, allowance for loan losses, liquidity discount, deferred loan fees, and the carrying value for the loans as of and for the three March 31, 2017 2016: (In thousands) Three Months Ended March 31, 2017 Principal Allowance for Loan Losses Liquidity Discount Deferred Loan Fees Carrying Value, Net Impaired Loans Balance at beginning of period $ 3,113 $ (937 ) $ - $ (249 ) $ 1,927 Repayments (44 ) - - - (44 ) Accretion of discount - - - (1 ) (1 ) Provision for loan losses - (971 ) - - (971 ) Transfers to/from non-impaired loans, net 1,947 - - (3 ) 1,944 Balance at end of period $ 5,016 $ (1,908 ) $ - $ (253 ) $ 2,855 Non-impaired Loans Balance at beginning of period $ 664,124 $ (5,603 ) $ - $ (6,321 ) $ 652,200 Purchases 50,733 - - (611 ) 50,122 Repayments (14,900 ) - - - (14,900 ) Accretion of discount - - - 526 526 Provision for loan losses - 416 - - 416 Sales and payoff (78,896 ) - - 576 (78,320 ) Transfers to/from impaired loans, net (1,947 ) - - 3 (1,944 ) Balance at end of period $ 619,114 $ (5,187 ) $ - $ (5,827 ) $ 608,100 (In thousands) Three Months Ended March 31, 2016 Principal Allowance for Loan Losses Liquidity Discount Deferred Loan Fees Carrying Value, Net Non-impaired Loans Balance at beginning of period $ 984,110 $ (5,397 ) $ (918 ) $ (8,130 ) $ 969,665 Purchases 53,409 - - (1,228 ) 52,181 Repayments (15,997 ) - - 136 (15,861 ) Accretion of discount - - 36 360 396 Provision for loan losses - (631 ) - - (631 ) Sales and payoff (54,371 ) - - 297 (54,074 ) Balance at end of period $ 967,151 $ (6,028 ) $ (882 ) $ (8,565 ) $ 951,676 Allowance for Loan Losses A summary of the activity in the allowance for loan losses for loans collateralizing asset-backed securities for the three March 31, 2017 2016 (In thousands) Three Months Ended March 31, 2017 2016 Balance at beginning of period $ (6,540 ) $ (5,397 ) Provision for loan losses: Specific reserve (971 ) - General reserve 416 (631 ) Balance at end of period $ (7,095 ) $ (6,028 ) Impaired Loans, Non-Accru al, Past Due Loans and Restructured Loans A loan is considered to be impaired when, based on current information, it is probable that the Company will be unable to collect all amounts due in accordance with the contractual terms of the original loan agreement, including scheduled principal and interest payments. As of March 31, 2017 December 31, 2016, $4.8 $2.9 $613.3 $657.8 March 31, 2017 December 31, 2016, $1.4 $32.5 As of March 31, 2017 December 31, 2016, March 31, 2017 December 31, 2016: (In thousands) Recorded Investment Unpaid Principal Balance Related Allowance Average Recorded Investment Interest Income Recognized March 31, 2017 Impaired loans with an allowance recorded $ 4,763 $ 5,158 $ 1,908 $ 4,779 $ 25 Impaired loans with no related allowance recorded - - - - - $ 4,763 $ 5,158 $ 1,908 $ 4,779 $ 25 December 31, 2016 Impaired loans with an allowance recorded $ 2,864 $ 3,211 $ 938 $ 2,913 $ 75 Impaired loans with no related allowance recorded - - - - - $ 2,864 $ 3,211 $ 938 $ 2,913 $ 75 Loans are considered past due if the required principal and interest payments have not been received as of the date such payments were due. No March 31, 2017 December 31, 2016. March 31, 2017 December 31, 2016, not Credit Quality of Loans The Company’s management, at least on a quarterly basis, reviews each loan and evaluates the credit quality of the loan. The review primarily includes the following credit quality indicators with regard to each loan: 1) 2) 3) 4) March 31, 2017 December 31, 2016: (In thousands) Cash Flow Loans Loans Held for Sale - Cash Flow March 31, December 31, March 31, December 31, 2017 2016 2017 2016 Moody's rating: Baa1 - Baa3 $ 10,467 $ 12,145 $ - $ 6,769 Ba1 - Ba3 109,954 137,717 - 13,957 B1 - B3 449,911 467,125 1,437 11,377 Caa1 - Caa3 44,899 37,913 - 565 Ca - 2,903 - - C 1,319 - - - Not Rated 1,500 2,864 - - Total: $ 618,050 $ 660,667 $ 1,437 $ 32,668 Internal rating: (1) 2 $ 528,737 $ 545,181 $ - $ 27,109 3 66,320 94,407 1,437 5,559 4 18,230 18,215 - - 5 4,763 2,864 - - Total: $ 618,050 $ 660,667 $ 1,437 $ 32,668 Performance: Performing $ 613,285 $ 657,803 $ 1,437 $ 32,668 Non-Performing 4,765 2,864 - - Total: $ 618,050 $ 660,667 $ 1,437 $ 32,668 (1) Loans with an internal rating of 4 The Company determined the fair value of loans collateralizing asset-backed securities to be $610.9 $685.4 March 31, 2017 December 31, 2016, 2 $1.4 $33.7 March 31, 2017 December 31, 2016,

Note 6 - Debt

Note 6 - Debt	3 Months Ended
	Mar. 31, 2017
Notes to Financial Statements
Debt Disclosure [Text Block]	6 . Debt Bond Payable In January 2013, $46.0 8.00% “2013 January 2014, $48.3 7.25% “2014 2013 January 15, 2023 may January 15, 2016, 8.00% January 15, April 15, July 15 October 15 2014 January 15, 2021, may January 15, 2017, 7.25% January 15, April 15, July 15 October 15 April 15, 2014. The 2013 2014 eight 25% may The Senior Notes are general unsecured senior obligations, must rank equally with all existing and future senior unsecured indebtedness and are senior to any other indebtedness expressly made subordinate to the notes. The notes will be effectively subordinated to all of JMP Group Inc.’s existing and future secured indebtedness (to the extent of the value of the assets securing such indebtedness) and structurally subordinated to all existing and future liabilities of our subsidiaries, including trade payables. JMP Group Inc., as a wholly owned subsidiary of JMP Group LLC, is the primary obligor of the Senior Notes. In connection with the Reorganization Transaction, on January 1, 2015, In February 2016, $0.5 $0.4 $0.1 The Company incurred no three March 31, 2017 2016. March 31, 2017 December 31, 2016, $1.9 $2.0 As of March 31, 2017 As of December 31, 2016 Principal Unamortized Discount and Debt Issuance Costs Principal Unamortized Discount and Debt Issuance Costs 7.25% Senior Notes $ 47,922,500 $ 939,979 $ 47,922,500 $ 1,001,956 8.00% Senior Notes $ 45,905,250 $ 997,297 $ 45,905,250 $ 1,040,347 Note Payable and Lines of Credit As of March 31, 2017 December 31, 2016, The Company’s Credit Agreement (the “Credit Agreement”), dated as of August 3, 2006, $25.0 two April 30, 2017. 3.75% first two 5.00% two August 24, 2017. $5.0 zero March 31, 2017 December 31, 2016. JMP Securities holds a $20.0 0.25% May 6, 2016, April 26, 2016, $20.0 one May 6, 2017, no March 31, 2017 December 31, 2016. The Credit Agreement contains financial and other covenants, including, but not limited to, limitations on debt, liens and investments, as well as the maintenance of certain financial covenants. A violation of any one March 31, 2017 December 31, 2016,

Note 7 - Asset-backed Securitie

Note 7 - Asset-backed Securities Issued	3 Months Ended
	Mar. 31, 2017
Notes to Financial Statements
Asset Backed Securities Issued [Text Block]	7 . Asset-backed Securities Issued CLO I On May 17, 2007, $500.0 $455.0 $45.0 six 94.0% $13.8 ($2.0 $4.1 $7.7 March 31, 2017 December 31, 2016. The reinvestment period for CLO I ended in May 2013. fourth 2016, first 2017 The below table list the notes outstanding as of December 31, 2016. no March 31, 2017. (In millions) As of December 31, 2016 Notes Originally Issued Net Outstanding Balance Interest Rate Spread to LIBOR Ratings (Moody's /S&P) Class A Senior Secured Floating Rate Revolving Notes due 2021 $ 72.2 $ 72.2 0.26% - 0.29% Aaa/AAA Class B Senior Secured Floating Rate Notes due 2021 30.0 30.0 0.50% Aaa/AAA Class C Senior Secured Deferrable Floating Rate Notes due 2021 35.0 35.0 1.10% Aaa/AAA Class D Secured Deferrable Floating Rate Notes due 2021 34.0 34.0 2.40% Aa1/A+ Class E Secured Deferrable Floating Rate Notes due 2021 30.0 30.0 5.00% Baa1/BB+ Total secured notes sold to investors $ 201.2 $ 201.2 Unsecured subordinated notes due 2021 45.0 45.0 Total notes for the CLO I offering $ 246.2 $ 246.2 Consolidation elimination N/A (58.7 ) Total asset-backed securities issued N/A $ 187.5 The secured notes and subordinated notes are limited recourse obligations payable solely from cash flows of the CLO I loan portfolio and related collection and payment accounts pledged as security. Payment on the Class A- 1 2 1 2 December 31, 2016, The activity in the note principal for the three March 31, 2017 2016 (In thousands) Three Months Ended March 31, 2017 2016 Balance at beginning of period $ 187,417 $ 293,457 Repayments (187,417 ) (11,444 ) Asset-backed securities at end of period $ - $ 282,013 CLO II On April 30, 2013, $343.8 $320.0 $23.8 72.8% first 2014, $6.0 third 72.8% 98.0%. $7.0 March 2017. $7.0 March 31, 2017 December 31, 2016. (In millions) As of March 31, 2017 Notes Originally Issued Outstanding Principal Balance Issuance Discount Net Outstanding Balance Interest Rate Spread to LIBOR Ratings (S&P) Class X Senior Secured Floating Rate Notes due 2016 $ 3.8 $ - $ - $ - 1.00 % AAA Class A Senior Secured Floating Rate Notes due 2023 217.6 198.8 (0.4 ) 198.4 1.18 % AAA Class B Senior Deferrable Floating Rate Notes due 2023 34.0 34.0 (0.2 ) 33.8 1.75 % AA Class C Senior Deferrable Floating Rate Notes due 2023 17.0 17.0 (0.3 ) 16.7 2.75 % A Class D Senior Deferrable Floating Rate Notes due 2023 18.7 18.7 (0.9 ) 17.8 3.85 % BBB Class E Senior Deferrable Floating Rate Notes due 2023 18.7 18.7 (1.5 ) 17.2 5.25 % BB Class F Senior Deferrable Floating Rate Notes due 2023 10.2 10.2 (1.3 ) 8.9 5.75 % B Total secured notes sold to investors $ 320.0 $ 297.4 $ (4.6 ) $ 292.8 Unsecured subordinated notes due 2023 23.8 23.8 (0.3 ) 23.5 Total notes for the CLO II offering $ 343.8 $ 321.2 $ (4.9 ) $ 316.3 Consolidation elimination N/A (30.8 ) 0.3 (30.5 ) Total CLO II asset-backed securities issued N/A $ 290.4 $ (4.6 ) $ 285.8 (In millions) As of December 31, 2016 Notes Originally Issued Outstanding Principal Balance Issuance Discount Net Outstanding Balance Interest Rate Spread to LIBOR Ratings (S&P) Class X Senior Secured Floating Rate Notes due 2016 $ 3.8 $ - $ - $ - 1.00 % AAA Class A Senior Secured Floating Rate Notes due 2023 217.6 217.6 (0.5 ) 217.1 1.18 % AAA Class B Senior Deferrable Floating Rate Notes due 2023 34.0 34.0 (0.2 ) 33.8 1.75 % AA Class C Senior Deferrable Floating Rate Notes due 2023 17.0 17.0 (0.4 ) 16.6 2.75 % A Class D Senior Deferrable Floating Rate Notes due 2023 18.7 18.7 (1.0 ) 17.7 3.85 % BBB Class E Senior Deferrable Floating Rate Notes due 2023 18.7 18.7 (1.6 ) 17.1 5.25 % BB Class F Senior Deferrable Floating Rate Notes due 2023 10.2 10.2 (1.2 ) 9.0 5.75 % B Total secured notes sold to investors $ 320.0 $ 316.2 $ (4.9 ) $ 311.3 Unsecured subordinated notes due 2023 23.8 23.8 (0.3 ) 23.5 Total notes for the CLO II offering $ 343.8 $ 340.0 $ (5.2 ) $ 334.8 Consolidation elimination N/A (23.8 ) 0.3 (23.5 ) Total CLO II asset-backed securities issued N/A $ 316.2 $ (4.9 ) $ 311.3 The Secured Notes and Subordinated Notes are limited recourse obligations payable solely from cash flows of the CLO II loan portfolio and related collection and payment accounts pledged as security. Payment on the Class X notes rank equal, or pari-passu, in right of payment with payments on the Class A notes and payment on the Class X and Class A notes rank senior in right of payment to the other Secured Notes and the Subordinated Notes. Payment on the Class B, Class C, Class D, Class E and Class F notes generally rank subordinate in right of payment to any other class of notes which has an earlier alphabetical designation. The Subordinated Notes are subordinated in right of payment to all other classes of notes and accrue interest. Interest on the Secured Notes is paid quarterly at a per annum rate equal to LIBOR plus the applicable spread set forth in the table above. Payment of interest on the Class C, Class D, Class E and Class F notes is payable only to the extent proceeds are available under the applicable payment priority provisions. To the extent proceeds are not so available, interest on the Class C, Class D, Class E and Class F notes will be deferred. The Secured Notes are secured by the CLO II loan portfolio and the funds on deposit in various related collection and payment accounts. The terms of the debt securitization subject the loans included in the CLO II loan portfolio to a number of collateral quality, portfolio profile, interest coverage and overcollateralization tests. The CLO II notes recorded at fair value upon the issuance of CLO II in April 2013 three March 31, 2017 2016 (In thousands) Three Months Ended March 31, 2017 Three Months Ended March 31, 2016 Principal Issuance Discount Net Principal Issuance Discount Net Balance at beginning of period $ 316,200 $ (4,915 ) $ 311,285 $ 316,960 $ (5,960 ) $ 311,000 Repayments (18,785 ) - (18,785 ) (380 ) - (380 ) Amortization of discount - 295 295 - 255 255 Balance at end of period $ 297,415 $ (4,620 ) $ 292,795 $ 316,580 $ (5,705 ) $ 310,875 CLO III On September 30, 2014, $370.5 $332.1 $38.4 46.7% March 31, 2017 December 31, 2016. March 31, 2017 December 31, 2016. (In millions) As of March 31, 2017 Notes Originally Issued Outstanding Principal Balance Issuance Discount Net Outstanding Balance Interest Rate Spread to LIBOR Ratings (Moody's/Fitch) Class A Senior Secured Floating Rate Notes due 2025 $ 228.0 $ 228.0 $ (0.5 ) $ 227.5 1.24 % Aaa/AAA Class B Senior Deferrable Floating Rate Notes due 2025 41.7 41.7 (0.6 ) 41.1 1.80 % Aa1/NR Class C Senior Deferrable Floating Rate Notes due 2025 22.5 22.5 (0.5 ) 22.0 2.60 % A1/NR Class D Senior Deferrable Floating Rate Notes due 2025 21.6 21.6 - 21.6 3.90 % Baa3/NR Class E Senior Deferrable Floating Rate Notes due 2025 18.3 18.3 - 18.3 7.10 % Ba3/NR Total secured notes sold to investors $ 332.1 $ 332.1 $ (1.6 ) $ 330.5 Unsecured subordinated notes due 2025 38.4 38.4 (4.5 ) 33.9 Total notes for the CLO III offering $ 370.5 $ 370.5 $ (6.1 ) $ 364.4 Consolidation elimination N/A (38.4 ) 4.5 (33.9 ) Total CLO III asset-backed securities issued N/A $ 332.1 $ (1.6 ) $ 330.5 (In millions) As of December 31, 2016 Notes Originally Issued Outstanding Principal Balance Issuance Discount Net Outstanding Balance Interest Rate Spread to LIBOR Ratings (Moody's Fitch) Class A Senior Secured Floating Rate Notes due 2025 $ 228.0 $ 228.0 $ (0.5 ) $ 227.5 1.53 % Aaa/AAA Class B Senior Deferrable Floating Rate Notes due 2025 41.7 41.7 (0.7 ) 41.0 2.05 % Aa2/NR Class C Senior Deferrable Floating Rate Notes due 2025 22.5 22.5 (0.5 ) 22.0 2.90 % A2/NR Class D Senior Deferrable Floating Rate Notes due 2025 21.6 21.6 - 21.6 5.10 % Baa3/NR Class E Senior Deferrable Floating Rate Notes due 2025 18.3 18.3 - 18.3 7.35 % Ba3/NR Total secured notes sold to investors $ 332.1 $ 332.1 $ (1.7 ) $ 330.4 Unsecured subordinated notes due 2025 38.4 38.4 (4.5 ) 33.9 Total notes for the CLO III offering $ 370.5 $ 370.5 $ (6.2 ) $ 364.3 Consolidation elimination N/A (38.4 ) 4.5 (33.9 ) Total CLO III asset-backed securities issued N/A $ 332.1 $ (1.7 ) $ 330.4 The Secured Notes and Subordinated Notes are limited recourse obligations payable solely from cash flows of the CLO III loan portfolio and related collection and payment accounts pledged as security. Payment on the Class A notes rank senior in right of payment with payments on the Class B notes and payment on the Class A and Class B notes rank senior in right of payment to the other Secured Notes and the Subordinated Notes. Payment on the Class C, Class D and Class E notes generally rank subordinate in right of payment to any other class of notes which has an earlier alphabetical designation. The Subordinated Notes are subordinated in right of payment to all other classes of notes and accrue interest. Interest on the Secured Notes is paid quarterly at a per annum rate equal to LIBOR plus the applicable spread set forth in the table above. Payment of interest on the Class C, Class D and Class E notes is payable only to the extent proceeds are available under the applicable payment priority provisions. To the extent proceeds are not so available, interest on the Class B, Class C, Class D and Class E notes will be deferred. The Secured Notes are secured by the CLO III loan portfolio and the funds on deposit in various related collection and payment accounts. The terms of the debt securitization subject the loans included in the CLO III loan portfolio to a number of collateral quality, portfolio profile, interest coverage and overcollateralization tests. The Notes were recorded at fair value upon the issuance of CLO III in September 2014, three March 31, 2017 2016 (In thousands) Three Months Ended March 31, 2017 Three Months Ended March 31, 2016 Principal Issuance Discount Net Principal Issuance Discount Net Balance at beginning of period $ 332,100 $ (1,676 ) $ 330,424 $ 332,100 $ (2,165 ) $ 329,935 Amortization of discount - 124 124 - 121 121 Balance at end of period $ 332,100 $ (1,552 ) $ 330,548 $ 332,100 $ (2,044 ) $ 330,056 Interest on Asset Backed Securities Total interest expense related to the asset-backed securities issued for the three March 31, 2017 $6.2 $5.5 $0.7 three March 31, 2016 $6.1 $5.5 $0.6 March 31, 2017 December 30, 2016, $4.0 $4.6 Fair Value of Asset Backed Securities The Company determined the fair value of asset-backed securities issued to be $621.8 $831.9 March 31, 2017 December 31, 2016, 2

Note 8 - Shareholders' Equity

Note 8 - Shareholders' Equity	3 Months Ended
	Mar. 31, 2017
Notes to Financial Statements
Stockholders' Equity Note Disclosure [Text Block]	8 . Share holders’ Equity Share Repurchase Program On February 13, 2017, 1,000,000 December 31, 2017. no first 2017, 1,000,000 March 31, 2017. The timing and amount of any future open market share repurchases will be determined by the Company’s management based on its evaluation of market conditions, the relative attractiveness of other capital deployment activities, regulatory considerations and other factors. Any open market share repurchase activities will be conducted in compliance with the safe harbor provisions of Rule 10b 18 may 10b5 1 may may

Note 9 - Share-based Compensati

Note 9 - Share-based Compensation	3 Months Ended
	Mar. 31, 2017
Notes to Financial Statements
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]	9 . Share-Based Compensation The JMP Group LLC Amended and Restated Equity Incentive Plan (“JMP Group Plan”) authorized the issuance of 4,000,000 may 2004 2004 2,960,000 2004 Share Options The following table summarizes the share option activity for the three March 31, 2017: Three Months Ended March 31, 2017 Shares Subject Weighted Average to Option Exercise Price Balance, beginning of year 2,710,000 $ 6.53 Exercised (145,000 ) 6.24 Balance, end of period 2,565,000 $ 6.54 Options exercisable at end of period 2,565,000 $ 6.54 The following table summarizes the share options outstanding as well as share options vested and exercisable as of March 31, 2017: March 31, 2017 Options Outstanding Options Vested and Exercisable Weighted Weighted Average Weighted Average Weighted Range of Remaining Average Aggregate Remaining Average Aggregate Exercise Number Contractual Exercise Intrinsic Number Contractual Exercise Intrinsic Prices Outstanding Life in Years Price Value Exercisable Life in Years Price Value $6.05 - $7.33 2,565,000 2.26 $ 6.54 $ 1,500 2,565,000 2.26 $ 6.54 1,500 The Company recognizes share-based compensation expense for share options over the vesting period using the straight-line method. The Company recognized compensation expense related to share options of $0.1 $0.2 three March 31, 2017 2016, As of March 31, 2017, no The Company recognized current income tax benefits of $11 March 31, 2017. no three March 31, 2016. not The Company uses the Black-Scholes option-pricing model or other quantitative models to calculate the fair value of option awards. Restricted Share Units and Restricted Shares On February 7, 2017, 117,000 2016 50% December 1, 2017 50% December 1, 2018, 153,000 50% December 1, 2017, 50% December 1, 2018. December 1, 2019. March 16, 2017, 58,000 one three The following table summarizes RSU activity for the three March 31, 2017: Three Months Ended March 31, 2017 Restricted Weighted Average Share Units Grant Date Fair Value Balance, beginning of year 646,558 $ 5.14 Granted 328,797 6.08 Vested (79,842 ) 7.11 Forfeited (31,071 ) 4.10 Balance, end of period 864,442 $ 5.35 The aggregate fair value of RSUs vested during the three March 31, 2017 2016 $0.5 $38 three March 31, 2017 2016, $14 $14 The Company recognizes compensation expense for RSUs over the vesting period using the accelerated attribution method when they are subject to graded vesting and on a straight-line basis when they are subject to cliff vesting. For the three March 31, 2017 2016, $0.7 $1.0 For the three March 31, 2017 2016, $0.4 $0.4 March 31, 2017, $2.6 1.14 The Company pays cash distribution equivalents on certain unvested RSUs. Distribution equivalents paid on RSUs are generally charged to retained earnings. Distribution equivalents paid on RSUs expected to be forfeited are included in compensation expense. The Company accounts for the tax benefit related to distribution equivalents paid on RSUs as an increase in additional paid-in capital. Share Appreciation Rights The following table summarizes the SARs activity for the three March 31, 2017: Three Months Ended March 31, 2017 Share Appreciation Weighted Average Rights Exercise Price Balance, beginning of year 2,580,000 $ 7.33 Forfeited (95,000 ) 7.33 Balance, end of period 2,485,000 $ 7.33 The following table summarizes the share options outstanding as well as share options vested and exercisable as of March 31, 2017: March 31, 2017 Options Outstanding Weighted Average Weighted Range of Remaining Average Aggregate Exercise Number Contractual Exercise Intrinsic Prices Outstanding Life in Years Price Value $7.33 - $7.33 2,485,000 2.75 $ 7.33 $ - The Company recognizes compensation expense for SARs over the vesting period, through monthly mark to market of adjustments to the liability award. For the three March 31, 2017 2016, $17 $39 For the three March 31, 2017 2016, $4 $15 March 31, 2017, $0.3 0.75

Note 10 - Net Income (Loss) Per

Note 10 - Net Income (Loss) Per Common Share	3 Months Ended
	Mar. 31, 2017
Notes to Financial Statements
Earnings Per Share [Text Block]	10. (Loss) per Common Share Basic net income (loss) per share for the Company is calculated by dividing net income (loss) by the weighted average number of common shares outstanding for the reporting period. Diluted net income (loss) per share is calculated by adjusting the weighted average number of outstanding shares to reflect the potential dilutive impact as if all potentially dilutive share options or RSUs were exercised or converted under the treasury share method. However, for periods that the Company has a net loss, the effect of outstanding share options or RSUs is anti-dilutive and, accordingly, is excluded from the calculation of diluted loss per share. The computations of basic and diluted net income per share for the quarters ended March 31, 2017 2016 (In thousands, except per share data) Three Months Ended March 31, 2017 2016 Numerator: Net income (loss) attributable to JMP Group, LLC $ (4,740 ) $ 1,803 Denominator: Basic weighted average shares outstanding 21,573 21,349 Effect of potential dilutive securities: Restricted share units - 516 Diluted weighted average shares outstanding 21,573 21,865 Net income (loss) per share Basic $ (0.22 ) $ 0.08 Diluted $ (0.22 ) $ 0.08 In the table above, for the quarter ended March 31, 2016, zero Share options to purchase zero 2,779,286 March 31, 2017 2016, Restricted share units for 169,639 481,010 March 31, 2017 2016,

Note 11 - Employee Benefits

Note 11 - Employee Benefits	3 Months Ended
	Mar. 31, 2017
Notes to Financial Statements
Pension and Other Postretirement Benefits Disclosure [Text Block]	11 . Employee Benefits All full-time employees of the Company are eligible to participate in the JMP Group 401(k) three may 100% 401(k) 3% 50% 3% 5%. 100% 401(k) $0.9 $1.0 three March 31, 2017 2016,

Note 12 - Income Taxes

Note 12 - Income Taxes	3 Months Ended
	Mar. 31, 2017
Notes to Financial Statements
Income Tax Disclosure [Text Block]	12. JMP Group LLC qualifies as a partnership for United States federal income tax purposes. The consolidated entities of the Company consist of wholly-owned corporate subsidiaries and entities treated as partnerships for U.S. income tax purposes. Income earned by the corporate subsidiaries is subject to U.S. federal and state income taxation. Income earned by the non-corporate subsidiaries is not subject to U.S. federal and state corporate income tax. These amounts are allocated to JMP Group LLCs’ partners. For the three March 31, 2017 2016, $1.1 $0.1 20.8% 1.5% three March 31, 2017 2016, For financial reporting purposes, the Company’s effective tax rate used for the interim periods is based on the estimated full-year income tax rate. The effective tax rate differs from the statutory rate primarily due to the following: (i) a portion of the reported pre-tax income is attributable to non-controlling interests held in the Company’s consolidated entities by third The Company recognizes deferred tax assets and liabilities in accordance with ASC 740,

Note 13 - Commitments and Conti

Note 13 - Commitments and Contingencies	3 Months Ended
	Mar. 31, 2017
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	13 . Commitments and Contingencies The Company leases office space in California, Illinois, Georgia, Massachusetts, Minnesota, New York, and Florida under various operating leases. Occupancy expense for the quarters ended March 31, 2017 2016 $1.1 $0.9 $49 $0.1 March 31, 2017 2016, Minimum Future Lease Commitments Year Ending December 31, 2017 $ 3,542 2018 4,777 2019 3,984 2020 2,568 2021 2,553 Thereafter 10,020 Total Lease Commitments $ 27,444 In connection with its underwriting activities, JMP Securities enters into firm commitments for the purchase of securities in return for a fee. These commitments require JMP Securities to purchase securities at a specified price. Securities underwriting exposes JMP Securities to market and credit risk, primarily in the event that, for any reason, securities purchased by JMP Securities cannot be distributed at anticipated price levels. Settlement of transactions relating to such underwriting commitments, which were open at March 31, 2017 December 31, 2016, The marketable securities owned and the restricted cash, as well as the cash held by the clearing broker, may $0.3 March 31, 2017 December 31, 2016. may Unfunded commitments are agreements to lend to a borrower, provided that all conditions have been met. The Company had unfunded commitments to lend $3.9 March 31, 2017. December 31, 2016, $20.7 $1.5 $34.0 March 31, 2017 December 31, 2016, $5.9 March 31, 2017, $2.9 December 31, 2016, $9.3 $7.8 March 31, 2017 December 31, 2016, $3.2 March 31, 2017, $18.5 December 31, 2016,

Note 14 - Regulatory Requiremen

Note 14 - Regulatory Requirements	3 Months Ended
	Mar. 31, 2017
Notes to Financial Statements
Regulatory Capital Requirements under Banking Regulations [Text Block]	14 . Regulatory Requirements JMP Securities is subject to the SEC’s Uniform Net Capital Rule (Rule 15c3 1), 15 1. $30.4 $29.7 $29.3 $28.6 $1.1 March 31, 2017 December 31, 2016, 0.54 1 0.56 1 March 31, 2017 December 31, 2016, Since all customer transactions are cleared through another broker-dealer on a fully disclosed basis, JMP Securities is not required to maintain a separate bank account for the exclusive benefit of customers in accordance with Rule 15c3 3

Note 15 - Related Party Transac

Note 15 - Related Party Transactions	3 Months Ended
	Mar. 31, 2017
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	15 . Related Party Transactions The Company earns base management fees and incentive fees from serving as investment advisor for various entities, including corporations, partnerships limited liability companies, and offshore investment companies. The Company also owns an investment in most of such affiliated entities. As of March 31, 2017 December 31, 2016, $26.6 $27.8 $16.5 $17.3 $10.1 $10.5 from these affiliated entities were $4.0 $4.1 March 31, 2017 2016, $1.9 $5.2 three March 31, 2017 2016, March 31, 2017 December 31, 2016, $0.2 $0.5

Note 16 - Guarantees

Note 16 - Guarantees	3 Months Ended
	Mar. 31, 2017
Notes to Financial Statements
Guarantees [Text Block]	16 . Guarantees JMP Securities has agreed to indemnify its clearing broker for losses that the clearing broker may may March 31, 2017 December 31, 2016 three March 31, 2017 2016, March 31, 2017 December 31, 2016. The Company is engaged in various investment banking and brokerage activities whose counterparties primarily include broker-dealers, banks and other financial institutions. In the event counterparties do not fulfill their obligations, the Company may

Note 17 - Litigation

Note 17 - Litigation	3 Months Ended
	Mar. 31, 2017
Notes to Financial Statements
Legal Matters and Contingencies [Text Block]	17 . Litigation The Company may The Company reviews the need for any loss contingency reserves and establish reserves when, in the opinion of management, it is probable that a matter would result in liability and the amount of loss, if any, can be reasonably estimated. Generally, given the inherent difficulty of predicting the outcome of matters the Company is involved in, particularly cases in which claimants seek substantial or indeterminate damages, it is not possible to determine whether a liability has been incurred or to reasonably estimate the ultimate or minimum amount of that liability until the case is close to resolution. For these matters, no reserve is established until such time, other than for reasonably estimable legal fees and expenses. Management, after consultation with legal counsel, believes that the currently known actions or threats will not result in any material adverse effect on the Company’s financial condition, results of operations or cash flows.

Note 18 - Financial Instruments

Note 18 - Financial Instruments with Off-balance Sheet Risk, Credit Risk or Market Risk	3 Months Ended
	Mar. 31, 2017
Notes to Financial Statements
Concentration Risk Disclosure [Text Block]	18 . Financial Instruments with Off-Balance Sheet Risk, Credit Risk or Market Risk The majority of the Company’s transactions, and consequently the concentration of its credit exposure, is with its clearing broker. The clearing broker is also a significant source of short-term financing for the Company, which is collateralized by cash and securities owned by the Company and held by the clearing broker. The Company’s securities owned may The Company is also exposed to credit risk from other brokers, dealers and other financial institutions with which it transacts business. In the event that counterparties do not fulfill their obligations, the Company may The Company’s trading activities include providing securities brokerage services to institutional clients. To facilitate these customer transactions, the Company purchases proprietary securities positions (“long positions”) in equity securities. The Company also enters into transactions to sell securities not yet purchased (“short positions”), which are recorded as liabilities on the Consolidated Statements of Financial Condition. The Company is exposed to market risk on these long and short securities positions as a result of decreases in market value of long positions and increases in market value of short positions. Short positions create a liability to purchase the security in the market at prevailing prices. Such transactions result in off-balance sheet market risk as the Company’s ultimate obligation to satisfy the sale of securities sold, but not yet purchased, may In connection with the CLOs, the Company is party to financial instruments with off-balance sheet risk in the normal course of business to meet the financing needs of its customers. These financial instruments include unfunded commitments to lend and standby letters of credit. The instruments involve, to varying degrees, elements of credit and interest rate risk in excess of the amount recognized in the consolidated balance sheet of the Company. Unfunded commitments are agreements to lend to a borrower, provided that all conditions have been met. Commitments generally have fixed expiration dates or other termination clauses and may may Standby letters of credit are conditional commitments issued by the Company to guarantee the performance by a borrower to a third $20.7 December 31, 2016 $1.5 $34.0 March 31, 2017 December 31, 2016, $5.9 March 31, 2017, $2.9 December 31, 2016, $9.3 $7.8 March 31, 2017 December 31, 2016, $3.2 March 31, 2017, $18.5 December 31, 2016,

Note 19 - Business Segments

Note 19 - Business Segments	3 Months Ended
	Mar. 31, 2017
Notes to Financial Statements
Segment Reporting Disclosure [Text Block]	19. The Company’s business results are categorized into the following three Management uses operating Net Income as a key metric when evaluating the performance of JMP Group’s core business strategy and ongoing operations. This measure adjusts the Company’s net income as follows: (i) reverses non-cash share-based compensation expense related to historical equity awards granted in prior periods, (ii) recognizes 100% may The Company’s segment information for the quarters ended March 31, 2017 2016 • Revenues and expenses directly associated with each segment are included in determining segment operating income. • Revenues and expenses not directly associated with a specific segment are allocated based on the most relevant measures applicable, including revenues, headcount and other factors. • Each segment’s operating expenses include: a) compensation and benefits expenses that are incurred directly in support of the segments and b) other operating expenses, which include expenses for premises and occupancy, professional fees, travel and entertainment, communications and information services, equipment and indirect support costs (including compensation and other operating expenses related thereto) for administrative services. • Assets directly associated with each segment are allocated to the respective segment. One exception is depreciable assets, which are held at the Corporate segment. The associated depreciation is allocated to the related segment. Segment Operating Results Management believes that the following information provides a reasonable representation of each segment’s contribution to revenues, income and assets: (In thousands) Three Months Ended March 31, 2017 2016 Broker-Dealer Non-interest revenues $ 18,890 $ 24,391 Total net revenues after provision for loan losses $ 18,890 $ 24,391 Non-interest expenses 18,561 21,999 Segment operating pre-tax net income $ 329 $ 2,392 Segment assets $ 48,498 $ 67,044 Asset Management Non-interest revenues $ 5,311 $ 10,176 Total net revenues after provision for loan losses $ 5,311 $ 10,176 Non-interest expenses 5,095 9,442 Segment operating pre-tax net income $ 216 $ 734 Segment assets $ 17,581 $ 28,956 Corporate Non-interest revenues $ 3,499 $ 1,003 Net interest income 15 2,371 Provision for loan losses (1,413 ) 12 Total net revenues after provision for loan losses $ 2,101 $ 3,386 Non-interest expenses 5,284 4,299 Segment operating pre-tax net income $ (3,183 ) $ (913 ) Segment assets $ 1,139,774 1,481,249 Eliminations Non-interest revenues $ (1,041 ) $ (1,337 ) Total net revenues after provision for loan losses $ (1,041 ) $ (1,337 ) Non-interest expenses (1,041 ) (1,337 ) Segment operating pre-tax net loss $ - $ - Segment assets $ (324,665 ) $ (344,294 ) Total Segments Non-interest revenues $ 26,659 $ 34,233 Net interest income 15 2,371 Provision for loan losses (1,413 ) 12 Total net revenues after provision for loan losses $ 25,261 $ 36,616 Non-interest expenses 27,899 34,403 Segment operating pre-tax net income $ (2,638 ) $ 2,213 Total assets $ 881,188 $ 1,232,955 The following tables reconcile the total segments to consolidated net income before income tax expense and total assets as of and for the three March 31, 2017 2016. (In thousands) As of and Three Months Ended March 31, 2017 As of and Three Months Ended March 31, 2016 Total Segments Consolidation Adjustments and Reconciling Items JMP Consolidated Total Segments Consolidation Adjustments and Reconciling Items JMP Consolidated Non-interest revenues $ 26,659 $ (1,987 ) (a) $ 24,672 $ 34,233 $ 527 (a) $ 34,760 Net Interest Income 15 957 (b) 972 2,371 2,055 (b) 4,426 Provision for loan losses (1,413 ) 147 (1,266 ) 12 (643 ) (631 ) Total net revenues after provision for loan losses $ 25,261 $ (883 ) $ 24,378 $ 36,616 $ 1,939 $ 38,555 Non-interest expenses 27,899 1,706 (c ) 29,605 34,403 870 (c ) 35,273 Noncontrolling interest - 597 597 - 1,429 1,429 Operating pre-tax net income (loss) $ (2,638 ) $ (3,186 ) (d) $ (5,824 ) $ 2,213 $ (360 ) (d) $ 1,853 Total assets $ 881,188 $ - $ 881,188 $ 1,232,955 $ - $ 1,232,955 (a) Non-interest revenue adjustments is comprised of loan sale gains, mark-to-market gains/losses, strategic equity investments and warrants, and fund-related revenues recognized upon consolidation of certain Harvest Funds. (b) The Net Interest Income adjustment is comprised of the non-cash net amortization of liquidity discounts at the CLOs, due to scheduled contractual repayments, and amortization expense related to an intangible asset. (c) Non-interest expense adjustments relate to reversals of share-based compensation and exclusion of fund-related expenses recognized upon consolidation of certain Harvest Funds. (d) Reconciling operating pre-tax net income to Consolidated Net Income before income tax expense in the Consolidated Statements of Operations consists of the following: (In thousands) Three Months Ended March 31, 2017 2016 Consolidated Net Income (loss) attributable to JMP Group LLC $ (4,740 ) $ 1,803 Income tax expense (benefit) (1,084 ) 50 Consolidated pre-tax net income (loss) attributable to JMP Group LLC $ (5,824 ) $ 1,853 Subtract (Add back) Compensation expense - RSUs (306 ) (467 ) Deferred compensation program accounting adjustment (654 ) 515 Net unrealized loss/ (gain) on strategic equity investments and warrants. (419 ) 329 General loan loss reserve for CLO II and CLO III 418 (407 ) Unrealized loss - real estate-related depreciation and amortization (2,156 ) (330 ) Amortization of intangible asset (68 ) - Total Consolidation Adjustments and Reconciling Items (3,186 ) (360 ) Segment operating pre-tax net income (loss) $ (2,638 ) $ 2,213

Note 20 - Summarized Financial

Note 20 - Summarized Financial Information for Equity Method Investments	3 Months Ended
	Mar. 31, 2017
Notes to Financial Statements
Equity Method Investments and Joint Ventures Disclosure [Text Block]	20 . Summarized Financial Information for Equity Method Investments The tables below present summarized financial information of the hedge funds and private equity fund, which the Company accounts for under the equity method. The financial information below represents 100% As of (In thousands) March 31, 2017 December 31, 2016 Net Assets Net Assets Harvest Small Cap Partners $ 310,375 $ 296,404 Harvest Agriculture Select 22,235 22,796 (In thousands) Three Months Ended March 31, 2017 2016 Net Realized and Unrealized Gains ( Losses) Net Investment Income (Loss) Net Realized and Unrealized Gains (Losses) Net Investment Income (Loss) Harvest Small Cap Partners $ 11,278 $ (4,781 ) $ 23,668 $ (5,390 ) Harvest Agriculture Select 71 (65 ) (153 ) (77 ) Harvest Technology Partners - - (44 ) (48 ) Harvest Financial Partners - - (607 ) (77 )

Note 21 - Condensed Consolidati

Note 21 - Condensed Consolidating Financial Statements	3 Months Ended
	Mar. 31, 2017
Notes to Financial Statements
Condensed Financial Statements [Text Block]	2 1. Condensed Consolidating Financial Statements JMP Group Inc., a 100% 8.00% 2023 7.25% 2021. January 1, 2015, may The following condensed consolidating financial statements present the consolidated statements of financial condition, condensed consolidated statements of operations, consolidated statements of comprehensive income and consolidated statements of cash flows of JMP Group LLC (parent company and guarantor), JMP Group Inc. (issuer), JMP Investment Holdings LLC (guarantor subsidiary), and the elimination of entries necessary to consolidate or combine the issuer with the guarantor and non-guarantor subsidiaries. These statements are presented in accordance with the disclosure requirements under SEC Regulation S-X Rule 3 10. As of March 31, 2017 Parent Company Subsidiary Issuer Guarantor Subsidiary Non-Guarantor Subsidiaries Eliminations Consolidated JMP Group LLC Assets Cash and cash equivalents $ 2,362 $ 2,137 $ 34,163 $ 42,573 $ - $ 81,235 Restricted cash and deposits - 1,471 - 65,662 - 67,133 Receivable from clearing broker - - - 6,051 - 6,051 Investment banking fees receivable, net of allowance for doubtful accounts - - - 8,122 - 8,122 Marketable securities owned, at fair value - - 10,461 10,569 (472 ) 20,558 Incentive fee receivable - - - 242 - 242 Other investments 7,000 5,876 9,789 14,614 (7,000 ) 30,279 Loans held for sale - - - 1,437 - 1,437 Loans held for investment, net of allowance for loan losses - - - 1,157 - 1,157 Loans collateralizing asset-backed securities issued, net of allowance for loan losses - - - 610,955 - 610,955 Interest receivable 94 - - 2,455 - 2,549 Collateral posted for derivative transaction - - - 25,940 - 25,940 Fixed assets, net - - - 2,863 - 2,863 Deferred tax assets - 7,942 - - - 7,942 Other assets (6 ) 140,096 (15,575 ) 44,366 (154,156 ) 14,725 Investment in subsidiaries 237,542 74,053 99,421 - (411,016 ) - Total assets $ 246,992 $ 231,575 $ 138,259 $ 837,006 $ (572,644 ) $ 881,188 Liabilities and Equity Liabilities: Marketable securities sold, but not yet purchased, at fair value $ - $ - $ - $ 5,206 $ - $ 5,206 Accrued compensation 250 474 228 7,568 - 8,520 Asset-backed securities issued - - - 620,354 (7,000 ) 613,354 Interest payable - 1,506 - 4,263 - 5,769 Note payable 137,603 - - 15,000 (152,603 ) - Bond payable - 92,363 - - (473 ) 91,890 Deferred tax liability - 2,093 - 560 - 2,653 Other liabilities 1,860 23,501 314 825 (1,444 ) 25,056 Total liabilities $ 139,713 $ 119,937 $ 542 $ 653,776 $ (161,520 ) $ 752,448 Total members' (deficit) equity 107,279 111,638 122,447 184,146 (411,336 ) 114,174 Nonredeemable Non-controlling Interest $ - $ - $ 15,270 $ (916 ) $ 212 $ 14,566 Total equity $ 107,279 $ 111,638 $ 137,717 $ 183,230 $ (411,124 ) $ 128,740 Total liabilities and equity $ 246,992 $ 231,575 $ 138,259 $ 837,006 $ (572,644 ) $ 881,188 As of December 31, 2016 Parent Company Subsidiary Issuer Guarantor Subsidiary Non-Guarantor Subsidiaries Eliminations Consolidated JMP Group LLC Assets Cash and cash equivalents $ 255 $ 1,763 $ 5,060 $ 78,414 $ - $ 85,492 Restricted cash and deposits - 1,471 - 226,185 - 227,656 Receivable from clearing broker - - - 6,586 - 6,586 Investment banking fees receivable, net of allowance for doubtful accounts - - - 5,681 - 5,681 Marketable securities owned, at fair value - - 10,877 8,317 (472 ) 18,722 Incentive fee receivable - - - 499 - 499 Other investments - 5,126 9,838 17,905 - 32,869 Loans held for sale 32,488 32,488 Loans held for investment, net of allowance for loan losses - - - 1,930 - 1,930 Loans collateralizing asset-backed securities issued, net of allowance for loan losses - - - 654,127 - 654,127 Interest receivable - - 72 3,429 (72 ) 3,429 Collateral posted for derivative transaction - 25,000 - 25,000 Fixed assets, net - - - 3,143 - 3,143 Deferred tax assets - 7,942 - - - 7,942 Other assets (1,045 ) 141,905 (8,957 ) 42,597 (154,234 ) 20,266 Investment in subsidiaries 252,486 74,166 117,537 - (444,189 ) - Total assets $ 251,696 $ 232,373 $ 134,427 $ 1,106,301 $ (598,967 ) $ 1,125,830 Liabilities and Equity Liabilities: Marketable securities sold, but not yet purchased, at fair value $ - $ - $ - $ 4,747 $ - $ 4,747 Accrued compensation 90 150 - 35,918 - 36,158 Asset-backed securities issued - - - 825,854 - 825,854 Interest payable - 1,506 - 4,811 - 6,317 Note payable 137,603 - - 15,000 (152,603 ) - Bond payable - 92,258 - - (473 ) 91,785 Deferred tax liability - 3,232 - 640 - 3,872 Other liabilities 1,520 22,706 313 (1,142 ) (1,594 ) 21,803 Total liabilities $ 139,213 $ 119,852 $ 313 $ 885,828 $ (154,670 ) $ 990,536 Total members' (deficit) equity 112,483 112,521 117,532 221,350 (444,509 ) 119,377 Nonredeemable Non-controlling Interest $ - $ - $ 16,582 $ (877 ) $ 212 $ 15,917 Total equity $ 112,483 $ 112,521 $ 134,114 $ 220,473 $ (444,297 ) $ 135,294 Total liabilities and equity $ 251,696 $ 232,373 $ 134,427 $ 1,106,301 $ (598,967 ) $ 1,125,830 For the Three Months Ended March 31, 2017 Parent Company Subsidiary Issuer Guarantor Subsidiary Non- Guarantor Subsidiaries Eliminations Consolidated JMP Group LLC Revenues Investment banking $ - $ - $ - $ 13,600 $ - $ 13,600 Brokerage - - - 5,286 - 5,286 Asset management fees - - - 5,951 (40 ) 5,911 Principal transactions - 8 (396 ) (1,505 ) - (1,893 ) Loss on sale, payoff and mark-to-market of loans - - - 847 - 847 Gain on repurchase of debt 210 - - - - 210 Net dividend income - - 256 10 - 266 Other income - - - 445 - 445 Equity earnings of subsidiaries (2,766 ) (284 ) 583 - 2,467 - Non-interest revenues (2,556 ) (276 ) 443 24,634 2,427 24,672 Interest income 368 1,139 98 9,545 (2,083 ) 9,067 Interest expense (1,139 ) (2,274 ) - (6,765 ) 2,083 (8,095 ) Net interest income (771 ) (1,135 ) 98 2,780 - 972 Provision for loan losses - - - (1,266 ) - (1,266 ) Total net revenues after provision for loan losses (3,327 ) (1,411 ) 541 26,148 2,427 24,378 Non-interest expenses Compensation and benefits 535 646 247 20,370 - 21,798 Administration 127 122 26 1,584 (40 ) 1,819 Brokerage, clearing and exchange fees - - - 759 - 759 Travel and business development 78 - - 837 - 915 Communications and technology 1 2 - 1,050 - 1,053 Occupancy - - - 1,111 - 1,111 Professional fees 672 67 - 423 - 1,162 Depreciation - - - 311 - 311 Other - 6 69 602 - 677 Total non-interest expenses 1,413 843 342 27,047 (40 ) 29,605 Net income (loss) before income tax expense (4,740 ) (2,254 ) 199 (899 ) 2,467 (5,227 ) Income tax expense (benefit) - (1,020 ) - (64 ) - (1,084 ) Net income (loss) (4,740 ) (1,234 ) 199 (835 ) 2,467 (4,143 ) Less: Net income (loss) attributable to nonredeemable non-controlling interest - - 437 160 - 597 Net income (loss) attributable to JMP Group LLC $ (4,740 ) $ (1,234 ) $ (238 ) $ (995 ) $ 2,467 $ (4,740 ) For the Three Months Ended March 31, 2016 Parent Company Subsidiary Issuer Guarantor Subsidiary Non-Guarantor Subsidiaries Eliminations Consolidated JMP Group LLC Revenues Investment banking $ - $ - $ - $ 18,296 $ - $ 18,296 Brokerage - - - 6,095 - 6,095 Asset management fees - - - 9,326 - 9,326 Principal transactions - 120 (127 ) 937 - 930 Loss on sale, payoff and mark-to-market of loans - - - (376 ) - (376 ) Net dividend income - - 239 24 - 263 Other income - - 87 139 - 226 Equity earnings of subsidiaries 3,866 1,812 4,768 - (10,446 ) - Non-interest revenues 3,866 1,932 4,967 34,441 (10,446 ) 34,760 Interest income 370 1,139 166 12,721 (1,995 ) 12,401 Interest expense (1,139 ) (2,288 ) - (6,543 ) 1,995 (7,975 ) Net interest income (769 ) (1,149 ) 166 6,178 - 4,426 Provision for loan losses - - - (631 ) - (631 ) Total net revenues after provision for loan losses 3,097 783 5,133 39,988 (10,446 ) 38,555 Non-interest expenses Compensation and benefits 505 1,172 162 25,586 - 27,425 Administration 118 130 71 386 1,113 1,818 Brokerage, clearing and exchange fees - - - 761 - 761 Travel and business development 85 - - 1,206 - 1,291 Communications and technology 2 2 - 1,012 - 1,016 Occupancy - - - 936 - 936 Professional fees 586 69 12 406 - 1,073 Depreciation - - - 332 - 332 Other - - - 1,734 (1,113 ) 621 Total non-interest expenses 1,296 1,373 245 32,359 - 35,273 Net income (loss) before income tax expense 1,801 (590 ) 4,888 7,629 (10,446 ) 3,282 Income tax expense (benefit) - (854 ) - 904 - 50 Net income (loss) 1,801 264 4,888 6,725 (10,446 ) 3,232 Less: Net income (loss) attributable to nonredeemable non-controlling interest - - 1,286 143 - 1,429 Net income (loss) attributable to JMP Group LLC $ 1,801 $ 264 $ 3,602 $ 6,582 $ (10,446 ) $ 1,803 For the Quarter Ended March 31, 2017 Parent Company Subsidiary Issuer Guarantor Subsidiary Non-Guarantor Subsidiaries Eliminations Consolidated JMP Group LLC Cash flows from operating activities: Net income (loss) $ (4,740 ) $ (1,234 ) $ 199 $ (835 ) $ 2,467 $ (4,143 ) Adjustments to reconcile net income to net cash provided by (used in) operating activities: Provision for doubtful accounts - - - 90 90 Provision for loan losses - - - 1,266 - 1,266 Accretion of deferred loan fees - - - (840 ) - (840 ) Amortization of liquidity discount, net - - - - - - Amortization of debt issuance costs - 105 - - - 105 Amortization of original issue discount, related to CLO II and CLO III - - - 702 - 702 Interest paid in kind - - - - - - Loss (gain) on sale and payoff of loans - - - (1,027 ) - (1,027 ) Gain on repurchase of asset-backed securities issued - - (210 ) - - (210 ) Change in other investments: Income from investments in equity method investees - - - 690 - 690 Fair value on other equity investments - (8 ) (19 ) 1,489 - 1,462 Realized gain on other investments - - - (371 ) - (371 ) Depreciation and amortization of fixed assets - - - 311 - 311 Stock-based compensation expense 780 - - - - 780 Deferred income taxes - (1,139 ) - (80 ) - (1,219 ) Net change in operating assets and liabilities: (Increase) decrease in interest receivable (94 ) - 72 974 (72 ) 880 Decrease (increase) in receivables - - - (1,739 ) - (1,739 ) Increase in marketable securities - - 416 (2,252 ) - (1,836 ) (Increase) decrease in restricted cash (excluding restricted cash reserved for lending activities) - - - 944 - 944 (Increase) decrease in deposits and other assets (1,039 ) 1,809 6,828 5,884 (22,157 ) (8,675 ) Increase in marketable securities sold, but not yet purchased - - - 459 - 459 Increase in interest payable - - - (548 ) - (548 ) (Decrease) increase in accrued compensation and other liabilities 505 1,119 229 (26,520 ) 149 (24,518 ) Net cash used in operating activities $ (4,588 ) $ 652 $ 7,515 $ (21,403 ) $ (19,613 ) $ (37,437 ) Cash flows from investing activities: Purchases of fixed assets - - - (31 ) - (31 ) Investment in subsidiary 14,944 113 18,116 - (33,173 ) - Purchases of other investments (7,000 ) (844 ) (146 ) - 7,000 (990 ) Sales of other investments - 102 214 (6,032 ) 15,080 9,364 Funding of loans collateralizing asset-backed securities issued - - - (50,122 ) - (50,122 ) Funding of loans held for sale (2,752 ) (2,752 ) Sale and payoff of loans collateralizing asset-backed securities issued - - - 111,743 - 111,743 Principal receipts on loans collateralizing asset-backed securities issued - - - 16,728 - 16,728 Net change in restricted cash reserved for lending activities - - - 159,579 - 159,579 Cash collateral posted for total return swap - - - (940 ) (940 ) Net cash provided by (used in) investing activities $ 7,944 $ (629 ) $ 18,184 $ 228,173 $ (11,093 ) $ 242,579 Cash flows from financing activities: Repayment of asset-backed securities issued - - - (206,202 ) - (206,202 ) Distributions and dividend equivalents paid on common shares and RSUs (1,954 ) - - - - (1,954 ) Capital contributions of parent - 351 5,153 (36,210 ) 30,706 - Capital contributions of nonredeemable non-controlling interest holders - - 92 - - 92 Distributions to non-controlling interest shareholders - - (1,841 ) (199 ) - (2,040 ) Net cash settlement of RSU vesting 889 - - - - 889 Employee Taxes Paid on Shares Withheld for Tax-withholding purposes (184 ) - - - - (184 ) Net cash (used in) provided by financing activities $ (1,249 ) $ 351 $ 3,404 $ (242,611 ) $ 30,706 $ (209,399 ) Net decrease in cash and cash equivalents 2,107 374 29,103 (35,841 ) - (4,257 ) Cash and cash equivalents, beginning of period $ 255 $ 1,763 $ 5,060 $ 78,414 $ - 85,492 Cash and cash equivalents, end of period 2,362 2,137 34,163 42,573 - 81,235 For the Three Months Ended March 31, 2016 Parent Company Subsidiary Issuer Guarantor Subsidiary Non-Guarantor Subsidiary Eliminations Consolidated JMP Group LLC Cash flows from operating activities: Net income (loss) $ 1,801 $ 264 $ 4,888 $ 6,725 $ (10,446 ) $ 3,232 Adjustments to reconcile net income to net cash provided by (used in) operating activities: Provision for loan losses - - - 631 - 631 Accretion of deferred loan fees - - - (360 ) - (360 ) Amortization of liquidity discount, net - - - (36 ) - (36 ) Amortization of debt issuance costs - 117 - - - 117 Amortization of original issue discount, related to CLO II and CLO III - - - 598 - 598 Interest paid in kind - - - (53 ) - (53 ) Loss (gain) on sale and payoff of loans - - - 376 - 376 Gain on repurchase of asset-backed securities issued - - (87 ) - - (87 ) Change in other investments: Income from investments in equity method investees (283 ) (283 ) Fair value on other equity investments - (120 ) 438 (415 ) - (97 ) Change in fair value of small business loans - - - - - Realized gain on other investments - - - (19 ) - (19 ) Depreciation and amortization of fixed assets - - - 332 - 332 Stock-based compensation expense 1,242 - - - 1,242 Deferred income taxes - (1,399 ) - (81 ) - (1,480 ) Net change in operating assets and liabilities: (Increase) decrease in interest receivable - - (3 ) (93 ) 135 39 Decrease (increase) in receivables - - - (1,866 ) (49 ) (1,915 ) Increase in marketable securities - - (796 ) 1,366 485 1,055 (Increase) decrease in restricted cash (excluding restricted cash reserved for lending activities) - - - 337 - 337 (Increase) decrease in deposits and other assets (1,073 ) 6,443 14,817 (31,519 ) 15,918 4,586 Increase in marketable securities sold, but not yet purchased - - - 89 - 89 Increase in interest payable - - - 500 (66 ) 434 (Decrease) increase in accrued compensation and other liabilities 588 732 144 (24,361 ) (1,304 ) (24,201 ) Net cash used in operating activities $ 2,558 $ 6,037 $ 19,401 $ (48,132 ) $ 4,673 $ (15,463 ) Cash flows from investing activities: Purchases of fixed assets - - - (72 ) - (72 ) Purchase of management contract - - - - - - Investment in subsidiary (6,493 ) (9,346 ) 360 12,983 2,496 - Purchases of other investments - (2,779 ) - - - (2,779 ) Sales of other investments - - 9,568 2,038 88 11,694 Funding of loans collateralizing asset-backed securities issued - - - (52,181 ) - (52,181 ) Sale and payoff of loans collateralizing asset-backed securities issued - - - 53,698 - 53,698 Principal receipts on loans collateralizing asset-backed securities issued - - - 15,861 - 15,861 Net change in restricted cash reserved for lending activities - - - (6,090 ) - (6,090 ) Cash transferred from consolidated subsidiary to non-consolidated hedge fund - - - - - - Cash and cash equivalents derecognized due to adoption of new consolidation guidance - - - (240 ) - (240 ) Net cash provided by (used in) investing activities $ (6,493 ) $ (12,125 ) $ 9,928 $ 25,997 $ 2,584 $ 19,891 Cash flows from financing activities: Repayment of note payable - - - 15,000 (15,000 ) - Repayment of line of credit - - - - - - Repayment of credit warehouse - - - - - - Repayment and repurchase of contingent consideration payable - - - - - - Proceeds from initial public offering, net of expenses - - - - - - Sale of asset-back securities issued - - - - - - Repurchase of asset-backed securities issued - - - - - - Repurchase of bonds payable - - - - (385 ) (385 ) Repayment of asset-backed securities issued - - - (11,824 ) - (11,824 ) Distributions paid to Class A and Class B common interests - - - - - - Distributions and dividend equivalents paid on common shares and RSUs (2,616 ) - - - - (2,616 ) Purchases of shares of common stock for treasury (2,629 ) - - - - (2,629 ) Capital contributions of parent 10,213 4,041 (22,382 ) - 8,128 - Purchase of assets with non-controlling interest - - - - - - Sale of assets with non-controlling interest - - - - - - Capital contributions of redeemable non-controlling interest holders - - (1,704 ) - - (1,704 ) Capital contributions of nonredeemable non-controlling interest holders - - - - - - Net cash (used in) provided by financing activities $ 4,968 $ 4,041 $ (24,086 ) $ 3,176 $ (7,257 ) $ (19,158 ) Net decrease in cash and cash equivalents 1,033 (2,047 ) 5,243 (18,959 ) - (14,730 ) Cash and cash equivalents, beginning of period $ 80 $ 11,260 $ 1,225 $ 55,986 $ - $ 68,551 Cash and cash equivalents, end of period 1,113 9,213 6,468 37,027 - 53,821

Note 22 - Subsequent Events

Note 22 - Subsequent Events	3 Months Ended
	Mar. 31, 2017
Notes to Financial Statements
Subsequent Events [Text Block]	22 . Subsequent Events On April 5, 2017, $200.0 On April 19, 2017, $0.03 April, May June 2017. April May 15, 2017, April 28, 2017. May June 15, 2017, May 31, 2017. June July 14, 2017, June 30, 2017. On May 3, 2017, $25.0 one May 2, 2018, July, 2018, 3.75% first two 5.00% two On May 3, 2017, $20.0 May 6, 2017, one May 2, 2018,

Significant Accounting Policies

Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2017
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	Basis of Presentation These condensed consolidated financial statements and related notes are unaudited and have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10 10 10 December 31, 2016 The consolidated accounts of the Company include the wholly-owned subsidiaries, JMP Securities, HCS, JMPCA, JMP Investment Holdings, JMPCA TRS, JMP Asset Management Inc., JMP Realty Trust Inc., and the partially-owned subsidiaries CLO I, CLO II, CLO III and HCAP Advisors. All material intercompany accounts and transactions have been eliminated in consolidation. Non-controlling interest on the Consolidated Statements of Financial Condition at March 31, 2017 December 31, 2016 third See Note 2

Note 4 - Fair Value Measureme30

Note 4 - Fair Value Measurements (Tables)	3 Months Ended
	Mar. 31, 2017
Notes Tables
Fair Value, by Balance Sheet Grouping [Table Text Block]	At March 31, 2017 (In thousands) Carrying Value Fair Value Level 1 Level 2 Level 3 Total Assets: Cash and cash equivalents $ 81,235 $ 81,235 $ - $ - $ 81,235 Restricted cash and deposits 67,133 67,133 - - 67,133 Marketable securities owned 20,558 20,558 - - 20,558 Other investments 12,420 - 12,420 - 12,420 Other investments measured at net asset value (1) 17,859 - - - - Loans held for investment, net of allowance for loan losses 1,157 - - 1,270 1,270 Loans collateralizing asset-backed securities issued, net of allowance for loan losses 610,955 - 610,948 - 610,948 Cash collateral posted for total return swap 25,940 25,940 - - 25,940 Total assets: $ 837,257 $ 194,866 $ 623,368 $ 1,270 $ 819,504 Liabilities: Marketable securities sold, but not yet purchased $ 5,206 $ 5,206 $ - $ - $ 5,206 Asset-backed securities issued 613,354 - 621,785 - 621,785 Total return swap 140 - 140 - 140 Bond payable 91,890 - 94,803 - 94,803 Total liabilities: $ 710,590 $ 5,206 $ 716,728 $ - $ 721,934 At December 31, 2016 (In thousands) Carrying Value Fair Value Level 1 Level 2 Level 3 Total Assets: Cash and cash equivalents $ 85,492 $ 85,492 $ - $ - $ 85,492 Restricted cash and deposits 227,656 227,656 - - 227,656 Marketable securities owned 18,722 18,722 - - 18,722 Other investments 13,697 - 13,697 - 13,697 Other investments measured at net asset value (1) 19,172 - - - - Loans held for sale 32,488 - 33,651 33,651 Loans held for investment, net of allowance for loan losses 1,930 - - 1,824 1,824 Loans collateralizing asset-backed securities issued, net of allowance for loan losses 654,127 - 685,392 - 685,392 Cash collateral posted for total return swap 25,000 25,000 - - 25,000 Total assets: $ 1,078,284 $ 356,870 $ 732,740 $ 1,824 $ 1,091,434 Liabilities: Marketable securities sold, but not yet purchased $ 4,747 $ 4,747 $ - $ - $ 4,747 Asset-backed securities issued 825,854 - 831,854 - 831,854 Bond payable 91,785 - 94,517 - 94,517 Total liabilities: $ 922,386 $ 4,747 $ 926,371 $ - $ 931,118
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	(In thousands) March 31, 2017 Carrying Value Level 1 Level 2 Level 3 Total Marketable securities owned 20,558 $ 20,558 $ - $ - $ 20,558 Other investments: Investments in hedge funds managed by HCS 12,420 - 12,420 - 12,420 Investments in private equity funds managed by HCS (1) 4,045 . . - - Investments in funds of funds managed by HCS (1) 5 - - - - Total investment in funds managed by HCS (1) 16,470 - 12,420 - 12,420 Limited partnership in investments in private equity/ real estate funds (1) 3,519 - - - - Total other investments 19,989 - 12,420 - 12,420 Total assets: 40,547 $ 20,558 $ 12,420 $ - $ 32,978 Marketable securities sold, but not yet purchased 5,206 5,206 - - 5,206 Total return swap 140 - 140 - 140 Total liabilities: 5,346 $ 5,206 $ 140 $ - $ 5,346 (In thousands) December 31, 2016 Carrying Value Level 1 Level 2 Level 3 Total Marketable securities owned 18,722 $ 18,722 $ - $ - $ 18,722 Other investments: Investments in hedge funds managed by HCS 12,444 - 12,444 - 12,444 Investments in private equity funds managed by HCS (1) 4,227 . . - - Investments in funds of funds managed by HCS (1) 5 - - - - Total investment in funds managed by HCS (1) 16,676 - 12,444 - 12,444 Limited partnership in investments in private equity/ real estate funds (1) 3,530 - - - - Total return swap 1,253 1,253 1,253 Total other investments 21,459 - 13,697 - 13,697 Total assets: $ 40,181 $ 18,722 $ 13,697 $ - $ 32,419 Marketable securities sold, but not yet purchased 4,747 4,747 - - 4,747 Total liabilities: $ 4,747 $ 4,747 $ - $ - $ 4,747
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Table Text Block]	Redemption Redemption Fair Value at Unfunded Commitments Dollars in thousands Frequency Notice Period March 31, 2017 December 31, 2016 March 31, 2017 December 31, 2016 Investments in Funds of Funds managed by HCS (1) N/A N/A $ 5 $ 5 $ - $ - Limited partner investments in private equity/ real estate funds Nonredeemable N/A $ 3,519 $ 3,530 $ - $ - Investment in private equity funds managed by HCS Nonredeemable N/A $ 4,045 $ 4,227 $ 1,085 $ 1,085

Note 5 - Loans Collateralizin31

Note 5 - Loans Collateralizing Asset-backed Securities Issued and Loans Held for Sale (Tables)	3 Months Ended
	Mar. 31, 2017
Notes Tables
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]	(In thousands) Loans Collateralizing Asset-backed Securities Loans Held for Sale March 31, 2017 December 31, 2016 March 31, 2017 December 31, 2016 Outstanding principal $ 624,130 $ 667,237 $ 1,454 $ 33,748 Allowance for loan losses (7,095 ) (6,540 ) - - Liquidity discount - - - (772 ) Deferred loan fees, net (6,080 ) (6,570 ) (17 ) (308 ) Valuation allowance N/A N/A - (180 ) Total loans, net $ 610,955 $ 654,127 $ 1,437 $ 32,488
Schedule of Credit Losses Related to Financing Receivables, Current and Noncurrent [Table Text Block]	(In thousands) Three Months Ended March 31, 2017 Principal Allowance for Loan Losses Liquidity Discount Deferred Loan Fees Carrying Value, Net Impaired Loans Balance at beginning of period $ 3,113 $ (937 ) $ - $ (249 ) $ 1,927 Repayments (44 ) - - - (44 ) Accretion of discount - - - (1 ) (1 ) Provision for loan losses - (971 ) - - (971 ) Transfers to/from non-impaired loans, net 1,947 - - (3 ) 1,944 Balance at end of period $ 5,016 $ (1,908 ) $ - $ (253 ) $ 2,855 Non-impaired Loans Balance at beginning of period $ 664,124 $ (5,603 ) $ - $ (6,321 ) $ 652,200 Purchases 50,733 - - (611 ) 50,122 Repayments (14,900 ) - - - (14,900 ) Accretion of discount - - - 526 526 Provision for loan losses - 416 - - 416 Sales and payoff (78,896 ) - - 576 (78,320 ) Transfers to/from impaired loans, net (1,947 ) - - 3 (1,944 ) Balance at end of period $ 619,114 $ (5,187 ) $ - $ (5,827 ) $ 608,100 (In thousands) Three Months Ended March 31, 2016 Principal Allowance for Loan Losses Liquidity Discount Deferred Loan Fees Carrying Value, Net Non-impaired Loans Balance at beginning of period $ 984,110 $ (5,397 ) $ (918 ) $ (8,130 ) $ 969,665 Purchases 53,409 - - (1,228 ) 52,181 Repayments (15,997 ) - - 136 (15,861 ) Accretion of discount - - 36 360 396 Provision for loan losses - (631 ) - - (631 ) Sales and payoff (54,371 ) - - 297 (54,074 ) Balance at end of period $ 967,151 $ (6,028 ) $ (882 ) $ (8,565 ) $ 951,676
Allowance for Credit Losses on Financing Receivables [Table Text Block]	(In thousands) Three Months Ended March 31, 2017 2016 Balance at beginning of period $ (6,540 ) $ (5,397 ) Provision for loan losses: Specific reserve (971 ) - General reserve 416 (631 ) Balance at end of period $ (7,095 ) $ (6,028 )
Impaired Financing Receivables [Table Text Block]	(In thousands) Recorded Investment Unpaid Principal Balance Related Allowance Average Recorded Investment Interest Income Recognized March 31, 2017 Impaired loans with an allowance recorded $ 4,763 $ 5,158 $ 1,908 $ 4,779 $ 25 Impaired loans with no related allowance recorded - - - - - $ 4,763 $ 5,158 $ 1,908 $ 4,779 $ 25 December 31, 2016 Impaired loans with an allowance recorded $ 2,864 $ 3,211 $ 938 $ 2,913 $ 75 Impaired loans with no related allowance recorded - - - - - $ 2,864 $ 3,211 $ 938 $ 2,913 $ 75
Financing Receivable Credit Quality Indicators [Table Text Block]	(In thousands) Cash Flow Loans Loans Held for Sale - Cash Flow March 31, December 31, March 31, December 31, 2017 2016 2017 2016 Moody's rating: Baa1 - Baa3 $ 10,467 $ 12,145 $ - $ 6,769 Ba1 - Ba3 109,954 137,717 - 13,957 B1 - B3 449,911 467,125 1,437 11,377 Caa1 - Caa3 44,899 37,913 - 565 Ca - 2,903 - - C 1,319 - - - Not Rated 1,500 2,864 - - Total: $ 618,050 $ 660,667 $ 1,437 $ 32,668 Internal rating: (1) 2 $ 528,737 $ 545,181 $ - $ 27,109 3 66,320 94,407 1,437 5,559 4 18,230 18,215 - - 5 4,763 2,864 - - Total: $ 618,050 $ 660,667 $ 1,437 $ 32,668 Performance: Performing $ 613,285 $ 657,803 $ 1,437 $ 32,668 Non-Performing 4,765 2,864 - - Total: $ 618,050 $ 660,667 $ 1,437 $ 32,668

Note 6 - Debt (Tables)

Note 6 - Debt (Tables)	3 Months Ended
	Mar. 31, 2017
Notes Tables
Schedule of Long-term Debt Instruments [Table Text Block]	As of March 31, 2017 As of December 31, 2016 Principal Unamortized Discount and Debt Issuance Costs Principal Unamortized Discount and Debt Issuance Costs 7.25% Senior Notes $ 47,922,500 $ 939,979 $ 47,922,500 $ 1,001,956 8.00% Senior Notes $ 45,905,250 $ 997,297 $ 45,905,250 $ 1,040,347

Note 7 - Asset-backed Securit33

Note 7 - Asset-backed Securities Issued (Tables)	3 Months Ended
	Mar. 31, 2017
Notes Tables
Schedule of Long-term Debt Instruments [Table Text Block]	As of March 31, 2017 As of December 31, 2016 Principal Unamortized Discount and Debt Issuance Costs Principal Unamortized Discount and Debt Issuance Costs 7.25% Senior Notes $ 47,922,500 $ 939,979 $ 47,922,500 $ 1,001,956 8.00% Senior Notes $ 45,905,250 $ 997,297 $ 45,905,250 $ 1,040,347
CLO III [Member]
Notes Tables
Schedule of Long-term Debt Instruments [Table Text Block]	(In millions) As of March 31, 2017 Notes Originally Issued Outstanding Principal Balance Issuance Discount Net Outstanding Balance Interest Rate Spread to LIBOR Ratings (Moody's/Fitch) Class A Senior Secured Floating Rate Notes due 2025 $ 228.0 $ 228.0 $ (0.5 ) $ 227.5 1.24 % Aaa/AAA Class B Senior Deferrable Floating Rate Notes due 2025 41.7 41.7 (0.6 ) 41.1 1.80 % Aa1/NR Class C Senior Deferrable Floating Rate Notes due 2025 22.5 22.5 (0.5 ) 22.0 2.60 % A1/NR Class D Senior Deferrable Floating Rate Notes due 2025 21.6 21.6 - 21.6 3.90 % Baa3/NR Class E Senior Deferrable Floating Rate Notes due 2025 18.3 18.3 - 18.3 7.10 % Ba3/NR Total secured notes sold to investors $ 332.1 $ 332.1 $ (1.6 ) $ 330.5 Unsecured subordinated notes due 2025 38.4 38.4 (4.5 ) 33.9 Total notes for the CLO III offering $ 370.5 $ 370.5 $ (6.1 ) $ 364.4 Consolidation elimination N/A (38.4 ) 4.5 (33.9 ) Total CLO III asset-backed securities issued N/A $ 332.1 $ (1.6 ) $ 330.5 (In millions) As of December 31, 2016 Notes Originally Issued Outstanding Principal Balance Issuance Discount Net Outstanding Balance Interest Rate Spread to LIBOR Ratings (Moody's Fitch) Class A Senior Secured Floating Rate Notes due 2025 $ 228.0 $ 228.0 $ (0.5 ) $ 227.5 1.53 % Aaa/AAA Class B Senior Deferrable Floating Rate Notes due 2025 41.7 41.7 (0.7 ) 41.0 2.05 % Aa2/NR Class C Senior Deferrable Floating Rate Notes due 2025 22.5 22.5 (0.5 ) 22.0 2.90 % A2/NR Class D Senior Deferrable Floating Rate Notes due 2025 21.6 21.6 - 21.6 5.10 % Baa3/NR Class E Senior Deferrable Floating Rate Notes due 2025 18.3 18.3 - 18.3 7.35 % Ba3/NR Total secured notes sold to investors $ 332.1 $ 332.1 $ (1.7 ) $ 330.4 Unsecured subordinated notes due 2025 38.4 38.4 (4.5 ) 33.9 Total notes for the CLO III offering $ 370.5 $ 370.5 $ (6.2 ) $ 364.3 Consolidation elimination N/A (38.4 ) 4.5 (33.9 ) Total CLO III asset-backed securities issued N/A $ 332.1 $ (1.7 ) $ 330.4
CLO III [Member]
Notes Tables
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]	(In thousands) Three Months Ended March 31, 2017 Three Months Ended March 31, 2016 Principal Issuance Discount Net Principal Issuance Discount Net Balance at beginning of period $ 332,100 $ (1,676 ) $ 330,424 $ 332,100 $ (2,165 ) $ 329,935 Amortization of discount - 124 124 - 121 121 Balance at end of period $ 332,100 $ (1,552 ) $ 330,548 $ 332,100 $ (2,044 ) $ 330,056
CLO II [Member]
Notes Tables
Schedule of Long-term Debt Instruments [Table Text Block]	(In millions) As of March 31, 2017 Notes Originally Issued Outstanding Principal Balance Issuance Discount Net Outstanding Balance Interest Rate Spread to LIBOR Ratings (S&P) Class X Senior Secured Floating Rate Notes due 2016 $ 3.8 $ - $ - $ - 1.00 % AAA Class A Senior Secured Floating Rate Notes due 2023 217.6 198.8 (0.4 ) 198.4 1.18 % AAA Class B Senior Deferrable Floating Rate Notes due 2023 34.0 34.0 (0.2 ) 33.8 1.75 % AA Class C Senior Deferrable Floating Rate Notes due 2023 17.0 17.0 (0.3 ) 16.7 2.75 % A Class D Senior Deferrable Floating Rate Notes due 2023 18.7 18.7 (0.9 ) 17.8 3.85 % BBB Class E Senior Deferrable Floating Rate Notes due 2023 18.7 18.7 (1.5 ) 17.2 5.25 % BB Class F Senior Deferrable Floating Rate Notes due 2023 10.2 10.2 (1.3 ) 8.9 5.75 % B Total secured notes sold to investors $ 320.0 $ 297.4 $ (4.6 ) $ 292.8 Unsecured subordinated notes due 2023 23.8 23.8 (0.3 ) 23.5 Total notes for the CLO II offering $ 343.8 $ 321.2 $ (4.9 ) $ 316.3 Consolidation elimination N/A (30.8 ) 0.3 (30.5 ) Total CLO II asset-backed securities issued N/A $ 290.4 $ (4.6 ) $ 285.8 (In millions) As of December 31, 2016 Notes Originally Issued Outstanding Principal Balance Issuance Discount Net Outstanding Balance Interest Rate Spread to LIBOR Ratings (S&P) Class X Senior Secured Floating Rate Notes due 2016 $ 3.8 $ - $ - $ - 1.00 % AAA Class A Senior Secured Floating Rate Notes due 2023 217.6 217.6 (0.5 ) 217.1 1.18 % AAA Class B Senior Deferrable Floating Rate Notes due 2023 34.0 34.0 (0.2 ) 33.8 1.75 % AA Class C Senior Deferrable Floating Rate Notes due 2023 17.0 17.0 (0.4 ) 16.6 2.75 % A Class D Senior Deferrable Floating Rate Notes due 2023 18.7 18.7 (1.0 ) 17.7 3.85 % BBB Class E Senior Deferrable Floating Rate Notes due 2023 18.7 18.7 (1.6 ) 17.1 5.25 % BB Class F Senior Deferrable Floating Rate Notes due 2023 10.2 10.2 (1.2 ) 9.0 5.75 % B Total secured notes sold to investors $ 320.0 $ 316.2 $ (4.9 ) $ 311.3 Unsecured subordinated notes due 2023 23.8 23.8 (0.3 ) 23.5 Total notes for the CLO II offering $ 343.8 $ 340.0 $ (5.2 ) $ 334.8 Consolidation elimination N/A (23.8 ) 0.3 (23.5 ) Total CLO II asset-backed securities issued N/A $ 316.2 $ (4.9 ) $ 311.3
Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]	(In thousands) Three Months Ended March 31, 2017 Three Months Ended March 31, 2016 Principal Issuance Discount Net Principal Issuance Discount Net Balance at beginning of period $ 316,200 $ (4,915 ) $ 311,285 $ 316,960 $ (5,960 ) $ 311,000 Repayments (18,785 ) - (18,785 ) (380 ) - (380 ) Amortization of discount - 295 295 - 255 255 Balance at end of period $ 297,415 $ (4,620 ) $ 292,795 $ 316,580 $ (5,705 ) $ 310,875
CLO I [Member]
Notes Tables
Schedule of Long-term Debt Instruments [Table Text Block]	(In millions) As of December 31, 2016 Notes Originally Issued Net Outstanding Balance Interest Rate Spread to LIBOR Ratings (Moody's /S&P) Class A Senior Secured Floating Rate Revolving Notes due 2021 $ 72.2 $ 72.2 0.26% - 0.29% Aaa/AAA Class B Senior Secured Floating Rate Notes due 2021 30.0 30.0 0.50% Aaa/AAA Class C Senior Secured Deferrable Floating Rate Notes due 2021 35.0 35.0 1.10% Aaa/AAA Class D Secured Deferrable Floating Rate Notes due 2021 34.0 34.0 2.40% Aa1/A+ Class E Secured Deferrable Floating Rate Notes due 2021 30.0 30.0 5.00% Baa1/BB+ Total secured notes sold to investors $ 201.2 $ 201.2 Unsecured subordinated notes due 2021 45.0 45.0 Total notes for the CLO I offering $ 246.2 $ 246.2 Consolidation elimination N/A (58.7 ) Total asset-backed securities issued N/A $ 187.5
Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]	(In thousands) Three Months Ended March 31, 2017 2016 Balance at beginning of period $ 187,417 $ 293,457 Repayments (187,417 ) (11,444 ) Asset-backed securities at end of period $ - $ 282,013

Note 9 - Share-based Compensa34

Note 9 - Share-based Compensation (Tables)	3 Months Ended
	Mar. 31, 2017
Notes Tables
Share-based Compensation, Stock Options, Activity [Table Text Block]	Three Months Ended March 31, 2017 Shares Subject Weighted Average to Option Exercise Price Balance, beginning of year 2,710,000 $ 6.53 Exercised (145,000 ) 6.24 Balance, end of period 2,565,000 $ 6.54 Options exercisable at end of period 2,565,000 $ 6.54
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Table Text Block]	March 31, 2017 Options Outstanding Options Vested and Exercisable Weighted Weighted Average Weighted Average Weighted Range of Remaining Average Aggregate Remaining Average Aggregate Exercise Number Contractual Exercise Intrinsic Number Contractual Exercise Intrinsic Prices Outstanding Life in Years Price Value Exercisable Life in Years Price Value $6.05 - $7.33 2,565,000 2.26 $ 6.54 $ 1,500 2,565,000 2.26 $ 6.54 1,500
Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block]	Three Months Ended March 31, 2017 Restricted Weighted Average Share Units Grant Date Fair Value Balance, beginning of year 646,558 $ 5.14 Granted 328,797 6.08 Vested (79,842 ) 7.11 Forfeited (31,071 ) 4.10 Balance, end of period 864,442 $ 5.35
Schedule of Share-based Compensation, Stock Appreciation Rights Award Activity [Table Text Block]	Three Months Ended March 31, 2017 Share Appreciation Weighted Average Rights Exercise Price Balance, beginning of year 2,580,000 $ 7.33 Forfeited (95,000 ) 7.33 Balance, end of period 2,485,000 $ 7.33
Stock Appreciation Rights Outstanding Detail [Table Text Block]	March 31, 2017 Options Outstanding Weighted Average Weighted Range of Remaining Average Aggregate Exercise Number Contractual Exercise Intrinsic Prices Outstanding Life in Years Price Value $7.33 - $7.33 2,485,000 2.75 $ 7.33 $ -

Note 10 - Net Income (Loss) P35

Note 10 - Net Income (Loss) Per Common Share (Tables)	3 Months Ended
	Mar. 31, 2017
Notes Tables
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	(In thousands, except per share data) Three Months Ended March 31, 2017 2016 Numerator: Net income (loss) attributable to JMP Group, LLC $ (4,740 ) $ 1,803 Denominator: Basic weighted average shares outstanding 21,573 21,349 Effect of potential dilutive securities: Restricted share units - 516 Diluted weighted average shares outstanding 21,573 21,865 Net income (loss) per share Basic $ (0.22 ) $ 0.08 Diluted $ (0.22 ) $ 0.08

Note 13 - Commitments and Con36

Note 13 - Commitments and Contingencies (Tables)	3 Months Ended
	Mar. 31, 2017
Notes Tables
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]	Minimum Future Lease Commitments Year Ending December 31, 2017 $ 3,542 2018 4,777 2019 3,984 2020 2,568 2021 2,553 Thereafter 10,020 Total Lease Commitments $ 27,444

Note 19 - Business Segments (Ta

Note 19 - Business Segments (Tables)	3 Months Ended
	Mar. 31, 2017
Notes Tables
Schedule of Segment Reporting Information, by Segment [Table Text Block]	(In thousands) Three Months Ended March 31, 2017 2016 Broker-Dealer Non-interest revenues $ 18,890 $ 24,391 Total net revenues after provision for loan losses $ 18,890 $ 24,391 Non-interest expenses 18,561 21,999 Segment operating pre-tax net income $ 329 $ 2,392 Segment assets $ 48,498 $ 67,044 Asset Management Non-interest revenues $ 5,311 $ 10,176 Total net revenues after provision for loan losses $ 5,311 $ 10,176 Non-interest expenses 5,095 9,442 Segment operating pre-tax net income $ 216 $ 734 Segment assets $ 17,581 $ 28,956 Corporate Non-interest revenues $ 3,499 $ 1,003 Net interest income 15 2,371 Provision for loan losses (1,413 ) 12 Total net revenues after provision for loan losses $ 2,101 $ 3,386 Non-interest expenses 5,284 4,299 Segment operating pre-tax net income $ (3,183 ) $ (913 ) Segment assets $ 1,139,774 1,481,249 Eliminations Non-interest revenues $ (1,041 ) $ (1,337 ) Total net revenues after provision for loan losses $ (1,041 ) $ (1,337 ) Non-interest expenses (1,041 ) (1,337 ) Segment operating pre-tax net loss $ - $ - Segment assets $ (324,665 ) $ (344,294 ) Total Segments Non-interest revenues $ 26,659 $ 34,233 Net interest income 15 2,371 Provision for loan losses (1,413 ) 12 Total net revenues after provision for loan losses $ 25,261 $ 36,616 Non-interest expenses 27,899 34,403 Segment operating pre-tax net income $ (2,638 ) $ 2,213 Total assets $ 881,188 $ 1,232,955
Reconciliation of Assets from Segment to Consolidated [Table Text Block]	(In thousands) As of and Three Months Ended March 31, 2017 As of and Three Months Ended March 31, 2016 Total Segments Consolidation Adjustments and Reconciling Items JMP Consolidated Total Segments Consolidation Adjustments and Reconciling Items JMP Consolidated Non-interest revenues $ 26,659 $ (1,987 ) (a) $ 24,672 $ 34,233 $ 527 (a) $ 34,760 Net Interest Income 15 957 (b) 972 2,371 2,055 (b) 4,426 Provision for loan losses (1,413 ) 147 (1,266 ) 12 (643 ) (631 ) Total net revenues after provision for loan losses $ 25,261 $ (883 ) $ 24,378 $ 36,616 $ 1,939 $ 38,555 Non-interest expenses 27,899 1,706 (c ) 29,605 34,403 870 (c ) 35,273 Noncontrolling interest - 597 597 - 1,429 1,429 Operating pre-tax net income (loss) $ (2,638 ) $ (3,186 ) (d) $ (5,824 ) $ 2,213 $ (360 ) (d) $ 1,853 Total assets $ 881,188 $ - $ 881,188 $ 1,232,955 $ - $ 1,232,955
Reconciliation of Revenue from Segments to Consolidated [Table Text Block]	(In thousands) Three Months Ended March 31, 2017 2016 Consolidated Net Income (loss) attributable to JMP Group LLC $ (4,740 ) $ 1,803 Income tax expense (benefit) (1,084 ) 50 Consolidated pre-tax net income (loss) attributable to JMP Group LLC $ (5,824 ) $ 1,853 Subtract (Add back) Compensation expense - RSUs (306 ) (467 ) Deferred compensation program accounting adjustment (654 ) 515 Net unrealized loss/ (gain) on strategic equity investments and warrants. (419 ) 329 General loan loss reserve for CLO II and CLO III 418 (407 ) Unrealized loss - real estate-related depreciation and amortization (2,156 ) (330 ) Amortization of intangible asset (68 ) - Total Consolidation Adjustments and Reconciling Items (3,186 ) (360 ) Segment operating pre-tax net income (loss) $ (2,638 ) $ 2,213

Note 20 - Summarized Financia38

Note 20 - Summarized Financial Information for Equity Method Investments (Tables)	3 Months Ended
	Mar. 31, 2017
Notes Tables
Equity Method Investments [Table Text Block]	As of (In thousands) March 31, 2017 December 31, 2016 Net Assets Net Assets Harvest Small Cap Partners $ 310,375 $ 296,404 Harvest Agriculture Select 22,235 22,796 (In thousands) Three Months Ended March 31, 2017 2016 Net Realized and Unrealized Gains ( Losses) Net Investment Income (Loss) Net Realized and Unrealized Gains (Losses) Net Investment Income (Loss) Harvest Small Cap Partners $ 11,278 $ (4,781 ) $ 23,668 $ (5,390 ) Harvest Agriculture Select 71 (65 ) (153 ) (77 ) Harvest Technology Partners - - (44 ) (48 ) Harvest Financial Partners - - (607 ) (77 )

Note 21 - Condensed Consolida39

Note 21 - Condensed Consolidating Financial Statements (Tables)	3 Months Ended
	Mar. 31, 2017
Notes Tables
Condensed Balance Sheet [Table Text Block]	As of March 31, 2017 Parent Company Subsidiary Issuer Guarantor Subsidiary Non-Guarantor Subsidiaries Eliminations Consolidated JMP Group LLC Assets Cash and cash equivalents $ 2,362 $ 2,137 $ 34,163 $ 42,573 $ - $ 81,235 Restricted cash and deposits - 1,471 - 65,662 - 67,133 Receivable from clearing broker - - - 6,051 - 6,051 Investment banking fees receivable, net of allowance for doubtful accounts - - - 8,122 - 8,122 Marketable securities owned, at fair value - - 10,461 10,569 (472 ) 20,558 Incentive fee receivable - - - 242 - 242 Other investments 7,000 5,876 9,789 14,614 (7,000 ) 30,279 Loans held for sale - - - 1,437 - 1,437 Loans held for investment, net of allowance for loan losses - - - 1,157 - 1,157 Loans collateralizing asset-backed securities issued, net of allowance for loan losses - - - 610,955 - 610,955 Interest receivable 94 - - 2,455 - 2,549 Collateral posted for derivative transaction - - - 25,940 - 25,940 Fixed assets, net - - - 2,863 - 2,863 Deferred tax assets - 7,942 - - - 7,942 Other assets (6 ) 140,096 (15,575 ) 44,366 (154,156 ) 14,725 Investment in subsidiaries 237,542 74,053 99,421 - (411,016 ) - Total assets $ 246,992 $ 231,575 $ 138,259 $ 837,006 $ (572,644 ) $ 881,188 Liabilities and Equity Liabilities: Marketable securities sold, but not yet purchased, at fair value $ - $ - $ - $ 5,206 $ - $ 5,206 Accrued compensation 250 474 228 7,568 - 8,520 Asset-backed securities issued - - - 620,354 (7,000 ) 613,354 Interest payable - 1,506 - 4,263 - 5,769 Note payable 137,603 - - 15,000 (152,603 ) - Bond payable - 92,363 - - (473 ) 91,890 Deferred tax liability - 2,093 - 560 - 2,653 Other liabilities 1,860 23,501 314 825 (1,444 ) 25,056 Total liabilities $ 139,713 $ 119,937 $ 542 $ 653,776 $ (161,520 ) $ 752,448 Total members' (deficit) equity 107,279 111,638 122,447 184,146 (411,336 ) 114,174 Nonredeemable Non-controlling Interest $ - $ - $ 15,270 $ (916 ) $ 212 $ 14,566 Total equity $ 107,279 $ 111,638 $ 137,717 $ 183,230 $ (411,124 ) $ 128,740 Total liabilities and equity $ 246,992 $ 231,575 $ 138,259 $ 837,006 $ (572,644 ) $ 881,188 As of December 31, 2016 Parent Company Subsidiary Issuer Guarantor Subsidiary Non-Guarantor Subsidiaries Eliminations Consolidated JMP Group LLC Assets Cash and cash equivalents $ 255 $ 1,763 $ 5,060 $ 78,414 $ - $ 85,492 Restricted cash and deposits - 1,471 - 226,185 - 227,656 Receivable from clearing broker - - - 6,586 - 6,586 Investment banking fees receivable, net of allowance for doubtful accounts - - - 5,681 - 5,681 Marketable securities owned, at fair value - - 10,877 8,317 (472 ) 18,722 Incentive fee receivable - - - 499 - 499 Other investments - 5,126 9,838 17,905 - 32,869 Loans held for sale 32,488 32,488 Loans held for investment, net of allowance for loan losses - - - 1,930 - 1,930 Loans collateralizing asset-backed securities issued, net of allowance for loan losses - - - 654,127 - 654,127 Interest receivable - - 72 3,429 (72 ) 3,429 Collateral posted for derivative transaction - 25,000 - 25,000 Fixed assets, net - - - 3,143 - 3,143 Deferred tax assets - 7,942 - - - 7,942 Other assets (1,045 ) 141,905 (8,957 ) 42,597 (154,234 ) 20,266 Investment in subsidiaries 252,486 74,166 117,537 - (444,189 ) - Total assets $ 251,696 $ 232,373 $ 134,427 $ 1,106,301 $ (598,967 ) $ 1,125,830 Liabilities and Equity Liabilities: Marketable securities sold, but not yet purchased, at fair value $ - $ - $ - $ 4,747 $ - $ 4,747 Accrued compensation 90 150 - 35,918 - 36,158 Asset-backed securities issued - - - 825,854 - 825,854 Interest payable - 1,506 - 4,811 - 6,317 Note payable 137,603 - - 15,000 (152,603 ) - Bond payable - 92,258 - - (473 ) 91,785 Deferred tax liability - 3,232 - 640 - 3,872 Other liabilities 1,520 22,706 313 (1,142 ) (1,594 ) 21,803 Total liabilities $ 139,213 $ 119,852 $ 313 $ 885,828 $ (154,670 ) $ 990,536 Total members' (deficit) equity 112,483 112,521 117,532 221,350 (444,509 ) 119,377 Nonredeemable Non-controlling Interest $ - $ - $ 16,582 $ (877 ) $ 212 $ 15,917 Total equity $ 112,483 $ 112,521 $ 134,114 $ 220,473 $ (444,297 ) $ 135,294 Total liabilities and equity $ 251,696 $ 232,373 $ 134,427 $ 1,106,301 $ (598,967 ) $ 1,125,830
Condensed Income Statement [Table Text Block]	For the Three Months Ended March 31, 2017 Parent Company Subsidiary Issuer Guarantor Subsidiary Non- Guarantor Subsidiaries Eliminations Consolidated JMP Group LLC Revenues Investment banking $ - $ - $ - $ 13,600 $ - $ 13,600 Brokerage - - - 5,286 - 5,286 Asset management fees - - - 5,951 (40 ) 5,911 Principal transactions - 8 (396 ) (1,505 ) - (1,893 ) Loss on sale, payoff and mark-to-market of loans - - - 847 - 847 Gain on repurchase of debt 210 - - - - 210 Net dividend income - - 256 10 - 266 Other income - - - 445 - 445 Equity earnings of subsidiaries (2,766 ) (284 ) 583 - 2,467 - Non-interest revenues (2,556 ) (276 ) 443 24,634 2,427 24,672 Interest income 368 1,139 98 9,545 (2,083 ) 9,067 Interest expense (1,139 ) (2,274 ) - (6,765 ) 2,083 (8,095 ) Net interest income (771 ) (1,135 ) 98 2,780 - 972 Provision for loan losses - - - (1,266 ) - (1,266 ) Total net revenues after provision for loan losses (3,327 ) (1,411 ) 541 26,148 2,427 24,378 Non-interest expenses Compensation and benefits 535 646 247 20,370 - 21,798 Administration 127 122 26 1,584 (40 ) 1,819 Brokerage, clearing and exchange fees - - - 759 - 759 Travel and business development 78 - - 837 - 915 Communications and technology 1 2 - 1,050 - 1,053 Occupancy - - - 1,111 - 1,111 Professional fees 672 67 - 423 - 1,162 Depreciation - - - 311 - 311 Other - 6 69 602 - 677 Total non-interest expenses 1,413 843 342 27,047 (40 ) 29,605 Net income (loss) before income tax expense (4,740 ) (2,254 ) 199 (899 ) 2,467 (5,227 ) Income tax expense (benefit) - (1,020 ) - (64 ) - (1,084 ) Net income (loss) (4,740 ) (1,234 ) 199 (835 ) 2,467 (4,143 ) Less: Net income (loss) attributable to nonredeemable non-controlling interest - - 437 160 - 597 Net income (loss) attributable to JMP Group LLC $ (4,740 ) $ (1,234 ) $ (238 ) $ (995 ) $ 2,467 $ (4,740 ) For the Three Months Ended March 31, 2016 Parent Company Subsidiary Issuer Guarantor Subsidiary Non-Guarantor Subsidiaries Eliminations Consolidated JMP Group LLC Revenues Investment banking $ - $ - $ - $ 18,296 $ - $ 18,296 Brokerage - - - 6,095 - 6,095 Asset management fees - - - 9,326 - 9,326 Principal transactions - 120 (127 ) 937 - 930 Loss on sale, payoff and mark-to-market of loans - - - (376 ) - (376 ) Net dividend income - - 239 24 - 263 Other income - - 87 139 - 226 Equity earnings of subsidiaries 3,866 1,812 4,768 - (10,446 ) - Non-interest revenues 3,866 1,932 4,967 34,441 (10,446 ) 34,760 Interest income 370 1,139 166 12,721 (1,995 ) 12,401 Interest expense (1,139 ) (2,288 ) - (6,543 ) 1,995 (7,975 ) Net interest income (769 ) (1,149 ) 166 6,178 - 4,426 Provision for loan losses - - - (631 ) - (631 ) Total net revenues after provision for loan losses 3,097 783 5,133 39,988 (10,446 ) 38,555 Non-interest expenses Compensation and benefits 505 1,172 162 25,586 - 27,425 Administration 118 130 71 386 1,113 1,818 Brokerage, clearing and exchange fees - - - 761 - 761 Travel and business development 85 - - 1,206 - 1,291 Communications and technology 2 2 - 1,012 - 1,016 Occupancy - - - 936 - 936 Professional fees 586 69 12 406 - 1,073 Depreciation - - - 332 - 332 Other - - - 1,734 (1,113 ) 621 Total non-interest expenses 1,296 1,373 245 32,359 - 35,273 Net income (loss) before income tax expense 1,801 (590 ) 4,888 7,629 (10,446 ) 3,282 Income tax expense (benefit) - (854 ) - 904 - 50 Net income (loss) 1,801 264 4,888 6,725 (10,446 ) 3,232 Less: Net income (loss) attributable to nonredeemable non-controlling interest - - 1,286 143 - 1,429 Net income (loss) attributable to JMP Group LLC $ 1,801 $ 264 $ 3,602 $ 6,582 $ (10,446 ) $ 1,803
Condensed Cash Flow Statement [Table Text Block]	For the Quarter Ended March 31, 2017 Parent Company Subsidiary Issuer Guarantor Subsidiary Non-Guarantor Subsidiaries Eliminations Consolidated JMP Group LLC Cash flows from operating activities: Net income (loss) $ (4,740 ) $ (1,234 ) $ 199 $ (835 ) $ 2,467 $ (4,143 ) Adjustments to reconcile net income to net cash provided by (used in) operating activities: Provision for doubtful accounts - - - 90 90 Provision for loan losses - - - 1,266 - 1,266 Accretion of deferred loan fees - - - (840 ) - (840 ) Amortization of liquidity discount, net - - - - - - Amortization of debt issuance costs - 105 - - - 105 Amortization of original issue discount, related to CLO II and CLO III - - - 702 - 702 Interest paid in kind - - - - - - Loss (gain) on sale and payoff of loans - - - (1,027 ) - (1,027 ) Gain on repurchase of asset-backed securities issued - - (210 ) - - (210 ) Change in other investments: Income from investments in equity method investees - - - 690 - 690 Fair value on other equity investments - (8 ) (19 ) 1,489 - 1,462 Realized gain on other investments - - - (371 ) - (371 ) Depreciation and amortization of fixed assets - - - 311 - 311 Stock-based compensation expense 780 - - - - 780 Deferred income taxes - (1,139 ) - (80 ) - (1,219 ) Net change in operating assets and liabilities: (Increase) decrease in interest receivable (94 ) - 72 974 (72 ) 880 Decrease (increase) in receivables - - - (1,739 ) - (1,739 ) Increase in marketable securities - - 416 (2,252 ) - (1,836 ) (Increase) decrease in restricted cash (excluding restricted cash reserved for lending activities) - - - 944 - 944 (Increase) decrease in deposits and other assets (1,039 ) 1,809 6,828 5,884 (22,157 ) (8,675 ) Increase in marketable securities sold, but not yet purchased - - - 459 - 459 Increase in interest payable - - - (548 ) - (548 ) (Decrease) increase in accrued compensation and other liabilities 505 1,119 229 (26,520 ) 149 (24,518 ) Net cash used in operating activities $ (4,588 ) $ 652 $ 7,515 $ (21,403 ) $ (19,613 ) $ (37,437 ) Cash flows from investing activities: Purchases of fixed assets - - - (31 ) - (31 ) Investment in subsidiary 14,944 113 18,116 - (33,173 ) - Purchases of other investments (7,000 ) (844 ) (146 ) - 7,000 (990 ) Sales of other investments - 102 214 (6,032 ) 15,080 9,364 Funding of loans collateralizing asset-backed securities issued - - - (50,122 ) - (50,122 ) Funding of loans held for sale (2,752 ) (2,752 ) Sale and payoff of loans collateralizing asset-backed securities issued - - - 111,743 - 111,743 Principal receipts on loans collateralizing asset-backed securities issued - - - 16,728 - 16,728 Net change in restricted cash reserved for lending activities - - - 159,579 - 159,579 Cash collateral posted for total return swap - - - (940 ) (940 ) Net cash provided by (used in) investing activities $ 7,944 $ (629 ) $ 18,184 $ 228,173 $ (11,093 ) $ 242,579 Cash flows from financing activities: Repayment of asset-backed securities issued - - - (206,202 ) - (206,202 ) Distributions and dividend equivalents paid on common shares and RSUs (1,954 ) - - - - (1,954 ) Capital contributions of parent - 351 5,153 (36,210 ) 30,706 - Capital contributions of nonredeemable non-controlling interest holders - - 92 - - 92 Distributions to non-controlling interest shareholders - - (1,841 ) (199 ) - (2,040 ) Net cash settlement of RSU vesting 889 - - - - 889 Employee Taxes Paid on Shares Withheld for Tax-withholding purposes (184 ) - - - - (184 ) Net cash (used in) provided by financing activities $ (1,249 ) $ 351 $ 3,404 $ (242,611 ) $ 30,706 $ (209,399 ) Net decrease in cash and cash equivalents 2,107 374 29,103 (35,841 ) - (4,257 ) Cash and cash equivalents, beginning of period $ 255 $ 1,763 $ 5,060 $ 78,414 $ - 85,492 Cash and cash equivalents, end of period 2,362 2,137 34,163 42,573 - 81,235 For the Three Months Ended March 31, 2016 Parent Company Subsidiary Issuer Guarantor Subsidiary Non-Guarantor Subsidiary Eliminations Consolidated JMP Group LLC Cash flows from operating activities: Net income (loss) $ 1,801 $ 264 $ 4,888 $ 6,725 $ (10,446 ) $ 3,232 Adjustments to reconcile net income to net cash provided by (used in) operating activities: Provision for loan losses - - - 631 - 631 Accretion of deferred loan fees - - - (360 ) - (360 ) Amortization of liquidity discount, net - - - (36 ) - (36 ) Amortization of debt issuance costs - 117 - - - 117 Amortization of original issue discount, related to CLO II and CLO III - - - 598 - 598 Interest paid in kind - - - (53 ) - (53 ) Loss (gain) on sale and payoff of loans - - - 376 - 376 Gain on repurchase of asset-backed securities issued - - (87 ) - - (87 ) Change in other investments: Income from investments in equity method investees (283 ) (283 ) Fair value on other equity investments - (120 ) 438 (415 ) - (97 ) Change in fair value of small business loans - - - - - Realized gain on other investments - - - (19 ) - (19 ) Depreciation and amortization of fixed assets - - - 332 - 332 Stock-based compensation expense 1,242 - - - 1,242 Deferred income taxes - (1,399 ) - (81 ) - (1,480 ) Net change in operating assets and liabilities: (Increase) decrease in interest receivable - - (3 ) (93 ) 135 39 Decrease (increase) in receivables - - - (1,866 ) (49 ) (1,915 ) Increase in marketable securities - - (796 ) 1,366 485 1,055 (Increase) decrease in restricted cash (excluding restricted cash reserved for lending activities) - - - 337 - 337 (Increase) decrease in deposits and other assets (1,073 ) 6,443 14,817 (31,519 ) 15,918 4,586 Increase in marketable securities sold, but not yet purchased - - - 89 - 89 Increase in interest payable - - - 500 (66 ) 434 (Decrease) increase in accrued compensation and other liabilities 588 732 144 (24,361 ) (1,304 ) (24,201 ) Net cash used in operating activities $ 2,558 $ 6,037 $ 19,401 $ (48,132 ) $ 4,673 $ (15,463 ) Cash flows from investing activities: Purchases of fixed assets - - - (72 ) - (72 ) Purchase of management contract - - - - - - Investment in subsidiary (6,493 ) (9,346 ) 360 12,983 2,496 - Purchases of other investments - (2,779 ) - - - (2,779 ) Sales of other investments - - 9,568 2,038 88 11,694 Funding of loans collateralizing asset-backed securities issued - - - (52,181 ) - (52,181 ) Sale and payoff of loans collateralizing asset-backed securities issued - - - 53,698 - 53,698 Principal receipts on loans collateralizing asset-backed securities issued - - - 15,861 - 15,861 Net change in restricted cash reserved for lending activities - - - (6,090 ) - (6,090 ) Cash transferred from consolidated subsidiary to non-consolidated hedge fund - - - - - - Cash and cash equivalents derecognized due to adoption of new consolidation guidance - - - (240 ) - (240 ) Net cash provided by (used in) investing activities $ (6,493 ) $ (12,125 ) $ 9,928 $ 25,997 $ 2,584 $ 19,891 Cash flows from financing activities: Repayment of note payable - - - 15,000 (15,000 ) - Repayment of line of credit - - - - - - Repayment of credit warehouse - - - - - - Repayment and repurchase of contingent consideration payable - - - - - - Proceeds from initial public offering, net of expenses - - - - - - Sale of asset-back securities issued - - - - - - Repurchase of asset-backed securities issued - - - - - - Repurchase of bonds payable - - - - (385 ) (385 ) Repayment of asset-backed securities issued - - - (11,824 ) - (11,824 ) Distributions paid to Class A and Class B common interests - - - - - - Distributions and dividend equivalents paid on common shares and RSUs (2,616 ) - - - - (2,616 ) Purchases of shares of common stock for treasury (2,629 ) - - - - (2,629 ) Capital contributions of parent 10,213 4,041 (22,382 ) - 8,128 - Purchase of assets with non-controlling interest - - - - - - Sale of assets with non-controlling interest - - - - - - Capital contributions of redeemable non-controlling interest holders - - (1,704 ) - - (1,704 ) Capital contributions of nonredeemable non-controlling interest holders - - - - - - Net cash (used in) provided by financing activities $ 4,968 $ 4,041 $ (24,086 ) $ 3,176 $ (7,257 ) $ (19,158 ) Net decrease in cash and cash equivalents 1,033 (2,047 ) 5,243 (18,959 ) - (14,730 ) Cash and cash equivalents, beginning of period $ 80 $ 11,260 $ 1,225 $ 55,986 $ - $ 68,551 Cash and cash equivalents, end of period 1,113 9,213 6,468 37,027 - 53,821

Note 4 - Fair Value Measureme40

Note 4 - Fair Value Measurements (Details Textual) $ in Thousands	Sep. 26, 2016USD ($)	Dec. 02, 2015USD ($)	Nov. 16, 2015USD ($)	Jul. 01, 2013USD ($)	Apr. 05, 2011USD ($)	Mar. 31, 2017USD ($)	Jun. 30, 2016USD ($)	Mar. 31, 2016USD ($)	Jun. 30, 2015	Dec. 31, 2015USD ($)	Dec. 31, 2016USD ($)
Number of Loans Held for Investment						4					4
Financing Receivable, Allowance for Credit Losses						$ 1,155					$ 433
Financing Receivable, Net						1,157					1,930
Investments, Fair Value Disclosure						19,989					21,459
Derivative, Collateral, Right to Reclaim Cash						25,940					25,000
Total Return Swap [Member]
Gain (Loss) on Investments						(1,300)		$ 100
Credit Derivative, Term									3 years
Investments, Fair Value Disclosure						(100)					1,300
Derivative, Collateral, Right to Reclaim Cash						25,000
Derivative, Collateral, Additional Collateral Posted						900
Total Return Swap [Member] | Maximum [Member]
Derivative, Collateral, Right to Reclaim Cash						25,900
Total Return Swap [Member] | Revolving Period [Member]
Credit Derivative, Term									1 year 180 days
Total Return Swap [Member] | Amortization Period [Member]
Credit Derivative, Term									1 year 180 days
River Banc LLC [Member]
Gain (Loss) on Investments								100		$ 1,700
Payments to Acquire Equity Method Investments					$ 300
Proceeds from Equity Method Investment, Distribution								500		$ 1,700
Equity Method Investment, Realized Gain (Loss) on Disposal							$ 6,000
Mountain Opportunity Fund [Member]
Gain (Loss) on Investments								100
Payments to Acquire Equity Method Investments			$ 2,000
Proceeds from Equity Method Investment, Distribution								200
Equity Method Investment, Realized Gain (Loss) on Disposal	$ (100)
Workspace [Member]
Gain (Loss) on Investments								100
Payments to Acquire Equity Method Investments		$ 12,800
Proceeds from Equity Method Investment, Distribution								100
Equity Method Investment, Realized Gain (Loss) on Disposal	$ 400
Equity Method Investment, Ownership Percentage, Disposed Of	21.60%
Equity Method Investments						9,300					10,800
Health Sciences Fund [Member]
Loans and Leases Receivable, Commitments to Purchase or Sell				$ 2,000
Debt Instrument, Interest Rate, Stated Percentage				10.00%
Financing Receivable, Allowance for Credit Losses						1,200					400
Financing Receivable, Net						1,000					1,700
Loans Collateralizing Asset Backed Securities [Member]
Gain (Loss) on Investments						1,000		$ 0
Loans Collateralizing Asset Backed Securities [Member] | Non Accrual [Member]
Assets, Fair Value Disclosure, Nonrecurring						2,900					1,900
Loans Held for Investment [Member]
Loans Receivable, Fair Value Disclosure						$ 1,100					$ 1,600

Note 4 - Fair Value Measureme41

Note 4 - Fair Value Measurements - Fair Value of Financial Instruments (Details) - USD ($) $ in Thousands		Mar. 31, 2017	Dec. 31, 2016
Loans Collateralizing Assetbacked Securities Issued Net Of Allowance For Loan Losses Fair Value Disclosure		$ 610,900	$ 685,400
Derivative, Collateral, Right to Reclaim Cash		25,940	25,000
Marketable securities sold, but not yet purchased		5,206	4,747
Assets:
Loans held for sale		1,437	32,488
Loans Collateralizing Assetbacked Securities Issued Net Of Allowance For Loan Losses Fair Value Disclosure		610,900	685,400
Derivative, Collateral, Right to Reclaim Cash		25,940	25,000
Liabilities:
Marketable securities sold, but not yet purchased		5,206	4,747
Total Return Swap [Member]
Derivative, Collateral, Right to Reclaim Cash		25,000
Assets:
Derivative, Collateral, Right to Reclaim Cash		25,000
Reported Value Measurement [Member]
Cash and cash equivalents		81,235	85,492
Restricted cash and deposits		67,133	227,656
Marketable securities owned		20,558	18,722
Other investments		12,420	13,697
Other investments measured at net asset value (1)	[1]	17,859	19,172
Loans held for investment, net of allowance for loan losses		1,157	1,930
Loans Collateralizing Assetbacked Securities Issued Net Of Allowance For Loan Losses Fair Value Disclosure		610,955	654,127
Derivative, Collateral, Right to Reclaim Cash		25,940	25,000
Total assets:		837,257	1,078,284
Marketable securities sold, but not yet purchased		5,206	4,747
Asset-backed securities issued		613,354	825,854
Bond payable		91,890	91,785
Total liabilities:		710,590	922,386
Assets:
Cash and cash equivalents		81,235	85,492
Restricted cash and deposits		67,133	227,656
Marketable securities owned		20,558	18,722
Other investments		12,420	13,697
Other investments measured at net asset value (1)	[1]	17,859	19,172
Loans held for sale			32,488
Loans held for investment, net of allowance for loan losses		1,157	1,930
Loans Collateralizing Assetbacked Securities Issued Net Of Allowance For Loan Losses Fair Value Disclosure		610,955	654,127
Derivative, Collateral, Right to Reclaim Cash		25,940	25,000
Total assets:		837,257	1,078,284
Liabilities:
Marketable securities sold, but not yet purchased		5,206	4,747
Asset-backed securities issued		613,354	825,854
Bond payable		91,890	91,785
Total liabilities:		710,590	922,386
Reported Value Measurement [Member] | Total Return Swap [Member]
Total return swap		140
Estimate of Fair Value Measurement [Member]
Cash and cash equivalents		81,235	85,492
Restricted cash and deposits		67,133	227,656
Marketable securities owned		20,558	18,722
Other investments		12,420	13,697
Other investments measured at net asset value (1)	[1]
Loans held for investment, net of allowance for loan losses		1,270	1,824
Loans Collateralizing Assetbacked Securities Issued Net Of Allowance For Loan Losses Fair Value Disclosure		610,948	685,392
Derivative, Collateral, Right to Reclaim Cash		25,940	25,000
Total assets:		819,504	1,091,434
Marketable securities sold, but not yet purchased		5,206	4,747
Asset-backed securities issued		621,785	831,854
Bond payable		94,803	94,517
Total liabilities:		721,934	931,118
Assets:
Cash and cash equivalents		81,235	85,492
Restricted cash and deposits		67,133	227,656
Marketable securities owned		20,558	18,722
Other investments		12,420	13,697
Other investments measured at net asset value (1)	[1]
Loans held for sale		1,400	33,651
Loans held for investment, net of allowance for loan losses		1,270	1,824
Loans Collateralizing Assetbacked Securities Issued Net Of Allowance For Loan Losses Fair Value Disclosure		610,948	685,392
Derivative, Collateral, Right to Reclaim Cash		25,940	25,000
Total assets:		819,504	1,091,434
Liabilities:
Marketable securities sold, but not yet purchased		5,206	4,747
Asset-backed securities issued		621,785	831,854
Bond payable		94,803	94,517
Total liabilities:		721,934	931,118
Estimate of Fair Value Measurement [Member] | Total Return Swap [Member]
Total return swap		140
Estimate of Fair Value Measurement [Member] | Fair Value, Inputs, Level 1 [Member]
Cash and cash equivalents		81,235	85,492
Restricted cash and deposits		67,133	227,656
Marketable securities owned		20,558	18,722
Other investments
Other investments measured at net asset value (1)	[1]
Loans held for investment, net of allowance for loan losses
Loans Collateralizing Assetbacked Securities Issued Net Of Allowance For Loan Losses Fair Value Disclosure
Derivative, Collateral, Right to Reclaim Cash		25,940	25,000
Total assets:		194,866	356,870
Marketable securities sold, but not yet purchased		5,206	4,747
Asset-backed securities issued
Bond payable
Total liabilities:		5,206	4,747
Assets:
Cash and cash equivalents		81,235	85,492
Restricted cash and deposits		67,133	227,656
Marketable securities owned		20,558	18,722
Other investments
Other investments measured at net asset value (1)	[1]
Loans held for sale
Loans held for investment, net of allowance for loan losses
Loans Collateralizing Assetbacked Securities Issued Net Of Allowance For Loan Losses Fair Value Disclosure
Derivative, Collateral, Right to Reclaim Cash		25,940	25,000
Total assets:		194,866	356,870
Liabilities:
Marketable securities sold, but not yet purchased		5,206	4,747
Asset-backed securities issued
Bond payable
Total liabilities:		5,206	4,747
Estimate of Fair Value Measurement [Member] | Fair Value, Inputs, Level 1 [Member] | Total Return Swap [Member]
Total return swap
Estimate of Fair Value Measurement [Member] | Fair Value, Inputs, Level 2 [Member]
Cash and cash equivalents
Restricted cash and deposits
Marketable securities owned
Other investments		12,420	13,697
Other investments measured at net asset value (1)	[1]
Loans held for investment, net of allowance for loan losses
Loans Collateralizing Assetbacked Securities Issued Net Of Allowance For Loan Losses Fair Value Disclosure		610,948	685,392
Derivative, Collateral, Right to Reclaim Cash
Total assets:		623,368	732,740
Marketable securities sold, but not yet purchased
Asset-backed securities issued		621,785	831,854
Bond payable		94,803	94,517
Total liabilities:		716,728	926,371
Assets:
Cash and cash equivalents
Restricted cash and deposits
Marketable securities owned
Other investments		12,420	13,697
Other investments measured at net asset value (1)	[1]
Loans held for sale			33,651
Loans held for investment, net of allowance for loan losses
Loans Collateralizing Assetbacked Securities Issued Net Of Allowance For Loan Losses Fair Value Disclosure		610,948	685,392
Derivative, Collateral, Right to Reclaim Cash
Total assets:		623,368	732,740
Liabilities:
Marketable securities sold, but not yet purchased
Asset-backed securities issued		621,785	831,854
Bond payable		94,803	94,517
Total liabilities:		716,728	926,371
Estimate of Fair Value Measurement [Member] | Fair Value, Inputs, Level 2 [Member] | Total Return Swap [Member]
Total return swap		140
Estimate of Fair Value Measurement [Member] | Fair Value, Inputs, Level 3 [Member]
Cash and cash equivalents
Restricted cash and deposits
Marketable securities owned
Other investments
Other investments measured at net asset value (1)	[1]
Loans held for investment, net of allowance for loan losses		1,270	1,824
Loans Collateralizing Assetbacked Securities Issued Net Of Allowance For Loan Losses Fair Value Disclosure
Derivative, Collateral, Right to Reclaim Cash
Total assets:		1,270	1,824
Marketable securities sold, but not yet purchased
Asset-backed securities issued
Bond payable
Total liabilities:
Assets:
Cash and cash equivalents
Restricted cash and deposits
Marketable securities owned
Other investments
Other investments measured at net asset value (1)	[1]
Loans held for sale
Loans held for investment, net of allowance for loan losses		1,270	1,824
Loans Collateralizing Assetbacked Securities Issued Net Of Allowance For Loan Losses Fair Value Disclosure
Derivative, Collateral, Right to Reclaim Cash
Total assets:		1,270	1,824
Liabilities:
Marketable securities sold, but not yet purchased
Asset-backed securities issued
Bond payable
Total liabilities:
Estimate of Fair Value Measurement [Member] | Fair Value, Inputs, Level 3 [Member] | Total Return Swap [Member]
Total return swap
[1]	In accordance with ASC 820-10, certain investments that are measured at fair value using the net asset value per share (or its equivalent) have not been classified in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the statement of financial condition.

Note 4 - Fair Value Measureme42

Note 4 - Fair Value Measurements - Fair Value of Assets and Liabilities on a Recurring Basis (Details) - USD ($) $ in Thousands		Mar. 31, 2017	Dec. 31, 2016
Investments, Fair Value Disclosure		$ 19,989	$ 21,459
Investments In Funds Of Funds Managed By HCS [Member]
Investments, Fair Value Disclosure	[1]	5	5
Total Return Swap [Member]
Investments, Fair Value Disclosure		(100)	1,300
Fair Value, Measurements, Recurring [Member]
Marketable securities owned		20,558	18,722
Investments, Fair Value Disclosure		12,420	13,697
Total assets:		32,978	32,419
Marketable securities sold, but not yet purchased		5,206	4,747
Total liabilities:		5,346	4,747
Fair Value, Measurements, Recurring [Member] | Investments In Hedge Funds Managed By HCS [Member]
Investments, Fair Value Disclosure		12,420	12,444
Fair Value, Measurements, Recurring [Member] | Investments in Private Equity Funds Managed by HCS [Member]
Investments, Fair Value Disclosure	[2]
Fair Value, Measurements, Recurring [Member] | Investments In Funds Of Funds Managed By HCS [Member]
Investments, Fair Value Disclosure	[2]
Fair Value, Measurements, Recurring [Member] | Total Investment In Funds Managed By HCS [Member]
Investments, Fair Value Disclosure	[2]	12,420	12,444
Fair Value, Measurements, Recurring [Member] | Limited Partner Investment in Private Equity Fund and Real Estate Funds [Member]
Investments, Fair Value Disclosure	[2]
Fair Value, Measurements, Recurring [Member] | Total Return Swap [Member]
Investments, Fair Value Disclosure		140	1,253
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]
Marketable securities owned		20,558	18,722
Investments, Fair Value Disclosure
Total assets:		20,558	18,722
Marketable securities sold, but not yet purchased		5,206	4,747
Total liabilities:		5,206	4,747
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member] | Investments In Hedge Funds Managed By HCS [Member]
Investments, Fair Value Disclosure
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member] | Investments In Funds Of Funds Managed By HCS [Member]
Investments, Fair Value Disclosure	[2]
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member] | Total Investment In Funds Managed By HCS [Member]
Investments, Fair Value Disclosure	[2]
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member] | Limited Partner Investment in Private Equity Fund and Real Estate Funds [Member]
Investments, Fair Value Disclosure	[2]
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member] | Total Return Swap [Member]
Investments, Fair Value Disclosure
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Marketable securities owned
Investments, Fair Value Disclosure		12,420	13,697
Total assets:		12,420	13,697
Marketable securities sold, but not yet purchased
Total liabilities:		140
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Investments In Hedge Funds Managed By HCS [Member]
Investments, Fair Value Disclosure		12,420	12,444
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Investments In Funds Of Funds Managed By HCS [Member]
Investments, Fair Value Disclosure	[2]
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Total Investment In Funds Managed By HCS [Member]
Investments, Fair Value Disclosure	[2]	12,420	12,444
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Limited Partner Investment in Private Equity Fund and Real Estate Funds [Member]
Investments, Fair Value Disclosure	[2]
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Total Return Swap [Member]
Investments, Fair Value Disclosure		140	1,253
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member]
Marketable securities owned
Investments, Fair Value Disclosure
Total assets:
Marketable securities sold, but not yet purchased
Total liabilities:
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member] | Investments In Hedge Funds Managed By HCS [Member]
Investments, Fair Value Disclosure
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member] | Investments in Private Equity Funds Managed by HCS [Member]
Investments, Fair Value Disclosure	[2]
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member] | Investments In Funds Of Funds Managed By HCS [Member]
Investments, Fair Value Disclosure	[2]
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member] | Total Investment In Funds Managed By HCS [Member]
Investments, Fair Value Disclosure	[2]
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member] | Limited Partner Investment in Private Equity Fund and Real Estate Funds [Member]
Investments, Fair Value Disclosure	[2]
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member] | Total Return Swap [Member]
Investments, Fair Value Disclosure
Reported Value Measurement [Member]
Total assets:		837,257	1,078,284
Total liabilities:		710,590	922,386
Reported Value Measurement [Member] | Fair Value, Measurements, Recurring [Member]
Marketable securities owned		20,558	18,722
Investments, Fair Value Disclosure		19,989	21,459
Total assets:		40,547	40,181
Marketable securities sold, but not yet purchased		5,206	4,747
Total liabilities:		5,346	4,747
Reported Value Measurement [Member] | Fair Value, Measurements, Recurring [Member] | Investments In Hedge Funds Managed By HCS [Member]
Investments, Fair Value Disclosure		12,420	12,444
Reported Value Measurement [Member] | Fair Value, Measurements, Recurring [Member] | Investments in Private Equity Funds Managed by HCS [Member]
Investments, Fair Value Disclosure	[2]	4,045	4,227
Reported Value Measurement [Member] | Fair Value, Measurements, Recurring [Member] | Investments In Funds Of Funds Managed By HCS [Member]
Investments, Fair Value Disclosure	[2]	5	5
Reported Value Measurement [Member] | Fair Value, Measurements, Recurring [Member] | Total Investment In Funds Managed By HCS [Member]
Investments, Fair Value Disclosure	[2]	16,470	16,676
Reported Value Measurement [Member] | Fair Value, Measurements, Recurring [Member] | Limited Partner Investment in Private Equity Fund and Real Estate Funds [Member]
Investments, Fair Value Disclosure	[2]	3,519	3,530
Reported Value Measurement [Member] | Fair Value, Measurements, Recurring [Member] | Total Return Swap [Member]
Investments, Fair Value Disclosure		$ 140	$ 1,253
[1]	Investments in Funds of Funds managed by HCS began the process of liquidation on December 31, 2015.
[2]	In accordance with ASC 820-10, certain investments that are measured at fair value using the net asset value per share (or its equivalent) have not been classified in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the statement of financial condition.

Note 4 - Fair Value Measureme43

Note 4 - Fair Value Measurements - Valuation Techniques With Unobservable Inputs (Details) - USD ($) $ in Thousands		Mar. 31, 2017	Dec. 31, 2016
Investments at Fair Value		$ 19,989	$ 21,459
Investments In Funds Of Funds Managed By HCS [Member]
Investments at Fair Value	[1]	5	5
Limited Partner Investment in Private Equity Fund [Member] | Nonredeemable Funds [Member]
Investments at Fair Value		3,519	3,530
Investments in Private Equity Funds Managed by HCS [Member] | Nonredeemable Funds [Member]
Investments at Fair Value		4,045	4,227
Investment in private equity funds managed by HCS		$ 1,085	$ 1,085
[1]	Investments in Funds of Funds managed by HCS began the process of liquidation on December 31, 2015.

Note 5 - Loans Collateralizin44

Note 5 - Loans Collateralizing Asset-backed Securities Issued and Loans Held for Sale (Details Textual) xbrli-pure in Thousands, $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2017USD ($)	Dec. 31, 2016USD ($)
Loans Receivable Held-for-sale, Net, Not Part of Disposal Group	$ 1,437	$ 32,488
Loans Collateralizing Assetbacked Securities Issued Net Of Allowance For Loan Losses Fair Value Disclosure	610,900	685,400
Financing Receivable, Recorded Investment, Past Due	$ 0	$ 0
Financing Receivable, Modifications, Number of Contracts	0	0
Estimate of Fair Value Measurement [Member]
Loans Receivable Held-for-sale, Net, Not Part of Disposal Group	$ 1,400	$ 33,651
Loans Collateralizing Assetbacked Securities Issued Net Of Allowance For Loan Losses Fair Value Disclosure	610,948	685,392
Loans Collateralizing Asset Backed Securities [Member]
Financing Receivable, Collectively Evaluated for Impairment	613,300	657,800
Loans Collateralizing Asset Backed Securities [Member]
Financing Receivable, Individually Evaluated for Impairment	$ 4,800	$ 2,900

Note 5 - Loans Collateralizin45

Note 5 - Loans Collateralizing Asset-backed Securities Issued and Loans Held for Sale - Components of Loans Collateralizing Asset-backed Securities Issued (Details) - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016	Mar. 31, 2016	Dec. 31, 2015
Allowance for loan losses	$ (7,095)	$ (6,540)	$ (6,028)	$ (5,397)
Total loans, net	610,955	654,127
Loans Collateralizing Asset Backed Securities [Member]
Outstanding principal	624,130	667,237
Allowance for loan losses	(7,095)	(6,540)
Total loans, net	610,955	654,127
Loans Collateralizing Asset Backed Securities [Member] | Liquidity Discount [Member]
Liquidity discount
Loans Collateralizing Asset Backed Securities [Member] | Deferred Loan Fees Net [Member]
Liquidity discount	(6,080)	(6,570)
Loans Held For Sale [Member]
Outstanding principal	1,454	33,748
Allowance for loan losses
Valuation allowance		(180)
Total loans, net	1,437	32,488
Loans Held For Sale [Member] | Liquidity Discount [Member]
Liquidity discount		(772)
Loans Held For Sale [Member] | Deferred Loan Fees Net [Member]
Liquidity discount	$ (17)	$ (308)

Note 5 - Loans Collateralizin46

Note 5 - Loans Collateralizing Asset-backed Securities Issued and Loans Held for Sale - Loan Activity (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Balance at beginning of period	$ (6,540)	$ (5,397)
Provision for loan losses	(1,266)	(631)
Balance at end of period	(7,095)	(6,028)
Impaired Loans [Member]
Principal loans, beginning of period	3,113
Balance at beginning of period	(937)
Deferred loan fees, beginning of period	(249)
Net loans, beginning of period	1,927
Repayments	(44)
Repayments, net	(44)
Accretion of discount, deferred loan fees	(1)
Accretion of discount, net of deferred loan fees	(1)
Provision for loan losses	(971)
Transfers to/from impaired loans, net	1,947
Transfers to/from impaired loans, net, allowance for loan losses
Transfers to/from non-impaired loans, net, deferred loan fees	(3)
Transfers to/from non-impaired loans, net	1,944
Principal loans, end of period	5,016
Balance at end of period	(1,908)
Deferred loan fees, end of period	(253)
Net loans, end of period	2,855
Non Impaired Loans [Member]
Principal loans, beginning of period	664,124	984,110
Balance at beginning of period	(5,603)	(5,397)
Deferred loan fees, beginning of period	(6,321)	(8,130)
Net loans, beginning of period	652,200	969,665
Repayments	(14,900)	(15,997)
Repayments, net	(14,900)	(15,861)
Accretion of discount, deferred loan fees	526	360
Accretion of discount, net of deferred loan fees	526	396
Provision for loan losses	416	(631)
Transfers to/from impaired loans, net	(1,947)
Transfers to/from impaired loans, net, allowance for loan losses
Transfers to/from non-impaired loans, net, deferred loan fees	3
Transfers to/from non-impaired loans, net	(1,944)
Principal loans, end of period	619,114	967,151
Balance at end of period	(5,187)	(6,028)
Deferred loan fees, end of period	(5,827)	(8,565)
Net loans, end of period	608,100	951,676
Purchases	50,733	53,409
Purchases, deferred loan fees	(611)	(1,228)
Purchases, net of deferred loan fees	50,122	52,181
Repayments, deferred loan fees		136
Sales and payoff	(78,896)	(54,371)
Sales and payoff, deferred loan fees	576	297
Sales and payoff, net of deferred loan fees	$ (78,320)	(54,074)
Liquidity discount, beginning of period		(918)
Accretion of discount, liquidity discount		36
Liquidity discount, end of period		$ (882)

Note 5 - Loans Collateralizin47

Note 5 - Loans Collateralizing Asset-backed Securities Issued and Loans Held for Sale - Allowance for Loan Losses (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Balance at beginning of period	$ (6,540)	$ (5,397)
Provision for loan losses	(1,266)	(631)
Balance at end of period	(7,095)	(6,028)
Specific Reserve [Member]
Provision for loan losses	(971)
General Reserve [Member]
Provision for loan losses	$ 416	$ (631)

Note 5 - Loans Collateralizin48

Note 5 - Loans Collateralizing Asset-backed Securities Issued and Loans Held for Sale - Schedule of Impaired Financing Receivable (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2017	Dec. 31, 2016
Impaired loans with an allowance recorded, recorded investment	$ 4,763	$ 2,864
Impaired loans with an allowance recorded, unpaid principal balance	5,158	3,211
Impaired loans, related allowance	1,908	938
Impaired loans with an allowance recorded, average recorded investment	4,779	2,913
Impaired loans with an allowance recorded, interest income recognized	25	75
Impaired loans with no related allowance recorded, recorded investment	0	0
Impaired loans with no related allowance recorded, unpaid principal balance	0	0
Impaired loans with no related allowance recorded, average recorded investment	0	0
Impaired loans with no related allowance recorded, interest income recognized	0	0
Impaired loans, recorded investment	4,763	2,864
Impaired loans, unpaid principal balance	5,158	3,211
Impaired loans, average recorded investment	4,779	2,913
Impaired loans, interest income recognized	$ 25	$ 75

Note 5 - Loans Collateralizin49

Note 5 - Loans Collateralizing Asset-backed Securities Issued and Loans Held for Sale - Credit Quality of Loans (Details) - USD ($) $ in Thousands		Mar. 31, 2017	Dec. 31, 2016
Loans Collateralizing Asset Backed Securities [Member]
Recorded investment		$ 618,050	$ 660,667
Loans Collateralizing Asset Backed Securities [Member] | Performing Financial Instruments [Member]
Recorded investment		613,285	657,803
Loans Collateralizing Asset Backed Securities [Member] | Nonperforming Financial Instruments [Member]
Recorded investment		4,765	2,864
Loans Collateralizing Asset Backed Securities [Member] | Two [Member]
Recorded investment	[1]	528,737	545,181
Loans Collateralizing Asset Backed Securities [Member] | Three [Member]
Recorded investment	[1]	66,320	94,407
Loans Collateralizing Asset Backed Securities [Member] | Four [Member]
Recorded investment	[1]	18,230	18,215
Loans Collateralizing Asset Backed Securities [Member] | Five [Member]
Recorded investment	[1]	4,763	2,864
Loans Collateralizing Asset Backed Securities [Member] | Internal Ratings [Member]
Recorded investment	[1]	618,050	660,667
Loans Held For Sale [Member]
Recorded investment		1,437	32,668
Loans Held For Sale [Member] | Performing Financial Instruments [Member]
Recorded investment		1,437	32,668
Loans Held For Sale [Member] | Nonperforming Financial Instruments [Member]
Recorded investment
Loans Held For Sale [Member] | Two [Member]
Recorded investment	[1]		27,109
Loans Held For Sale [Member] | Three [Member]
Recorded investment	[1]	1,437	5,559
Loans Held For Sale [Member] | Four [Member]
Recorded investment	[1]
Loans Held For Sale [Member] | Five [Member]
Recorded investment	[1]
Loans Held For Sale [Member] | Internal Ratings [Member]
Recorded investment	[1]	1,437	32,668
Baa1 - Baa3 [Member] | Loans Collateralizing Asset Backed Securities [Member]
Recorded investment		10,467	12,145
Baa1 - Baa3 [Member] | Loans Held For Sale [Member]
Recorded investment			6,769
Ba1 - Ba3 [Member] | Loans Collateralizing Asset Backed Securities [Member]
Recorded investment		109,954	137,717
Ba1 - Ba3 [Member] | Loans Held For Sale [Member]
Recorded investment			13,957
B1 - B3 [Member] | Loans Collateralizing Asset Backed Securities [Member]
Recorded investment		449,911	467,125
B1 - B3 [Member] | Loans Held For Sale [Member]
Recorded investment		1,437	11,377
Caa1 - Caa3 [Member] | Loans Collateralizing Asset Backed Securities [Member]
Recorded investment		44,899	37,913
Caa1 - Caa3 [Member] | Loans Held For Sale [Member]
Recorded investment			565
Moody's, Ca Rating [Member] | Loans Collateralizing Asset Backed Securities [Member]
Recorded investment			2,903
Moody's, Ca Rating [Member] | Loans Held For Sale [Member]
Recorded investment
Moody's, C Rating [Member] | Loans Collateralizing Asset Backed Securities [Member]
Recorded investment		1,319
Moody's, C Rating [Member] | Loans Held For Sale [Member]
Recorded investment
Not Rated [Member] | Loans Collateralizing Asset Backed Securities [Member]
Recorded investment		1,500	2,864
Not Rated [Member] | Loans Held For Sale [Member]
Recorded investment
Moodys Credit Rating [Member] | Loans Collateralizing Asset Backed Securities [Member]
Recorded investment		618,050	660,667
Moodys Credit Rating [Member] | Loans Held For Sale [Member]
Recorded investment		$ 1,437	$ 32,668
[1]	Loans with an internal rating of 4 or below are reviewed individually to identify loans to be designated for non-accrual status.

Note 6 - Debt (Details Textual)

Note 6 - Debt (Details Textual) - USD ($) $ in Thousands	May 03, 2017	Apr. 26, 2016	Aug. 03, 2006	Feb. 29, 2016	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2016	Jan. 31, 2014	Jan. 31, 2013
Senior Notes					$ 91,890		$ 91,785
Gain (Loss) on Repurchase of Debt Instrument					210
Unamortized Debt Issuance Expense					1,937		2,042
Revolving Credit Facility [Member] | CNB [Member] | Increased Maximum Level of Borrowing [Member]
Line of Credit Facility, Expiration Period		1 year
Revolving Credit Facility [Member] | CNB [Member] | JMP Securities [Member]
Line of Credit Facility, Maximum Borrowing Capacity			$ 25,000		20,000
Line of Credit Facility, Expiration Period	1 year		2 years
Long-term Line of Credit					$ 0		0
Line of Credit Facility, Unused Capacity, Commitment Fee Percentage					0.25%
Revolving Credit Conversion to Term Loan Portion to Be Paid in First 2 Years [Member] | CNB [Member] | JMP Securities [Member]
Line of Credit Facility, Revolving Credit Conversion to Term Loan, Repayment, Percent of Funded Debt			3.75%
Revolving Credit Conversion to Term Loan Portion to Be Paid in Next 2 Years Member | CNB [Member] | JMP Securities [Member]
Line of Credit Facility, Revolving Credit Conversion to Term Loan, Repayment, Percent of Funded Debt			5.00%
Long-term Line of Credit					$ 0		0
Letter of Credit [Member] | CNB [Member] | JMP Securities [Member]
Line of Credit Facility, Maximum Borrowing Capacity					$ 5,000
Senior Notes 2013 [Member]
Senior Notes									$ 46,000
Debt Instrument, Interest Rate, Stated Percentage					8.00%				8.00%
Senior Notes 2014 [Member]
Senior Notes								$ 48,300
Debt Instrument, Interest Rate, Stated Percentage					7.25%			7.25%
Senior Notes [Member]
Debt Instrument, Repurchased Face Amount				$ 500
Debt Instrument, Repurchase Amount				400
Unamortized Debt Issuance Expense					$ 1,900		$ 2,000
Debt Issuance Costs, Gross					$ 0	$ 0
Senior Notes [Member] | Other Income [Member]
Gain (Loss) on Repurchase of Debt Instrument				$ 100

Note 6 - Debt - Debt Issuance C

Note 6 - Debt - Debt Issuance Costs (Details) - USD ($)	Mar. 31, 2017	Dec. 31, 2016
Bond payable, net of debt issuance costs	$ 1,937,000	$ 2,042,000
Senior Notes 7.25% [Member]
Outstanding Principal Balance	47,922,500	47,922,500
Bond payable, net of debt issuance costs	939,979	1,001,956
Senior Notes 8.00% [Member]
Outstanding Principal Balance	45,905,250	45,905,250
Bond payable, net of debt issuance costs	$ 997,297	$ 1,040,347

Note 7 - Asset-backed Securit52

Note 7 - Asset-backed Securities Issued (Details Textual) - USD ($) $ in Thousands	Sep. 30, 2014	Apr. 30, 2013	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2016	Dec. 31, 2015	Mar. 31, 2014	Dec. 31, 2013	May 17, 2007
Interest Payable			$ 5,769		$ 6,317
Asset-backed Securities [Member]
Interest Expense, Other			6,200	$ 6,100
Amortization of Debt Discount (Premium)			700	600
Interest Payable			4,000		4,600
Assetbacked Securities Issued Fair Value Disclosure			621,800		831,900
Asset-backed Securities [Member] | Cash Coupon [Member]
Interest Expense, Other			5,500	5,500
CLO I [Member]
Debt Instrument, Face Amount									$ 500,000
Proceeds from Issuance of Debt	$ 370,500	$ 343,800
Proceeds from Issuance of Secured Debt	332,100	320,000
Proceeds from Issuance of Unsecured Debt	$ 38,400	$ 23,800
CLO I [Member] | Total Asset Backed Securities Issued [Member]
Long-term Debt, Gross			0		$ 187,500
CLO I [Member] | Secured Debt [Member]
Debt Instrument, Face Amount									455,000
Ownership Of Notes Class CDE			13,800
Ownership Of Notes Class C			2,000
Ownership Of Notes Class D			4,100
Ownership Of Notes Class E			$ 7,700
CLO I [Member] | Unsecured Debt [Member]
Debt Instrument, Face Amount									$ 45,000
Noncontrolling Interest, Ownership Percentage by Parent			94.00%				98.00%	72.80%
Debt Instrument, Repurchase Amount			$ 7,000				$ 6,000
CLO III [Member]
Noncontrolling Interest, Ownership Percentage by Parent			46.70%		46.70%
Long-term Debt, Gross			$ 332,100	332,100	$ 332,100	$ 332,100
CLO III [Member] | Total Asset Backed Securities Issued [Member]
Long-term Debt, Gross			$ 332,100	$ 332,100

Note 7 - Asset-backed Securit53

Note 7 - Asset-backed Securities Issued - Asset-backed Securities Issued - CLO I (Details) - CLO I [Member] - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Mar. 31, 2017	May 17, 2007
Notes Originally Issued			$ 500,000
Consolidation, Eliminations [Member]
Outstanding Principal Balance	$ (58,700)
Total Secured Notes [Member]
Notes Originally Issued	201,200
Outstanding Principal Balance	201,200
Unsecured Subordinated Notes [Member]
Notes Originally Issued	45,000
Outstanding Principal Balance	45,000
Total Notes For CLOI Offering [Member]
Notes Originally Issued	246,200
Outstanding Principal Balance	246,200
Total Asset Backed Securities Issued [Member]
Outstanding Principal Balance	187,500	$ 0
Moody's, Aaa Rating [Member] | Standard & Poor's, AAA Rating [Member] | Class A Senior Secured [Member]
Notes Originally Issued	72,200
Outstanding Principal Balance	$ 72,200
Moody's, Aaa Rating [Member] | Standard & Poor's, AAA Rating [Member] | Class A Senior Secured [Member] | Minimum [Member] | London Interbank Offered Rate (LIBOR) [Member]
Interest Rate Spread to LIBOR	0.26%
Moody's, Aaa Rating [Member] | Standard & Poor's, AAA Rating [Member] | Class A Senior Secured [Member] | Maximum [Member] | London Interbank Offered Rate (LIBOR) [Member]
Interest Rate Spread to LIBOR	0.29%
Moody's, Aaa Rating [Member] | Standard & Poor's, AAA Rating [Member] | Class B Senior Secured [Member]
Notes Originally Issued	$ 30,000
Outstanding Principal Balance	$ 30,000
Moody's, Aaa Rating [Member] | Standard & Poor's, AAA Rating [Member] | Class B Senior Secured [Member] | London Interbank Offered Rate (LIBOR) [Member]
Interest Rate Spread to LIBOR	0.50%
Moody's, Aaa Rating [Member] | Standard & Poor's, AAA Rating [Member] | Class C Senior Secured [Member]
Notes Originally Issued	$ 35,000
Outstanding Principal Balance	$ 35,000
Moody's, Aaa Rating [Member] | Standard & Poor's, AAA Rating [Member] | Class C Senior Secured [Member] | London Interbank Offered Rate (LIBOR) [Member]
Interest Rate Spread to LIBOR	1.10%
Moody's, Aa1 Rating [Member] | Standard & Poor's, A+ Rating [Member] | Class D Senior Secured [Member]
Notes Originally Issued	$ 34,000
Outstanding Principal Balance	$ 34,000
Moody's, Aa1 Rating [Member] | Standard & Poor's, A+ Rating [Member] | Class D Senior Secured [Member] | London Interbank Offered Rate (LIBOR) [Member]
Interest Rate Spread to LIBOR	2.40%
Moody's, Baa1 Rating [Member] | Standard & Poor's, BB+ Rating [Member] | Class E Secured [Member]
Notes Originally Issued	$ 30,000
Outstanding Principal Balance	$ 30,000
Moody's, Baa1 Rating [Member] | Standard & Poor's, BB+ Rating [Member] | Class E Secured [Member] | London Interbank Offered Rate (LIBOR) [Member]
Interest Rate Spread to LIBOR	5.00%

Note 7 - Asset-backed Securit54

Note 7 - Asset-backed Securities Issued - Fair Value of Debt - CLO I (Details) - CLO I [Member] - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Balance at beginning of period	$ 187,417	$ 293,457
Repayments	(187,417)	(11,444)
Asset-backed securities at end of period		$ 282,013

Note 7 - Asset-backed Securit55

Note 7 - Asset-backed Securities Issued - Asset-backed Securities Issued - CLO II (Details) - CLO II [Member] - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2017	Dec. 31, 2016	Mar. 31, 2016	Dec. 31, 2015
Outstanding Principal Balance	$ 297,415	$ 316,200	$ 316,580	$ 316,960
Net Outstanding Balance	292,795	311,285	$ 310,875	$ 311,000
Consolidation, Eliminations [Member]
Outstanding Principal Balance	(30,800)	(23,800)
Issuance Discount	300	300
Net Outstanding Balance	(30,500)	(23,500)
Total Secured Notes [Member]
Notes Originally Issued	320,000	320,000
Outstanding Principal Balance	297,400	316,200
Issuance Discount	(4,600)	(4,900)
Net Outstanding Balance	292,800	311,300
Unsecured Subordinated Notes [Member]
Notes Originally Issued	23,800	23,800
Outstanding Principal Balance	23,800	23,800
Issuance Discount	(300)	(300)
Net Outstanding Balance	23,500	23,500
Total Notes for CLO II Offering [Member]
Notes Originally Issued	343,800	343,800
Outstanding Principal Balance	321,200	340,000
Issuance Discount	(4,900)	(5,200)
Net Outstanding Balance	316,300	334,800
Asset Backed Securities Issued [Member]
Outstanding Principal Balance	290,400	316,200
Issuance Discount	(4,600)	(4,900)
Net Outstanding Balance	285,800	311,300
Standard & Poor's, AAA Rating [Member] | Class X Senior Secured [Member]
Notes Originally Issued	3,800	3,800
Outstanding Principal Balance
Issuance Discount
Net Outstanding Balance
Standard & Poor's, AAA Rating [Member] | Class X Senior Secured [Member] | London Interbank Offered Rate (LIBOR) [Member]
Interest Rate Spread to LIBOR	1.00%	1.00%
Standard & Poor's, AAA Rating [Member] | Class A Senior Secured [Member]
Notes Originally Issued	$ 217,600	$ 217,600
Outstanding Principal Balance	198,800	217,600
Issuance Discount	(400)	(500)
Net Outstanding Balance	$ 198,400	$ 217,100
Standard & Poor's, AAA Rating [Member] | Class A Senior Secured [Member] | London Interbank Offered Rate (LIBOR) [Member]
Interest Rate Spread to LIBOR	1.18%	1.18%
Standard & Poor's, AAA Rating [Member] | Class B Senior Secured [Member] | London Interbank Offered Rate (LIBOR) [Member]
Interest Rate Spread to LIBOR	1.75%	1.75%
Standard & Poor's, AA Rating [Member] | Class B Senior Secured [Member]
Notes Originally Issued	$ 34,000	$ 34,000
Outstanding Principal Balance	34,000	34,000
Issuance Discount	(200)	(200)
Net Outstanding Balance	33,800	33,800
Standard & Poor's, A Rating [Member] | Class C Senior Secured [Member]
Notes Originally Issued	17,000	17,000
Outstanding Principal Balance	17,000	17,000
Issuance Discount	(300)	(400)
Net Outstanding Balance	$ 16,700	$ 16,600
Standard & Poor's, A Rating [Member] | Class C Senior Secured [Member] | London Interbank Offered Rate (LIBOR) [Member]
Interest Rate Spread to LIBOR	2.75%	2.75%
Standard & Poor's, BBB Rating [Member] | Class D Senior Secured [Member]
Notes Originally Issued	$ 18,700	$ 18,700
Outstanding Principal Balance	18,700	18,700
Issuance Discount	(900)	(1,000)
Net Outstanding Balance	$ 17,800	$ 17,700
Standard & Poor's, BBB Rating [Member] | Class D Senior Secured [Member] | London Interbank Offered Rate (LIBOR) [Member]
Interest Rate Spread to LIBOR	3.85%	3.85%
Standard & Poor's, BB Rating [Member] | Class E Secured [Member]
Notes Originally Issued	$ 18,700	$ 18,700
Outstanding Principal Balance	18,700	18,700
Issuance Discount	(1,500)	(1,600)
Net Outstanding Balance	$ 17,200	$ 17,100
Standard & Poor's, BB Rating [Member] | Class E Secured [Member] | London Interbank Offered Rate (LIBOR) [Member]
Interest Rate Spread to LIBOR	5.25%	5.25%
Standard & Poor's, B Rating [Member] | Class F Secured [Member]
Notes Originally Issued	$ 10,200	$ 10,200
Outstanding Principal Balance	10,200	10,200
Issuance Discount	(1,300)	(1,200)
Net Outstanding Balance	$ 8,900	$ 9,000
Standard & Poor's, B Rating [Member] | Class F Secured [Member] | London Interbank Offered Rate (LIBOR) [Member]
Interest Rate Spread to LIBOR	5.75%	5.75%

Note 7 - Asset-backed Securit56

Note 7 - Asset-backed Securities Issued - Fair Value of Debt - CLO II (Details) - CLO II [Member] - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Principal, beginning of period	$ 316,200	$ 316,960
Issuance discount, beginning of period	(4,915)	(5,960)
Balance at beginning of period	311,285	311,000
Repayments	(18,785)	(380)
Amortization of Debt Discount (Premium)	295	255
Principal, end of period	297,415	316,580
Issuance discount, end of period	(4,620)	(5,705)
Asset-backed securities at end of period	$ 292,795	$ 310,875

Note 7 - Asset-backed Securit57

Note 7 - Asset-backed Securities Issued - Asset-backed Securities Issued - CLO III (Details) - CLO III [Member] - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2016	Dec. 31, 2015
Outstanding Principal Balance	$ 332,100	$ 332,100	$ 332,100	$ 332,100
Net Outstanding Balance	330,548	330,056	$ 330,424	$ 329,935
Consolidation, Eliminations [Member]
Outstanding Principal Balance	(38,400)	(38,400)
Issuance Discount	4,500	4,500
Net Outstanding Balance	(33,900)	(33,900)
Total Secured Notes [Member]
Notes Originally Issued	332,100	332,100
Outstanding Principal Balance	332,100	332,100
Issuance Discount	(1,600)	(1,700)
Net Outstanding Balance	330,500	330,400
Unsecured Subordinated Notes [Member]
Notes Originally Issued	38,400	38,400
Outstanding Principal Balance	38,400	38,400
Issuance Discount	(4,500)	(4,500)
Net Outstanding Balance	33,900	33,900
Total Notes for the CLO III Offering [Member]
Notes Originally Issued	370,500	370,500
Outstanding Principal Balance	370,500	370,500
Issuance Discount	(6,100)	(6,200)
Net Outstanding Balance	364,400	364,300
Total Asset Backed Securities Issued [Member]
Outstanding Principal Balance	332,100	332,100
Issuance Discount	(1,600)	(1,700)
Net Outstanding Balance	330,500	330,400
Moody's, Aa1 Rating [Member] | Class B Senior Secured [Member]
Notes Originally Issued	41,700
Outstanding Principal Balance	41,700
Issuance Discount	(600)
Net Outstanding Balance	$ 41,100
Moody's, Aa1 Rating [Member] | Class B Senior Secured [Member] | London Interbank Offered Rate (LIBOR) [Member]
Interest Rate Spread to LIBOR	1.80%
Moody's, Aa2 Rating [Member] | Class B Senior Secured [Member]
Notes Originally Issued		41,700
Outstanding Principal Balance		41,700
Issuance Discount		(700)
Net Outstanding Balance		$ 41,000
Moody's, Aa2 Rating [Member] | Class B Senior Secured [Member] | London Interbank Offered Rate (LIBOR) [Member]
Interest Rate Spread to LIBOR		2.05%
Moody's, A1 Rating [Member] | Class C Senior Secured [Member]
Notes Originally Issued	$ 22,500
Outstanding Principal Balance	22,500
Issuance Discount	(500)
Net Outstanding Balance	$ 22,000
Moody's, A1 Rating [Member] | Class C Senior Secured [Member] | London Interbank Offered Rate (LIBOR) [Member]
Interest Rate Spread to LIBOR	2.60%
Moody's, A2 Rating [Member] | Class C Senior Secured [Member]
Notes Originally Issued		$ 22,500
Outstanding Principal Balance		22,500
Issuance Discount		(500)
Net Outstanding Balance		$ 22,000
Moody's, A2 Rating [Member] | Class C Senior Secured [Member] | London Interbank Offered Rate (LIBOR) [Member]
Interest Rate Spread to LIBOR		2.90%
Moody's, Baa3 Rating [Member] | Class D Senior Secured [Member]
Notes Originally Issued	$ 21,600	$ 21,600
Outstanding Principal Balance	21,600	21,600
Issuance Discount
Net Outstanding Balance	$ 21,600	$ 21,600
Moody's, Baa3 Rating [Member] | Class D Senior Secured [Member] | London Interbank Offered Rate (LIBOR) [Member]
Interest Rate Spread to LIBOR	3.90%	5.10%
Moody's, Ba3 Rating [Member] | Class E Secured [Member]
Notes Originally Issued	$ 18,300	$ 18,300
Outstanding Principal Balance	18,300	18,300
Issuance Discount
Net Outstanding Balance	$ 18,300	$ 18,300
Moody's, Ba3 Rating [Member] | Class E Secured [Member] | London Interbank Offered Rate (LIBOR) [Member]
Interest Rate Spread to LIBOR	7.10%	7.35%
Fitch, AAA Rating [Member] | Moody's, Aaa Rating [Member] | Class A Senior Secured [Member]
Notes Originally Issued	$ 228,000	$ 228,000
Outstanding Principal Balance	228,000	228,000
Issuance Discount	(500)	(500)
Net Outstanding Balance	$ 227,500	$ 227,500
Fitch, AAA Rating [Member] | Moody's, Aaa Rating [Member] | Class A Senior Secured [Member] | London Interbank Offered Rate (LIBOR) [Member]
Interest Rate Spread to LIBOR	1.24%	1.53%

Note 7 - Asset-backed Securit58

Note 7 - Asset-backed Securities Issued - Fair Value of Debt - CLO III (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Amortization of debt issuance costs	$ 105	$ 117
CLO III [Member]
Principal, beginning of period	332,100	332,100
Issuance discount, beginning of period	(1,676)	(2,165)
Balance at beginning of period	330,424	329,935
Amortization of debt issuance costs	124	121
Amortization of discount, net	124	121
Principal, end of period	332,100	332,100
Issuance discount, end of period	(1,552)	(2,044)
Asset-backed securities at end of period	$ 330,548	$ 330,056

Note 8 - Shareholders' Equity (

Note 8 - Shareholders' Equity (Details Textual) - shares	3 Months Ended
	Mar. 31, 2017	Feb. 13, 2017
Stock Repurchase Program, Number of Shares Authorized to be Repurchased		1,000,000
Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased	1,000,000
Treasury Stock, Shares, Acquired	0

Note 9 - Share-based Compensa60

Note 9 - Share-based Compensation (Details Textual) - USD ($) $ in Thousands	Mar. 16, 2017	Feb. 07, 2017	Mar. 31, 2017	Mar. 31, 2016
Employee Service Share-based Compensation, Tax Benefit from Compensation Expense			$ 400	$ 400
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period			145,000
Employee Stock Option [Member]
Allocated Share-based Compensation Expense			$ 100	200
Employee Service Share-based Compensation, Tax Benefit from Compensation Expense			11	$ 0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period				0
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options			0
Restricted Stock Units (RSUs) [Member]
Allocated Share-based Compensation Expense			700	$ 1,000
Employee Service Share-based Compensation, Tax Benefit from Compensation Expense			$ 14	14
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period		117,000	328,797
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value			$ 500	38
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized			$ 2,600
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition			1 year 51 days
Restricted Stock Units (RSUs) [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period	1 year
Restricted Stock Units (RSUs) [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period	3 years
Restricted Stock Units (RSUs) [Member] | Director [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	58,000
Restricted Stock Units (RSUs) [Member] | Share-based Compensation Award, Tranche One [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage		50.00%
Restricted Stock Units (RSUs) [Member] | Share-based Compensation Award, Tranche Two [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage		50.00%
RSUs for Long Term Incentive Purposes [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period		153,000
RSUs for Long Term Incentive Purposes [Member] | Share-based Compensation Award, Tranche One [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage		50.00%
RSUs for Long Term Incentive Purposes [Member] | Share-based Compensation Award, Tranche Two [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage		50.00%
Stock Appreciation Rights (SARs) [Member]
Allocated Share-based Compensation Expense			$ 17	39
Employee Service Share-based Compensation, Tax Benefit from Compensation Expense			4	$ 15
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized			$ 300
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition			273 days
Plan2007 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized			4,000,000
Plan2004 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized			2,960,000

Note 9 - Share-based Compensa61

Note 9 - Share-based Compensation - Stock Option Activity (Details)	3 Months Ended
	Mar. 31, 2017$ / sharesshares
Balance, beginning of year, Shares Subject to Option (in shares) | shares	2,710,000
Balance, beginning of year, Shares Subject to Option (in dollars per share) | $ / shares	$ 6.53
Exercised, Shares Subject to Option (in shares) | shares	(145,000)
Exercised, Shares Subject to Option (in dollars per share) | $ / shares	$ 6.24
Balance, end of period, Shares Subject to Option (in shares) | shares	2,565,000
Balance, end of period, Shares Subject to Option (in dollars per share) | $ / shares	$ 6.54
Options exercisable at end of period, Shares Subject to Option (in shares) | shares	2,565,000
Options exercisable at end of period, Shares Subject to Option (in dollars per share) | $ / shares	$ 6.54

Note 9 - Share-based Compensa62

Note 9 - Share-based Compensation - Stock Options Outstanding and Exercisable (Details) - USD ($)	3 Months Ended
	Mar. 31, 2017	Dec. 31, 2016
Lower exercise price range (in dollars per share)	$ 6.05
Upper exercise price range (in dollars per share)	$ 7.33
Number of options outstanding (in shares)	2,565,000	2,710,000
Options outstanding weighted average remaining contractual life (Year)	2 years 94 days
Options outstanding weighted average exercise price (in dollars per share)	$ 6.54	$ 6.53
Options outstanding aggregate intrinsic value	$ 1,500
Number of options vested and exercisable (in shares)	2,565,000
Options vested and exercisable weighted average remaining contractual life (Year)	2 years 94 days
Options vested and exercisable weighted average exercise price (in dollars per share)	$ 6.54
Options vested and exercisable aggregate intrinsic value	$ 1,500

Note 9 - Share-based Compensa63

Note 9 - Share-based Compensation - Restricted Stock Units Activity (RSUs) (Details) - Restricted Stock Units (RSUs) [Member] - $ / shares	Feb. 07, 2017	Mar. 31, 2017
Balance, beginning of year (in shares)		646,558
Balance, beginning of year (in dollars per share)		$ 5.14
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	117,000	328,797
Granted Restricted Share Units (in dollars per share)		$ 6.08
Vested Restricted Share Units (in shares)		(79,842)
Vested Restricted Share Units (in dollars per share)		$ 7.11
Forfeited Restricted Share Units (in shares)		(31,071)
Forfeited Restricted Share Units (in dollars per share)		$ 4.10
Balance, end of period (in shares)		864,442
Balance, end of period (in dollars per share)		$ 5.35

Note 9 - Share-based Compensa64

Note 9 - Share-based Compensation - SARs Activity (Stock Appreciation Rights (SARs) (Details) - Stock Appreciation Rights (SARs) [Member]	3 Months Ended
	Mar. 31, 2017$ / sharesshares
Balance, beginning of year (in shares) | shares	2,580,000
Balance, beginning of year (in dollars per share) | $ / shares	$ 7.33
Forfeited Restricted Share Units (in shares) | shares	(95,000)
Forfeited Restricted Share Units (in dollars per share) | $ / shares	$ 7.33
Balance, end of period (in shares) | shares	2,485,000
Balance, end of period (in dollars per share) | $ / shares	$ 7.33

Note 9 - Share-based Compensa65

Note 9 - Share-based Compensation - SARs Outstanding (Details) - Stock Appreciation Rights (SARs) [Member] - $ / shares	3 Months Ended
	Mar. 31, 2017	Dec. 31, 2016
Range of exercise prices, lower limit (in dollars per share)	$ 7.33
Range of exercise prices, upper limit (in shares)	7.33
Number outstanding, options outstanding (in shares)	2,485,000	2,580,000
Weighted average remaining contractual life, options outstanding (Year)	2 years 273 days
Weighted average exercise price, options outstanding (in dollars per share)	$ 7.33

Note 10 - Net Income (Loss) P66

Note 10 - Net Income (Loss) Per Common Share (Details Textual) - $ / shares $ / shares in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Two Class Method Effect on Basic Earnings Per Share		$ 0
Employee Stock Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	0	2,779,286
Restricted Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	169,639	481,010

Note 10 - Net Income Per Common

Note 10 - Net Income Per Common Share - Earnings Per Share, Basic and Diluted (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Net income (loss) attributable to JMP Group, LLC	$ (4,740)	$ 1,803
Basic (in shares)	21,573	21,349
Restricted share units (in shares)		516
Diluted (in shares)	21,573	21,865
Basic (in dollars per share)	$ (0.22)	$ 0.08
Diluted (in dollars per share)	$ (0.22)	$ 0.08

Note 11 - Employee Benefits (De

Note 11 - Employee Benefits (Details Textual) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Defined Contribution Plan, Employers Matching Contribution, Annual Vesting Percentage	100.00%
Defined Contribution Plan, Employer Discretionary Contribution Amount	$ 0.9	$ 1
Elective Deferrals Under 3 [Member]
Defined Contribution Plan, Employer Matching Contribution, Percent of Match	100.00%
Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay	3.00%
Elective Deferrals Between 3 and 5 [Member]
Defined Contribution Plan, Employer Matching Contribution, Percent of Match	50.00%
Elective Deferrals Between 3 and 5 [Member] | Minimum [Member]
Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay	3.00%
Elective Deferrals Between 3 and 5 [Member] | Maximum [Member]
Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay	5.00%

Note 12 - Income Taxes (Details

Note 12 - Income Taxes (Details Textual) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Income Tax Expense (Benefit)	$ (1,084)	$ 50
Effective Income Tax Rate Reconciliation, Percent	20.80%	1.50%

Note 13 - Commitments and Con70

Note 13 - Commitments and Contingencies (Details Textual) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2016
Operating Leases, Rent Expense	$ 1,100	$ 900
Operating Leases, Income Statement, Sublease Revenue	49	$ 100
Receivables from Clearing Organizations	250		$ 250
Contractual Obligation	3,200		18,500
Traded but Not Closed in CLO I [Member]
Unfunded Commitments	(1,500)		(34,000)
Traded but Not Closed in CLO II [Member]
Unfunded Commitments	(5,900)		2,900
Traded but Not Closed in CLO III [Member]
Unfunded Commitments	9,300		7,800
Corporate Credit [Member]
Unfunded Commitments	$ 3,900		$ (20,700)

Note 13 - Commitments and Con71

Note 13 - Commitments and Contingencies - Minimum Future Commitments of Leases (Details) $ in Thousands	Mar. 31, 2017USD ($)
2,017	$ 3,542
2,018	4,777
2,019	3,984
2,020	2,568
2,021	2,553
Thereafter	10,020
Total Lease Commitments	$ 27,444

Note 14 - Regulatory Requirem72

Note 14 - Regulatory Requirements (Details Textual) $ in Millions	Mar. 31, 2017USD ($)	Dec. 31, 2016USD ($)
Ratio of Indebtedness to Net Capital	0.54	0.56
Net Capital	$ 30.4	$ 29.7
Excess Net Capital at 1500 Percent	29.3	28.6
Minimum Net Capital Required	$ 1.1	$ 1.1
Maximum [Member]
Ratio of Indebtedness to Net Capital	15

Note 15 - Related Party Trans73

Note 15 - Related Party Transactions (Details Textual) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2016
Incentive Fees Receivable [Member]
Related Party Transaction, Due from (to) Related Party, Current	$ 0.2		$ 0.5
Total Investment [Member]
Related Party Transaction, Amounts of Transaction	26.6		27.8
General Partner Investments In Hedge And Other Private Funds [Member] | Private Funds [Member]
Investments in Related Parties	16.5		17.3
Harvest Capital Credit Corporation [Member]
Investments in Related Parties	10.1		$ 10.5
Affiliated Entity [Member]
Management Fees, Base Revenue	4	$ 4.1
Management Fees, Incentive Revenue	$ 1.9	$ 5.2

Note 18 - Financial Instrumen74

Note 18 - Financial Instruments with Off-balance Sheet Risk, Credit Risk or Market Risk (Details Textual) - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016
Contractual Obligation	$ 3,200	$ 18,500
Traded but Not Closed in CLO I [Member]
Unfunded Commitments	(1,500)	(34,000)
Traded but Not Closed in CLO II [Member]
Unfunded Commitments	(5,900)	2,900
Other Commitments CLO III [Member]
Unfunded Commitments	$ 9,300	7,800
Corporate Segment [Member]
Unfunded Commitments		$ (20,700)

Note 19 - Business Segments (De

Note 19 - Business Segments (Details Textual)	3 Months Ended
	Mar. 31, 2017
Number of Reportable Segments	3
Percent Of Deferred Compensation Recognized	100.00%

Note 19 - Business Segments - S

Note 19 - Business Segments - Segment Operating Results (Details) - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2016
Non-interest revenues		$ 24,672	$ 34,760
Total net revenues after provision for loan losses		24,378	38,555
Non-interest expenses		29,605	35,273
Operating pre-tax net income (loss)		(5,824)	1,853
Total assets		881,188	1,232,955	$ 1,125,830
Net Interest Income	[1]	972	4,426
Provision for loan losses		(1,266)	(631)
Intersegment Eliminations [Member]
Non-interest revenues		(1,041)	(1,337)
Total net revenues after provision for loan losses		(1,041)	(1,337)
Non-interest expenses		(1,041)	(1,337)
Operating pre-tax net income (loss)
Total assets		(324,665)	(344,294)
Operating Segments [Member]
Non-interest revenues		26,659	34,233
Total net revenues after provision for loan losses		25,261	36,616
Non-interest expenses		27,899	34,403
Operating pre-tax net income (loss)		(2,638)	2,213
Total assets		881,188	1,232,955
Net Interest Income	[1]	15	2,371
Provision for loan losses		(1,413)	12
Broker Dealer [Member]
Non-interest revenues		18,890	24,391
Total net revenues after provision for loan losses		18,890	24,391
Non-interest expenses		18,561	21,999
Operating pre-tax net income (loss)		329	2,392
Total assets		48,498	67,044
Asset Management [Member]
Non-interest revenues		5,311	10,176
Total net revenues after provision for loan losses		5,311	10,176
Non-interest expenses		5,095	9,442
Operating pre-tax net income (loss)		216	734
Total assets		17,581	28,956
Corporate Segment [Member]
Non-interest revenues		3,499	1,003
Total net revenues after provision for loan losses		2,101	3,386
Non-interest expenses		5,284	4,299
Operating pre-tax net income (loss)		(3,183)	(913)
Total assets		1,139,774	1,481,249
Net Interest Income		15	2,371
Provision for loan losses		$ (1,413)	$ 12
[1]	The Net Interest Income adjustment is comprised of the non-cash net amortization of liquidity discounts at JMP Credit, due to scheduled contractual repayments, and amortization expense related to an intangible asset.

Note 19 - Business Segments - R

Note 19 - Business Segments - Reconciliation of Total Segments to Consolidated Net Income Before Income Tax Expense (Details) - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2016
Non-interest revenues		$ 24,672	$ 34,760
Net Interest Income	[1]	972	4,426
Provision for loan losses		(1,266)	(631)
Total net revenues after provision for loan losses		24,378	38,555
Non-interest expenses		29,605	35,273
Noncontrolling interest		597	1,429
Operating pre-tax net income (loss)		(5,824)	1,853
Total assets		881,188	1,232,955	$ 1,125,830
Operating Segments [Member]
Non-interest revenues		26,659	34,233
Net Interest Income	[1]	15	2,371
Provision for loan losses		(1,413)	12
Total net revenues after provision for loan losses		25,261	36,616
Non-interest expenses		27,899	34,403
Noncontrolling interest
Operating pre-tax net income (loss)		(2,638)	2,213
Total assets		881,188	1,232,955
Segment Reconciling Items [Member]
Non-interest revenues	[2]	(1,987)	527
Net Interest Income	[1]	957	2,055
Provision for loan losses		147	(643)
Total net revenues after provision for loan losses		(883)	1,939
Non-interest expenses	[3]	1,706	870
Noncontrolling interest		597	1,429
Operating pre-tax net income (loss)	[4]	(3,186)	(360)
Total assets
[1]	The Net Interest Income adjustment is comprised of the non-cash net amortization of liquidity discounts at JMP Credit, due to scheduled contractual repayments, and amortization expense related to an intangible asset.
[2]	Non-interest revenue adjustments are comprised of loan sale gains, mark-to-market gains/losses, strategic equity investments and warrants, and fund-related revenues recognized upon consolidation of certain Harvest Funds.
[3]	Non-interest expense adjustments relate to reversals of share-based compensation and exclusion of fund-related expenses recognized upon consolidation of certain Harvest Funds.
[4]	Reconciling operating pre-tax net income to Consolidated Net Income before income tax expense in the Consolidated Statements of Operations consists of the following:

Note 19 - Business Segments -78

Note 19 - Business Segments - Reconciling Operating Pre-tax Net Income to Consolidated Net Income (Details) - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2017	Mar. 31, 2016
Consolidated Net Income (loss) attributable to JMP Group LLC		$ (4,740)	$ 1,803
Income Tax Expense (Benefit)		(1,084)	50
Consolidated pre-tax net income (loss) attributable to JMP Group LLC		(5,824)	1,853
Depreciation and amortization of fixed assets		311	332
Restricted Stock Units (RSUs) [Member]
Compensation expense - RSUs		700	1,000
Operating Segments [Member]
Consolidated Net Income (loss) attributable to JMP Group LLC		(4,740)	1,803
Income Tax Expense (Benefit)		(1,084)	50
Consolidated pre-tax net income (loss) attributable to JMP Group LLC		(2,638)	2,213
Segment Reconciling Items [Member]
Consolidated pre-tax net income (loss) attributable to JMP Group LLC	[1]	(3,186)	(360)
Deferred compensation program accounting adjustment		(654)	515
Net unrealized loss/ (gain) on strategic equity investments and warrants.		(419)	329
General loan loss reserve for CLO II and CLO III		418	(407)
Unrealized loss - real estate-related depreciation and amortization		(2,156)	(330)
Depreciation and amortization of fixed assets		(68)
Segment Reconciling Items [Member] | Restricted Stock Units (RSUs) [Member]
Compensation expense - RSUs		$ (306)	$ (467)
[1]	Reconciling operating pre-tax net income to Consolidated Net Income before income tax expense in the Consolidated Statements of Operations consists of the following:

Note 20 - Summarized Financia79

Note 20 - Summarized Financial Information for Equity Method Investments - Equity Method Investments (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2016
Income	$ (690)	$ 283
Harvest Small Cap Partners [Member]
Net Assets	310,375		$ 296,404
Harvest Small Cap Partners [Member] | Net Realized And Unrealized Gains Losses [Member]
Income	11,278	23,668
Harvest Small Cap Partners [Member] | Net Investment Income Loss [Member]
Income	(4,781)	(5,390)
Harvest Agricultural Select [Member]
Net Assets	22,235		$ 22,796
Harvest Agricultural Select [Member] | Net Realized And Unrealized Gains Losses [Member]
Income	71	(153)
Harvest Agricultural Select [Member] | Net Investment Income Loss [Member]
Income	(65)	(77)
Harvest Technology Partners [Member] | Net Realized And Unrealized Gains Losses [Member]
Income		(44)
Harvest Technology Partners [Member] | Net Investment Income Loss [Member]
Income		(48)
Harvest Financial Partners [Member] | Net Realized And Unrealized Gains Losses [Member]
Income		(607)
Harvest Financial Partners [Member] | Net Investment Income Loss [Member]
Income		$ (77)

Note 21 - Condensed Consolida80

Note 21 - Condensed Consolidating Financial Statements (Details Textual)	3 Months Ended
	Mar. 31, 2017	Jan. 31, 2014	Jan. 31, 2013
Senior Notes 2013 [Member]
Debt Instrument, Interest Rate, Stated Percentage	8.00%		8.00%
Senior Notes 2014 [Member]
Debt Instrument, Interest Rate, Stated Percentage	7.25%	7.25%
JMP Group Inc. [Member]
Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions	100.00%

Note 21 - Condensed Consolida81

Note 21 - Condensed Consolidating Financial Statements - Condensed Consolidating Balance Sheet (Details) - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016	Mar. 31, 2016	Dec. 31, 2015
Cash and cash equivalents	$ 81,235	$ 85,492	$ 53,821	$ 68,551
Restricted cash and deposits	67,133	227,656
Receivable from clearing broker	6,051	6,586
Investment banking fees receivable, net of allowance for doubtful accounts	8,122	5,681
Marketable securities owned, at fair value	20,558	18,722
Incentive fee receivable	242	499
Other investments	30,279	32,869
Loans held for sale	1,437	32,488
Loans held for investment, net of allowance for loan losses of $1,155 and $443 at March 31, 2017 and December 31, 2016, respectively	1,157	1,930
Total loans, net	610,955	654,127
Interest receivable	2,549	3,429
Cash collateral posted for total return swap	25,940	25,000
Fixed assets, net	2,863	3,143
Deferred tax assets	7,942	7,942
Other assets	14,725	20,266
Investment in subsidiaries
Total assets	881,188	1,125,830	1,232,955
Marketable securities sold, but not yet purchased, at fair value	5,206	4,747
Accrued compensation	8,520	36,158
Asset-backed securities issued	613,354	825,854
Interest payable	5,769	6,317
Note payable
Senior Notes	91,890	91,785
Deferred tax liability	2,653	3,872
Other liabilities	25,056	21,803
Total liabilities	752,448	990,536
Total members' (deficit) equity	114,174	119,377
Nonredeemable Non-controlling Interest	14,566	15,917
Total equity	128,740	135,294	150,243	152,894
Total liabilities and equity	881,188	1,125,830
Reportable Legal Entities [Member] | Parent Company [Member]
Cash and cash equivalents	2,362	255	1,113	80
Restricted cash and deposits
Receivable from clearing broker
Investment banking fees receivable, net of allowance for doubtful accounts
Marketable securities owned, at fair value
Incentive fee receivable
Other investments	7,000
Loans held for sale
Loans held for investment, net of allowance for loan losses of $1,155 and $443 at March 31, 2017 and December 31, 2016, respectively
Total loans, net
Interest receivable	94
Cash collateral posted for total return swap
Fixed assets, net
Deferred tax assets
Other assets	(6)	(1,045)
Investment in subsidiaries	237,542	252,486
Total assets	246,992	251,696
Marketable securities sold, but not yet purchased, at fair value
Accrued compensation	250	90
Asset-backed securities issued
Interest payable
Note payable	137,603	137,603
Senior Notes
Deferred tax liability
Other liabilities	1,860	1,520
Total liabilities	139,713	139,213
Total members' (deficit) equity	107,279	112,483
Nonredeemable Non-controlling Interest
Total equity	107,279	112,483
Total liabilities and equity	246,992	251,696
Reportable Legal Entities [Member] | Subsidiary Issuer [Member]
Cash and cash equivalents	2,137	1,763	9,213	11,260
Restricted cash and deposits	1,471	1,471
Receivable from clearing broker
Investment banking fees receivable, net of allowance for doubtful accounts
Marketable securities owned, at fair value
Incentive fee receivable
Other investments	5,876	5,126
Loans held for sale
Loans held for investment, net of allowance for loan losses of $1,155 and $443 at March 31, 2017 and December 31, 2016, respectively
Total loans, net
Interest receivable
Cash collateral posted for total return swap
Fixed assets, net
Deferred tax assets	7,942	7,942
Other assets	140,096	141,905
Investment in subsidiaries	74,053	74,166
Total assets	231,575	232,373
Marketable securities sold, but not yet purchased, at fair value
Accrued compensation	474	150
Asset-backed securities issued
Interest payable	1,506	1,506
Note payable
Senior Notes	92,363	92,258
Deferred tax liability	2,093	3,232
Other liabilities	23,501	22,706
Total liabilities	119,937	119,852
Total members' (deficit) equity	111,638	112,521
Nonredeemable Non-controlling Interest
Total equity	111,638	112,521
Total liabilities and equity	231,575	232,373
Reportable Legal Entities [Member] | Guarantor Subsidiaries [Member]
Cash and cash equivalents	34,163	5,060	6,468	1,225
Restricted cash and deposits
Receivable from clearing broker
Investment banking fees receivable, net of allowance for doubtful accounts
Marketable securities owned, at fair value	10,461	10,877
Incentive fee receivable
Other investments	9,789	9,838
Loans held for sale
Loans held for investment, net of allowance for loan losses of $1,155 and $443 at March 31, 2017 and December 31, 2016, respectively
Total loans, net
Interest receivable		72
Cash collateral posted for total return swap
Fixed assets, net
Deferred tax assets
Other assets	(15,575)	(8,957)
Investment in subsidiaries	99,421	117,537
Total assets	138,259	134,427
Marketable securities sold, but not yet purchased, at fair value
Accrued compensation	228
Asset-backed securities issued
Interest payable
Note payable
Senior Notes
Deferred tax liability
Other liabilities	314	313
Total liabilities	542	313
Total members' (deficit) equity	122,447	117,532
Nonredeemable Non-controlling Interest	15,270	16,582
Total equity	137,717	134,114
Total liabilities and equity	138,259	134,427
Reportable Legal Entities [Member] | Non-Guarantor Subsidiaries [Member]
Cash and cash equivalents	42,573	78,414	37,027	55,986
Restricted cash and deposits	65,662	226,185
Receivable from clearing broker	6,051	6,586
Investment banking fees receivable, net of allowance for doubtful accounts	8,122	5,681
Marketable securities owned, at fair value	10,569	8,317
Incentive fee receivable	242	499
Other investments	14,614	17,905
Loans held for sale	1,437	32,488
Loans held for investment, net of allowance for loan losses of $1,155 and $443 at March 31, 2017 and December 31, 2016, respectively	1,157	1,930
Total loans, net	610,955	654,127
Interest receivable	2,455	3,429
Cash collateral posted for total return swap	25,940	25,000
Fixed assets, net	2,863	3,143
Deferred tax assets
Other assets	44,366	42,597
Investment in subsidiaries
Total assets	837,006	1,106,301
Marketable securities sold, but not yet purchased, at fair value	5,206	4,747
Accrued compensation	7,568	35,918
Asset-backed securities issued	620,354	825,854
Interest payable	4,263	4,811
Note payable	15,000	15,000
Senior Notes
Deferred tax liability	560	640
Other liabilities	825	(1,142)
Total liabilities	653,776	885,828
Total members' (deficit) equity	184,146	221,350
Nonredeemable Non-controlling Interest	(916)	(877)
Total equity	183,230	220,473
Total liabilities and equity	837,006	1,106,301
Consolidation, Eliminations [Member]
Cash and cash equivalents
Restricted cash and deposits
Receivable from clearing broker
Investment banking fees receivable, net of allowance for doubtful accounts
Marketable securities owned, at fair value	(472)	(472)
Incentive fee receivable
Other investments	(7,000)
Loans held for sale
Loans held for investment, net of allowance for loan losses of $1,155 and $443 at March 31, 2017 and December 31, 2016, respectively
Total loans, net
Interest receivable		(72)
Cash collateral posted for total return swap
Fixed assets, net
Deferred tax assets
Other assets	(154,156)	(154,234)
Investment in subsidiaries	(411,016)	(444,189)
Total assets	(572,644)	(598,967)
Marketable securities sold, but not yet purchased, at fair value
Accrued compensation
Asset-backed securities issued	(7,000)
Interest payable
Note payable	(152,603)	(152,603)
Senior Notes	(473)	(473)
Deferred tax liability
Other liabilities	(1,444)	(1,594)
Total liabilities	(161,520)	(154,670)
Total members' (deficit) equity	(411,336)	(444,509)
Nonredeemable Non-controlling Interest	212	212
Total equity	(411,124)	(444,297)
Total liabilities and equity	$ (572,644)	$ (598,967)

Note 21 - Condensed Consolida82

Note 21 - Condensed Consolidating Financial Statements - Condensed Consolidating Income Statement (Details) - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2017	Mar. 31, 2016
Investment banking		$ 13,600	$ 18,296
Brokerage		5,286	6,095
Asset management fees		5,911	9,326
Principal transactions		(1,893)	930
Loss on sale, payoff and mark-to-market of loans		847	(376)
Gain (Loss) on Repurchase of Debt Instrument		210
Net dividend income		266	263
Other income		445	226
Equity earnings of subsidiaries
Non-interest revenues		24,672	34,760
Interest income		9,067	12,401
Interest expense		(8,095)	(7,975)
Net Interest Income	[1]	972	4,426
Provision for loan losses		(1,266)	(631)
Total net revenues after provision for loan losses		24,378	38,555
Compensation and benefits		21,798	27,425
Administration		1,819	1,818
Brokerage, clearing and exchange fees		759	761
Travel and business development		915	1,291
Communications and technology		1,053	1,016
Occupancy		1,111	936
Professional fees		1,162	1,073
Depreciation		311	332
Other		677	621
Total non-interest expenses		29,605	35,273
Net income (loss) before income tax expense		(5,227)	3,282
Income Tax Expense (Benefit)		(1,084)	50
Net income (loss)		(4,143)	3,232
Less: Net income (loss) attributable to nonredeemable non-controlling interest		597	1,429
Consolidated Net Income (loss) attributable to JMP Group LLC		(4,740)	1,803
Reportable Legal Entities [Member] | Parent Company [Member]
Investment banking
Brokerage
Asset management fees
Principal transactions
Loss on sale, payoff and mark-to-market of loans
Gain (Loss) on Repurchase of Debt Instrument		210
Net dividend income
Other income
Equity earnings of subsidiaries		(2,766)	3,866
Non-interest revenues		(2,556)	3,866
Interest income		368	370
Interest expense		(1,139)	(1,139)
Net Interest Income		(771)	(769)
Provision for loan losses
Total net revenues after provision for loan losses		(3,327)	3,097
Compensation and benefits		535	505
Administration		127	118
Brokerage, clearing and exchange fees
Travel and business development		78	85
Communications and technology		1	2
Occupancy
Professional fees		672	586
Depreciation
Other
Total non-interest expenses		1,413	1,296
Net income (loss) before income tax expense		(4,740)	1,801
Income Tax Expense (Benefit)
Net income (loss)		(4,740)	1,801
Less: Net income (loss) attributable to nonredeemable non-controlling interest
Consolidated Net Income (loss) attributable to JMP Group LLC		(4,740)	1,801
Reportable Legal Entities [Member] | Subsidiary Issuer [Member]
Investment banking
Brokerage
Asset management fees
Principal transactions		8	120
Loss on sale, payoff and mark-to-market of loans
Gain (Loss) on Repurchase of Debt Instrument
Net dividend income
Other income
Equity earnings of subsidiaries		(284)	1,812
Non-interest revenues		(276)	1,932
Interest income		1,139	1,139
Interest expense		(2,274)	(2,288)
Net Interest Income		(1,135)	(1,149)
Provision for loan losses
Total net revenues after provision for loan losses		(1,411)	783
Compensation and benefits		646	1,172
Administration		122	130
Brokerage, clearing and exchange fees
Travel and business development
Communications and technology		2	2
Occupancy
Professional fees		67	69
Depreciation
Other		6
Total non-interest expenses		843	1,373
Net income (loss) before income tax expense		(2,254)	(590)
Income Tax Expense (Benefit)		(1,020)	(854)
Net income (loss)		(1,234)	264
Less: Net income (loss) attributable to nonredeemable non-controlling interest
Consolidated Net Income (loss) attributable to JMP Group LLC		(1,234)	264
Reportable Legal Entities [Member] | Guarantor Subsidiaries [Member]
Investment banking
Brokerage
Asset management fees
Principal transactions		(396)	(127)
Loss on sale, payoff and mark-to-market of loans
Gain (Loss) on Repurchase of Debt Instrument
Net dividend income		256	239
Other income			87
Equity earnings of subsidiaries		583	4,768
Non-interest revenues		443	4,967
Interest income		98	166
Interest expense
Net Interest Income		98	166
Provision for loan losses
Total net revenues after provision for loan losses		541	5,133
Compensation and benefits		247	162
Administration		26	71
Brokerage, clearing and exchange fees
Travel and business development
Communications and technology
Occupancy
Professional fees			12
Depreciation
Other		69
Total non-interest expenses		342	245
Net income (loss) before income tax expense		199	4,888
Income Tax Expense (Benefit)
Net income (loss)		199	4,888
Less: Net income (loss) attributable to nonredeemable non-controlling interest		437	1,286
Consolidated Net Income (loss) attributable to JMP Group LLC		(238)	3,602
Reportable Legal Entities [Member] | Non-Guarantor Subsidiaries [Member]
Investment banking		13,600	18,296
Brokerage		5,286	6,095
Asset management fees		5,951	9,326
Principal transactions		(1,505)	937
Loss on sale, payoff and mark-to-market of loans		847	(376)
Gain (Loss) on Repurchase of Debt Instrument
Net dividend income		10	24
Other income		445	139
Equity earnings of subsidiaries
Non-interest revenues		24,634	34,441
Interest income		9,545	12,721
Interest expense		(6,765)	(6,543)
Net Interest Income		2,780	6,178
Provision for loan losses		(1,266)	(631)
Total net revenues after provision for loan losses		26,148	39,988
Compensation and benefits		20,370	25,586
Administration		1,584	386
Brokerage, clearing and exchange fees		759	761
Travel and business development		837	1,206
Communications and technology		1,050	1,012
Occupancy		1,111	936
Professional fees		423	406
Depreciation		311	332
Other		602	1,734
Total non-interest expenses		27,047	32,359
Net income (loss) before income tax expense		(899)	7,629
Income Tax Expense (Benefit)		(64)	904
Net income (loss)		(835)	6,725
Less: Net income (loss) attributable to nonredeemable non-controlling interest		160	143
Consolidated Net Income (loss) attributable to JMP Group LLC		(995)	6,582
Consolidation, Eliminations [Member]
Investment banking
Brokerage
Asset management fees		(40)
Principal transactions
Loss on sale, payoff and mark-to-market of loans
Gain (Loss) on Repurchase of Debt Instrument
Net dividend income
Other income
Equity earnings of subsidiaries		2,467	(10,446)
Non-interest revenues		2,427	(10,446)
Interest income		(2,083)	(1,995)
Interest expense		2,083	1,995
Net Interest Income
Provision for loan losses
Total net revenues after provision for loan losses		2,427	(10,446)
Compensation and benefits
Administration		(40)	1,113
Brokerage, clearing and exchange fees
Travel and business development
Communications and technology
Occupancy
Professional fees
Depreciation
Other			(1,113)
Total non-interest expenses		(40)
Net income (loss) before income tax expense		2,467	(10,446)
Income Tax Expense (Benefit)
Net income (loss)		2,467	(10,446)
Less: Net income (loss) attributable to nonredeemable non-controlling interest
Consolidated Net Income (loss) attributable to JMP Group LLC		$ 2,467	$ (10,446)
[1]	The Net Interest Income adjustment is comprised of the non-cash net amortization of liquidity discounts at JMP Credit, due to scheduled contractual repayments, and amortization expense related to an intangible asset.

Note 21 - Condensed Consolida83

Note 21 - Condensed Consolidating Financial Statements - Condensed Consolidating Cash Flows (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Cash flows from operating activities:
Net income (loss)	$ (4,143)	$ 3,232
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Provision for doubtful accounts	90
Provision for loan losses	1,266	631
Accretion of deferred loan fees	(840)	(360)
Amortization of liquidity discount, net		(36)
Amortization of debt issuance costs	105	117
Amortization of original issue discount, related to CLO II and CLO III	702	598
Interest paid in kind		(53)
Loss (gain) on sale and payoff of loans	(1,027)	376
Gain on repurchase of bonds payable and asset-backed securities issued	(210)	(87)
Change in other investments:
Income from investments in equity method investees	690	(283)
Fair value on other equity investments	1,462	(97)
Realized loss on other investments	(371)	(19)
Depreciation and amortization of fixed assets	311	332
Stock-based compensation expense	780	1,242
Deferred income taxes	(1,219)	(1,480)
Net change in operating assets and liabilities:
Decrease in interest receivable	880	39
Increase in receivables	(1,739)	(1,915)
Increase in marketable securities	(1,836)	1,055
Decrease (increase) in restricted cash (excluding restricted cash reserved for lending activities)	944	337
Decrease in deposits and other assets	(8,675)	4,586
Increase in marketable securities sold, but not yet purchased	459	89
Increase in interest payable	(548)	434
(Decrease) increase in accrued compensation and other liabilities	(24,518)	(24,201)
Net cash used in operating activities	(37,437)	(15,463)
Cash flows from investing activities:
Purchases of fixed assets	(31)	(72)
Investment in subsidiary
Purchases of other investments	(990)	(2,779)
Sales of other investments	9,364	11,694
Funding of loans collateralizing asset-backed securities issued	(50,122)	(52,181)
Funding of loans held for sale	(2,752)
Sale and payoff of loans collateralizing asset-backed securities issued	111,743	53,698
Principal receipts on loans collateralizing asset-backed securities issued	16,728	15,861
Net change in restricted cash reserved for lending activities	159,579	(6,090)
Cash collateral posted for total return swap	(940)	(240)
Net cash provided by (used in) investing activities	242,579	19,891
Cash and cash equivalents derecognized due to adoption of new consolidation guidance		(240)
Cash flows from financing activities:
Repayment of asset-backed securities issued	(206,202)	(11,824)
Distributions and distribution equivalents paid on common shares and RSUs	(1,954)	(2,616)
Capital contributions of parent
Capital contributions of nonredeemable non-controlling interest holders	92
Distributions to non-controlling interest shareholders	(2,040)	(1,704)
Net cash settlement of RSU vesting	889	(2,629)
Employee taxes paid on shares withheld for tax-withholding purposes	(184)
Net cash (used in) provided by financing activities	(209,399)	(19,158)
Net decrease in cash and cash equivalents	(4,257)	(14,730)
Cash and cash equivalents, beginning of period	85,492	68,551
Cash and cash equivalents, end of period	81,235	53,821
Repayment of note payable
Repayment of line of credit
Repurchase of asset-backed securities issued
Repurchase of bonds payable		(385)
Purchases of shares of common stock for treasury		(2,629)
Reportable Legal Entities [Member] | Parent Company [Member]
Cash flows from operating activities:
Net income (loss)	(4,740)	1,801
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Provision for doubtful accounts
Provision for loan losses
Accretion of deferred loan fees
Amortization of liquidity discount, net
Amortization of debt issuance costs
Amortization of original issue discount, related to CLO II and CLO III
Interest paid in kind
Loss (gain) on sale and payoff of loans
Gain on repurchase of bonds payable and asset-backed securities issued
Change in other investments:
Income from investments in equity method investees
Fair value on other equity investments
Realized loss on other investments
Depreciation and amortization of fixed assets
Stock-based compensation expense	780	1,242
Deferred income taxes
Net change in operating assets and liabilities:
Decrease in interest receivable	(94)
Increase in receivables
Increase in marketable securities
Decrease (increase) in restricted cash (excluding restricted cash reserved for lending activities)
Decrease in deposits and other assets	(1,039)	(1,073)
Increase in marketable securities sold, but not yet purchased
Increase in interest payable
(Decrease) increase in accrued compensation and other liabilities	505	588
Net cash used in operating activities	(4,588)	2,558
Cash flows from investing activities:
Purchases of fixed assets
Investment in subsidiary	14,944	(6,493)
Purchases of other investments	(7,000)
Sales of other investments
Funding of loans collateralizing asset-backed securities issued
Funding of loans held for sale
Sale and payoff of loans collateralizing asset-backed securities issued
Principal receipts on loans collateralizing asset-backed securities issued
Net change in restricted cash reserved for lending activities
Cash collateral posted for total return swap
Net cash provided by (used in) investing activities	7,944	(6,493)
Cash and cash equivalents derecognized due to adoption of new consolidation guidance
Cash flows from financing activities:
Repayment of asset-backed securities issued
Distributions and distribution equivalents paid on common shares and RSUs	(1,954)	(2,616)
Capital contributions of parent		10,213
Capital contributions of nonredeemable non-controlling interest holders
Distributions to non-controlling interest shareholders
Net cash settlement of RSU vesting	889
Employee taxes paid on shares withheld for tax-withholding purposes	(184)
Net cash (used in) provided by financing activities	(1,249)	4,968
Net decrease in cash and cash equivalents	2,107	1,033
Cash and cash equivalents, beginning of period	255	80
Cash and cash equivalents, end of period	2,362	1,113
Repayment of note payable
Repayment of line of credit
Repurchase of asset-backed securities issued
Repurchase of bonds payable
Purchases of shares of common stock for treasury		(2,629)
Reportable Legal Entities [Member] | Subsidiary Issuer [Member]
Cash flows from operating activities:
Net income (loss)	(1,234)	264
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Provision for doubtful accounts
Provision for loan losses
Accretion of deferred loan fees
Amortization of liquidity discount, net
Amortization of debt issuance costs	105	117
Amortization of original issue discount, related to CLO II and CLO III
Interest paid in kind
Loss (gain) on sale and payoff of loans
Gain on repurchase of bonds payable and asset-backed securities issued
Change in other investments:
Income from investments in equity method investees
Fair value on other equity investments	(8)	(120)
Realized loss on other investments
Depreciation and amortization of fixed assets
Stock-based compensation expense
Deferred income taxes	(1,139)	(1,399)
Net change in operating assets and liabilities:
Decrease in interest receivable
Increase in receivables
Increase in marketable securities
Decrease (increase) in restricted cash (excluding restricted cash reserved for lending activities)
Decrease in deposits and other assets	1,809	6,443
Increase in marketable securities sold, but not yet purchased
Increase in interest payable
(Decrease) increase in accrued compensation and other liabilities	1,119	732
Net cash used in operating activities	652	6,037
Cash flows from investing activities:
Purchases of fixed assets
Investment in subsidiary	113	(9,346)
Purchases of other investments	(844)	(2,779)
Sales of other investments	102
Funding of loans collateralizing asset-backed securities issued
Funding of loans held for sale
Sale and payoff of loans collateralizing asset-backed securities issued
Principal receipts on loans collateralizing asset-backed securities issued
Net change in restricted cash reserved for lending activities
Cash collateral posted for total return swap
Net cash provided by (used in) investing activities	(629)	(12,125)
Cash and cash equivalents derecognized due to adoption of new consolidation guidance
Cash flows from financing activities:
Repayment of asset-backed securities issued
Distributions and distribution equivalents paid on common shares and RSUs
Capital contributions of parent	351	4,041
Capital contributions of nonredeemable non-controlling interest holders
Distributions to non-controlling interest shareholders
Net cash settlement of RSU vesting
Employee taxes paid on shares withheld for tax-withholding purposes
Net cash (used in) provided by financing activities	351	4,041
Net decrease in cash and cash equivalents	374	(2,047)
Cash and cash equivalents, beginning of period	1,763	11,260
Cash and cash equivalents, end of period	2,137	9,213
Repayment of note payable
Repayment of line of credit
Repurchase of asset-backed securities issued
Repurchase of bonds payable
Purchases of shares of common stock for treasury
Reportable Legal Entities [Member] | Guarantor Subsidiaries [Member]
Cash flows from operating activities:
Net income (loss)	199	4,888
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Provision for doubtful accounts
Provision for loan losses
Accretion of deferred loan fees
Amortization of liquidity discount, net
Amortization of debt issuance costs
Amortization of original issue discount, related to CLO II and CLO III
Interest paid in kind
Loss (gain) on sale and payoff of loans
Gain on repurchase of bonds payable and asset-backed securities issued	(210)	(87)
Change in other investments:
Income from investments in equity method investees
Fair value on other equity investments	(19)	438
Realized loss on other investments
Depreciation and amortization of fixed assets
Stock-based compensation expense
Deferred income taxes
Net change in operating assets and liabilities:
Decrease in interest receivable	72	(3)
Increase in receivables
Increase in marketable securities	416	(796)
Decrease (increase) in restricted cash (excluding restricted cash reserved for lending activities)
Decrease in deposits and other assets	6,828	14,817
Increase in marketable securities sold, but not yet purchased
Increase in interest payable
(Decrease) increase in accrued compensation and other liabilities	229	144
Net cash used in operating activities	7,515	19,401
Cash flows from investing activities:
Purchases of fixed assets
Investment in subsidiary	18,116	360
Purchases of other investments	(146)
Sales of other investments	214	9,568
Funding of loans collateralizing asset-backed securities issued
Funding of loans held for sale
Sale and payoff of loans collateralizing asset-backed securities issued
Principal receipts on loans collateralizing asset-backed securities issued
Net change in restricted cash reserved for lending activities
Cash collateral posted for total return swap
Net cash provided by (used in) investing activities	18,184	9,928
Cash and cash equivalents derecognized due to adoption of new consolidation guidance
Cash flows from financing activities:
Repayment of asset-backed securities issued
Distributions and distribution equivalents paid on common shares and RSUs
Capital contributions of parent	5,153	(22,382)
Capital contributions of nonredeemable non-controlling interest holders	92
Distributions to non-controlling interest shareholders	(1,841)	(1,704)
Net cash settlement of RSU vesting
Employee taxes paid on shares withheld for tax-withholding purposes
Net cash (used in) provided by financing activities	3,404	(24,086)
Net decrease in cash and cash equivalents	29,103	5,243
Cash and cash equivalents, beginning of period	5,060	1,225
Cash and cash equivalents, end of period	34,163	6,468
Repayment of note payable
Repayment of line of credit
Repurchase of asset-backed securities issued
Repurchase of bonds payable
Purchases of shares of common stock for treasury
Reportable Legal Entities [Member] | Non-Guarantor Subsidiaries [Member]
Cash flows from operating activities:
Net income (loss)	(835)	6,725
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Provision for doubtful accounts	90
Provision for loan losses	1,266	631
Accretion of deferred loan fees	(840)	(360)
Amortization of liquidity discount, net		(36)
Amortization of debt issuance costs
Amortization of original issue discount, related to CLO II and CLO III	702	598
Interest paid in kind		(53)
Loss (gain) on sale and payoff of loans	(1,027)	376
Gain on repurchase of bonds payable and asset-backed securities issued
Change in other investments:
Income from investments in equity method investees	690	(283)
Fair value on other equity investments	1,489	(415)
Realized loss on other investments	(371)	(19)
Depreciation and amortization of fixed assets	311	332
Stock-based compensation expense
Deferred income taxes	(80)	(81)
Net change in operating assets and liabilities:
Decrease in interest receivable	974	(93)
Increase in receivables	(1,739)	(1,866)
Increase in marketable securities	(2,252)	1,366
Decrease (increase) in restricted cash (excluding restricted cash reserved for lending activities)	944	337
Decrease in deposits and other assets	5,884	(31,519)
Increase in marketable securities sold, but not yet purchased	459	89
Increase in interest payable	(548)	500
(Decrease) increase in accrued compensation and other liabilities	(26,520)	(24,361)
Net cash used in operating activities	(21,403)	(48,132)
Cash flows from investing activities:
Purchases of fixed assets	(31)	(72)
Investment in subsidiary		12,983
Purchases of other investments
Sales of other investments	(6,032)	2,038
Funding of loans collateralizing asset-backed securities issued	(50,122)	(52,181)
Funding of loans held for sale	(2,752)
Sale and payoff of loans collateralizing asset-backed securities issued	111,743	53,698
Principal receipts on loans collateralizing asset-backed securities issued	16,728	15,861
Net change in restricted cash reserved for lending activities	159,579	(6,090)
Cash collateral posted for total return swap	(940)
Net cash provided by (used in) investing activities	228,173	25,997
Cash and cash equivalents derecognized due to adoption of new consolidation guidance		(240)
Cash flows from financing activities:
Repayment of asset-backed securities issued	(206,202)	(11,824)
Distributions and distribution equivalents paid on common shares and RSUs
Capital contributions of parent	(36,210)
Capital contributions of nonredeemable non-controlling interest holders
Distributions to non-controlling interest shareholders	(199)
Net cash settlement of RSU vesting
Employee taxes paid on shares withheld for tax-withholding purposes
Net cash (used in) provided by financing activities	(242,611)	3,176
Net decrease in cash and cash equivalents	(35,841)	(18,959)
Cash and cash equivalents, beginning of period	78,414	55,986
Cash and cash equivalents, end of period	42,573	37,027
Repayment of note payable		15,000
Repayment of line of credit
Repurchase of asset-backed securities issued
Repurchase of bonds payable
Purchases of shares of common stock for treasury
Consolidation, Eliminations [Member]
Cash flows from operating activities:
Net income (loss)	2,467	(10,446)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Provision for doubtful accounts
Provision for loan losses
Accretion of deferred loan fees
Amortization of liquidity discount, net
Amortization of debt issuance costs
Amortization of original issue discount, related to CLO II and CLO III
Interest paid in kind
Loss (gain) on sale and payoff of loans
Gain on repurchase of bonds payable and asset-backed securities issued
Change in other investments:
Income from investments in equity method investees
Fair value on other equity investments
Realized loss on other investments
Depreciation and amortization of fixed assets
Stock-based compensation expense
Deferred income taxes
Net change in operating assets and liabilities:
Decrease in interest receivable	(72)	135
Increase in receivables		(49)
Increase in marketable securities		485
Decrease (increase) in restricted cash (excluding restricted cash reserved for lending activities)
Decrease in deposits and other assets	(22,157)	15,918
Increase in marketable securities sold, but not yet purchased
Increase in interest payable		(66)
(Decrease) increase in accrued compensation and other liabilities	149	(1,304)
Net cash used in operating activities	(19,613)	4,673
Cash flows from investing activities:
Purchases of fixed assets
Investment in subsidiary	(33,173)	2,496
Purchases of other investments	7,000
Sales of other investments	15,080	88
Funding of loans collateralizing asset-backed securities issued
Funding of loans held for sale
Sale and payoff of loans collateralizing asset-backed securities issued
Principal receipts on loans collateralizing asset-backed securities issued
Net change in restricted cash reserved for lending activities
Cash collateral posted for total return swap
Net cash provided by (used in) investing activities	(11,093)	2,584
Cash and cash equivalents derecognized due to adoption of new consolidation guidance
Cash flows from financing activities:
Repayment of asset-backed securities issued
Distributions and distribution equivalents paid on common shares and RSUs
Capital contributions of parent	30,706	8,128
Capital contributions of nonredeemable non-controlling interest holders
Distributions to non-controlling interest shareholders
Net cash settlement of RSU vesting
Employee taxes paid on shares withheld for tax-withholding purposes
Net cash (used in) provided by financing activities	30,706	(7,257)
Net decrease in cash and cash equivalents
Cash and cash equivalents, beginning of period
Cash and cash equivalents, end of period
Repayment of note payable		(15,000)
Repayment of line of credit
Repurchase of asset-backed securities issued
Repurchase of bonds payable		(385)
Purchases of shares of common stock for treasury

Note 22 - Subsequent Events (De

Note 22 - Subsequent Events (Details Textual) - USD ($) $ / shares in Units, $ in Thousands	May 03, 2017	Apr. 19, 2017	Aug. 03, 2006	Mar. 31, 2017	Mar. 31, 2016	Apr. 05, 2017
Common Stock, Dividends, Per Share, Declared				$ 0.09	$ 0.12
Subsequent Event [Member]
Common Stock, Dividends, Per Share, Declared		$ 0.03
Revolving Credit Facility [Member] | CNB [Member] | JMP Securities [Member]
Line of Credit Facility, Maximum Borrowing Capacity			$ 25,000	$ 20,000
Line of Credit Facility, Expiration Period	1 year		2 years
Revolving Credit Facility [Member] | CNB [Member] | Subsequent Event [Member]
Line of Credit Facility, Maximum Borrowing Capacity	$ 25,000					$ 200,000
Line of Credit Facility, Expiration Period	1 year
Revolving Credit Facility [Member] | CNB [Member] | Subsequent Event [Member] | JMP Securities [Member]
Line of Credit Facility, Maximum Borrowing Capacity	$ 20,000
Revolving Credit Conversion to Term Loan Portion to Be Paid in First 2 Years [Member] | CNB [Member] | JMP Securities [Member]
Line of Credit Facility, Revolving Credit Conversion to Term Loan, Repayment, Percent of Funded Debt			3.75%
Revolving Credit Conversion to Term Loan Portion to Be Paid in First 2 Years [Member] | CNB [Member] | Subsequent Event [Member]
Line of Credit Facility, Revolving Credit Conversion to Term Loan, Repayment, Percent of Funded Debt	3.75%
Revolving Credit Conversion to Term Loan Portion to Be Paid in Next 2 Years Member | CNB [Member] | JMP Securities [Member]
Line of Credit Facility, Revolving Credit Conversion to Term Loan, Repayment, Percent of Funded Debt			5.00%
Revolving Credit Conversion to Term Loan Portion to Be Paid in Next 2 Years Member | CNB [Member] | Subsequent Event [Member]
Line of Credit Facility, Revolving Credit Conversion to Term Loan, Repayment, Percent of Funded Debt	5.00%